The effects of feeding prebiotics, antibiotics, and alternative proteins during the preweaning period to dairy calves on growth, health, and the gastrointestinal microbiota by Wolfswinkel, Tricia Lee
Graduate Theses and Dissertations Iowa State University Capstones, Theses andDissertations
2016
The effects of feeding prebiotics, antibiotics, and
alternative proteins during the preweaning period
to dairy calves on growth, health, and the
gastrointestinal microbiota
Tricia Lee Wolfswinkel
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/etd
Part of the Physiology Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Wolfswinkel, Tricia Lee, "The effects of feeding prebiotics, antibiotics, and alternative proteins during the preweaning period to dairy
calves on growth, health, and the gastrointestinal microbiota" (2016). Graduate Theses and Dissertations. 15464.
https://lib.dr.iastate.edu/etd/15464
 
 
The effects of feeding prebiotics, antibiotics, and alternative proteins during the 
preweaning period to dairy calves on growth, health, and the gastrointestinal 
microbiota 
   
 
by 
 
 
Tricia Lee Wolfswinkel 
 
 
 
 
A dissertation submitted to the graduate faculty 
 
in partial fulfillment of the requirements for the degree of 
 
 DOCTOR OF PHILOSOPHY 
 
 
 
 
Major:  Animal Physiology 
 
Program of Study Committee: 
Howard D. Tyler, Major Professor 
Leo L. Timms 
Michael D. Kenealy 
Joan E. Cunnick 
Anna K. Johnson-Butters 
 
 
The student author and the program of study committee are solely responsible for the 
content of this dissertation. The Graduate College will ensure this dissertation is globally 
accessible and will not permit alterations after a degree is conferred. 
 
 
 
Iowa State University 
 
Ames, Iowa 
 
2017 
 
Copyright © Tricia Lee Wolfswinkel, 2017.  All rights reserved. 
ii 
 
TABLE OF CONTENTS 
LIST OF TABLES v 
LIST OF FIGURES vi 
CHAPTER 1.  GENERAL INTRODUCTION 1 
 Thesis Organization 1 
CHAPTER 2. LITERATURE REVIEW 2 
Introduction 2 
Commensal Microbiota and Their Interactions with the Host 3 
Microbes and Antibiotics 24 
Prebiotic Supplements 39 
Non-Digestible Oligosaccharides 39 
Short-Chain Fatty Acids 53 
Phytonutrients and Herbal Extracts 56 
Mixtures of Prebiotics 59 
Probiotic Supplements 63 
Summary 67 
 References 68 
CHAPTER 3.  THE EFFECTS OF FEEDING THREE DIFFERENT 
PREBIOTIC ADDITIVES IN MILK DIETS ON GROWTH AND 
PERFORMANCE OF DAIRY CALVES 126 
            Interpretive Summary 126 
            Abstract 127 
iii 
 
            Introduction 128 
 Materials and Methods 130 
  Animals and Housing 130 
                        Feeding Regime 131 
  Dietary Treatments 132 
  Passive Immunity 133 
Morbidity and Mortality 133 
Cell Population Counts 133 
  Mitogen Proliferation 134 
                        Statistical Analysis 135 
            Results 136 
Weight Gain 136 
  Mitogen Proliferation 136 
  Morbidity 139 
  Mortality 140 
 Discussion and Conclusion 140 
 References 146 
CHAPTER 4.  THE EFFECTS OF FEEDING MILK REPLACER WITH AND 
WITHOUT ALTERNATIVE PROTEINS AND ANTIBIOTICS ON 
GROWTH, HEALTH, AND THE MICROBIOTA OF DAIRY CALVES 159 
            Interpretive Summary 159 
            Abstract 160 
iv 
 
            Introduction 161 
 Materials and Methods 163 
  Animals and Housing 163 
  Dietary Treatments 163 
  Milk Replacer Treatments 164 
Passive Immunity 165 
                        Measurements 165 
  Fecal Microbiota Samples 165 
                        Extraction and Amplification of Bacterial DNA 166 
                        Sequence Analysis 168 
                        Statistical Analysis 168 
            Results 169 
                        Passive Immunity 169 
Weight Gain 170 
  Fecal Scores 170 
  Morbidity and Mortality 170 
                       Bacterial Community Diversity 170 
 Discussion and Conclusion 173 
 References 177 
CHAPTER 5. GENERAL CONCLUSIONS 194 
CHAPTER 6. ACKNOWLEDGEMENTS 195 
  
 
v 
 
LIST OF TABLES 
 
  
Table 3.1         Mean total serum protein levels by treatment group and for  
                        calves that died versus those that survived 151 
  
Table 3.2         Mean weight gains in kilograms by treatment group 151 
  
Table 3.3         Mean mitogen proliferation assay counts data by treatment group 152 
  
Table 3.4 Mean morbidity numbers by treatment group 153 
  
Table 3.5         Mean mortality numbers by treatment group 153 
  
Table 4.1 Mean initial total serum protein levels of calves by dietary   
                        treatment group 183 
  
Table 4.2 Mean fecal scores per week by dietary treatment group 183 
  
Table 4.3         Number of calves treated with antibiotics for scours and   
                        pneumonia during the study by dietary treatment group 184 
  
Table 4.4         Mean abundance of bacteria percentages from combined data  
                        from the 2 sample periods by phylum and genus by dietary  
                        treatment group  185 
  
Table 4.5         Mean abundance of bacteria percentages by phylum and        
                        genus by dietary treatment group per sampling period 186 
  
  
  
  
vi 
 
LIST OF FIGURES 
 
Figure 3.1        Mean weekly weights in kilograms of calves by treatment  
                        group  154 
  
Figure 3.2        Mean mitogen proliferation counts for T-lymphocytes by   
                        treatment group and by sampling period 155 
  
Figure 3.3       Mean mitogen proliferation counts for B-lymphocytes with   
                        and without corticosterone to simulate stress and percent   
                        difference demonstrating the difference of suboptimal   
                        B-lymphocyte stimulation with and without stress simulated  
                        by treatment group and sampling period 156 
  
Figure 3.4  Mean morbidity numbers by total number of calves given   
                        medical treatments by treatment and by time period 157 
  
Figure 3.5 Mean morbidity numbers by the infection or disease that the   
                        calves were given medical treatments for by treatment group 158 
  
Figure 4.1       Mean weights in kilograms of calves by dietary treatment  187 
                        group at d 1, d 42, and total weight gains  
  
Figure 4.2 A stacked bar graph showing the overall abundance of phyla  188 
                        between individual samples that are clustered by dietary  
                        treatment group and by sampling period  
  
Figure 4.3 A stacked bar graph showing the overall abundance of genus  
                        between individual samples that are clustered by treatment  
                        and by sampling period 189 
  
Figure 4.4 PCoA plot visualizing the variation among samples between  
                        dietary treatment groups  190 
  
Figure 4.5 PCoA plot visualizing the variation among samples between   
                        sample periods 191 
  
Figure 4.6 NMDS plot visualizing the similarities among bacterial   
                        communities between dietary treatment groups 192 
  
Figure 4.7 NMDS plot visualizing the similarities among bacterial  
                        communities between sampling periods 193 
  
1 
 
CHAPTER 1 
GENERAL INTRODUCTION 
Thesis Organization 
 The following thesis is organized into 6 chapters.  Chapter 1 is a general introduction 
into the organization of the thesis. Chapter 2 is literature review summarizing previous 
research on the interactions between the commensal microbes and the host they inhabit, how 
antibiotics can create dysbiosis in the commensal microbe population and lead to antibiotic 
resistance, an overview of prebiotics and how they positively impact the host microbiome, an 
overview of prebiotic supplements, and finally an overview of probiotic supplements.  
Chapter 3 is a summary of research conducted to evaluate the effects of three different 
prebiotic additives in milk replacer for dairy calves and how they impact growth, health, and 
immune function during the first 130 d of life in the calf.  Chapter 4 is a summary of research 
conducted looking at how antibiotics and non-milk proteins in milk replacer effect the 
growth, health, and gastrointestinal microbial populations in the preweaned calf.  Chapter 5 
presents general conclusions about the two research studies conducted.  Finally, chapter 6 
contains acknowledgements. 
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CHAPTER 2 
LITERATURE REVIEW 
Introduction 
 Maintaining a healthy microbiota in calves leads to less immune disturbances as well 
as increases feed efficiency for optimal growth and production.  Form of calf delivery, events 
during and after birth such as hypoxia, hygiene of the environment, preweaning diet, 
vaccination, and use of antibiotics, may alter the commensal microbe population, the 
outcome of immune development, and potentially effect production and health of calves 
(Palmer et al., 2007, Hill and Artis, 2010).  Although antibiotics decrease populations of 
beneficial bacteria, and in particular bacteria that produce butyrate for the host energy 
metabolism (Ubeda et al., 2010, Dethlefsen and Relman, 2011), they have been commonly 
fed to livestock at subtherapeutic levels due to the growth promotion and disease prevention 
that has been associated with their supplementation, leading to reductions in morbidity and 
mortality (Morrill et al., 1977, Braidwood and Henry, 1990, Berge et al., 2005, Wileman et 
al., 2009).   
Prebiotics, or non-digestible feed ingredients, have been proposed as feed additives 
that could accomplish the benefits associated with antibiotics without concerns regarding 
withdrawal times or the potential for resistance development from pathogenic organisms.  
Prebiotics help maintain a healthy commensal microbial population in the gastrointestinal 
tract.  Prebiotics have been widely accepted as gut microbiota stabilizers because they help 
inhibit pathogenic colonization, while selectively stimulating the growth of bacteria that are 
capable of health-promoting functions, such as bifidobacteria or lactobacilli (May et al., 
1994, Gibson et al., 2005, Brunser et al., 2006, Sharon, 2006, Baurhoo et al., 2007).  The use 
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of these antibiotic alternatives ultimately results in effective and efficient immune responses 
by creating a more optimal gut environment for ingestion and digestion, providing a suitable 
pH, and better availability of items necessary for the immune system to function properly 
(Roberfroid, 1998). 
Nutritional status, good management, and overall health may outweigh the benefits 
associated with subtherapeutic feeding of antibiotics since the benefits of medicated milk 
replacer have not been observed in young calves fed a higher level of nutrition than 
conventional feeding practices (Witte, 1998, Thames et al., 2012).  Exactly which dietary 
changes significantly affect the commensal microbe populations is not known, but recently it 
has become a quickly growing area of interest to study.  There is a very complex relationship 
between diet, intestinal microbiota, their metabolites, and the host immune system, and the 
intrinsic immunomodulation induced by different ingredients in the diet that needs to be 
better understood (Franklin et al., 1998, Vos et al., 2007b, Moschen et al., 2012).   
Commensal Microbiota and Their Interactions with the Host 
In utero, during and/or after birth, the mammals researched thus far undergo 
colonization by microorganisms that inhabit most environmentally exposed surfaces.  The 
vast numbers and diversity of microbiota in each mammalian species are similar to the 
microbiotas of other mammals at the phylum level, but they are very distinct at the species 
and strain levels (Dethlefsen et al., 2007).  Lactobacilli and bifidobacteria are both well-
known commensal microbial species present in the intestinal tract of mammals, and they are 
very important in maintaining homeostasis of the gastrointestinal microbiota (Sandine, 1979, 
Stephenson et al., 2010).  Lactobacilli are generally found in the small intestine, whereas 
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bifidobacteria colonize the colon most likely due to differences in adaptability to anaerobic 
conditions (Wang et al., 2012).  The gastrointestinal tract is one of the largest interfaces that 
microbiota, both symbiotic and pathogenic, interact with the external environment and the 
host (Round and Mazmanian, 2009).  The microbiota of the intestinal tract varies by both 
species and density in different parts of the gastrointestinal tract, and for each specific area of 
the intestinal tract there is a different symbiotic relationship between the microbes and the 
host (Lavker and Matoltsy, 1970, Steele et al., 2016).   
The gastrointestinal epithelium of the mammal is critical in protecting the host from 
the contents of the luminal milieu while controlling the absorption and metabolism of 
nutrients.  The epithelial lining of the intestinal tract serves as a barrier between the 
lymphatic and portal circulation and the luminal from the mixture of microorganisms, toxins, 
and chemicals (Gabel et al., 2002, Steele et al., 2016).  The microorganisms of the 
mammalian gut have evolved to aid the gastrointestinal epithelium, as well as to provide 
benefits to the host through biochemical and metabolic pathways not found in the host 
genome: provision and absorption of essential nutrients (Hooper and Gordon, 2001, Candela 
et al., 2010, Delzenne and Cani, 2011), metabolism of non-digestible feeds and 
carbohydrates produced by other microbes (Hooper and Gordon, 2001, Korakli et al., 2002, 
Brisbin et al., 2008, Hoffmann et al., 2009), providing energy sources for the intestinal 
epithelium microbes (Hooper and Gordon, 2001), protection against colonization by 
opportunistic pathogenic organisms (Asahara et al., 2001, Round and Mazmanian, 2009), 
production of bacterocins and antimicrobial peptides, contributions to the development of the 
intestinal tissues, repair of and protection against epithelial damage (Rakoff-Nahoum et al., 
2004, Guarner, 2006, Brisbin et al., 2008, Hoffmann et al., 2009, Gallo and Hooper, 2012, 
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Hooper et al., 2012, Belkaid and Hand, 2014), providing a protective biofilm, promoting 
development and maintenance of a healthy immune system, and regulating innate immune 
responses to protect the gastrointestinal environment (Macpherson and Harris, 2004, 
Backhed et al., 2005, Gallo and Hooper, 2012, Goto and Kiyono, 2012,).  Microbes 
contribute to the energy balance and nutrition of the host by regulation of fat storage, 
increasing host glucose and polysaccharide uptake and stimulating hepatic lipogenesis, and 
biosynthesis of essential vitamins (Backhed et al., 2004, Candela et al., 2010, Sekirov et al., 
2010).  When pathogens attach to the epithelial lining of the gastrointestinal tract, the 
integrity and function of the intestinal lining is changed and causes the renewal of the 
epithelial lining and increases the amount of dietary energy spent on gut maintenance 
(Gaskins, 1998). 
Nutrients consumed by mammals provide not only metabolic substrates, but they can 
also serve as signals that are able to alter gastrointestinal growth and barrier function (Steele 
et al., 2016).  The gut microbiota enhance the energy yield of the host by processing 
indigestible dietary polysaccharides to short-chain fatty acids.  Short-chain fatty acids, such 
as butyrate, acetate, propionate, lactic acid, ethanol, and formic acid, constitute an important 
energy source for intestinal epithelium and provide from 5 to 15% of the total energy 
requirement (Neish, 2009).  The energy supplied by the short-chain fatty acids fuels basic 
metabolic requirements in the animal, can be used for growth of the gastrointestinal tract, and 
is utilized by bifidobacteria and lactobacilli for metabolic requirements (Bergman, 1990).  
The gastrointestinal tract utilizes 20% of the oxygen in the whole mammal and accounts for 
30% of metabolic and protein synthesis activities (Cant et al., 1996, Steele et al., 2016).  In 
the growing animal, there is a point at which the consumption of more metabolizable energy 
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by the intestine to improve nutrient digestion and absorption capacity can become 
detrimental to the energy utilization and growth of the animal (Cant et al., 1996).   
In addition to being energy sources, short-chain fatty acids also mediate 
communication between the microbiota and the intestinal epithelial cells (Kabat et al., 2014).  
Short-chain fatty acids and antimicrobial compounds produced by commensal bacteria help 
maintain homeostasis (Kabat et al., 2014), enhance gastrointestinal immunity (Corthesy et 
al., 2007, Hamer et al., 2008), improve barrier integrity (Vernia et al., 1988, Fukuda et al., 
2011), reduce inflammation (Kalina et al., 2002), and decrease pH to further help inhibit 
pathogenic growth (Paul and Hirshfield, 2003, Smulders et al., 2007, Mani-López et al., 
2012).  Microbiota-derived short-chain fatty acids help protect intestinal epithelial cells 
during and following a pathogenic infection (Kabat et al., 2014).  Short-chain fatty acids are 
able to penetrate the microbial cell and hinder metabolic functions of pathogenic organisms 
(Smulders et al., 2007) or release cellular contents via permeabilization (Alakomi et al., 
2000).  Fatty acids are inactive against the species that produced them (Huang et al., 2011), 
which ensures the commensal microbes are protected from this function of short-chain fatty 
acids. 
Commensal metabolites activate several pathways that control the adaptive immunity 
of the host by stimulating IgA secretion and regulating the balance between effector T-helper 
and cytokine cells and the regulatory T cells, as well as promoting homeostasis of the 
intestinal epithelial cells (Kabat et al., 2014).  Intestinal epithelial cells form a single cell 
barrier layer on the surface of the intestinal mucosa and their interactions with intestinal 
microbiota influence the immune response, immune tissue development, and affect the 
maintenance of homeostasis (Goto and Kiyono, 2012, Kabat et al., 2014).  Intestinal 
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epithelial cells are important in many immunological functions: secretion and response to 
various cytokines and expression of molecules that directly interact with lymphocytes, 
expression and localization of pattern-recognition receptors by the epithelium (Round and 
Mazmanian, 2009), and they influence recruitment, activation, and differentiation of immune 
cells by secretion of modulatory factors in response to commensal microbiota (Hill and Artis, 
2010).  The cascade of events resulting from cytokines includes increased metabolic rates, 
decreased appetites, decreased production, and the directing of nutrients away from growth to 
fuel the immune response (Williams et al., 1997, Sauber et al., 1999). 
Many dysfunctional immune responses and instances of disease are associated with 
shifts in the microbe populations resulting in lower production of important metabolites.  In 
humans, patients with IBD have lower populations of butyrate-producing microbes (Frank et 
al., 2007, Willing et al., 2010).  Out of all the metabolites produced by the microbiota, 
butyrate most effectively protects the intestinal mucosal lining and promotes healing of that 
lining (Roediger, 1980, Vernia et al., 1988, Breuer et al., 1991, Scheppach et al., 1992) and 
helps to promote changes in the gastrointestinal tract to handle the increasing levels of 
metabolites (Backhed et al., 2004).  The intestinal microbiota favor the renewal and barrier 
function of the gastrointestinal epithelium, and help to enhance the epithelial cell turnover 
and reduce permeability of the epithelium (Neish, 2009).  Lactic acid producing bacteria are 
also important in the microbiome due to their ability to modulate the immune system of the 
host by their production of bacteriocins and other antimicrobial compounds (Cintas et al., 
2001).  Altered intestinal microbiota is also linked to other disorders, such as obesity, 
autoimmune diseases, allergenic responses, eczema and rheumatoid arthritis (Kalliomaki and 
Isolauri, 2002, 2003, Turnbaugh et al., 2006).   
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By the time a mammal is mature, they host an extremely complex microbial 
ecosystem with over 100 trillion bacteria, encompassing thousands of microbial species in 
the gut in a mutualistic relationship (Hooper, 2004, Gill et al., 2006, Mazmanian and Kasper, 
2006, Frank and Pace, 2008, Ley et al., 2008, Peterson et al., 2008).  Over time, microbial 
populations within the gut of the host have evolved and adapted to the host’s environment 
and aided the host in surviving particular epidemics.  Evolutionary selection against hosts 
that lack certain bacterial species may have helped ensure the survival and enrichment of the 
beneficial host-specific bacteria (Round and Mazmanian, 2009, Chung et al., 2012).  
Zaneveld et al. (2008) proposed that the mammalian genome does not encode the information 
(i.e., molecules) capable of carrying out all functions required for health, and that products of 
our microbiome (the collective genomes of the microbiota) are crucial for protection from 
various diseases.  The symbiotic nature of the host/microbiota relationship is further 
demonstrated by how the host employs many mechanisms to maintain the microbiota 
population, including production of antimicrobial factors and immunosuppressive cytokines 
and selective differentiation of specialized immune cells (Hooper et al., 2012, Belkaid and 
Hand, 2014). 
Establishment of the early foundation for a mature and diverse intestinal microbiota 
stimulates immune maturation, helps reduce the incidence of infections by pathogenic 
organisms, creates competition for oxygen and nutrients, protects the host from injury, 
shapes the proper structuring of inductive and effector sites of the host gastrointestinal 
immune system, and improves gut barrier function, which together results in improved feed 
efficiency, immune function, and animal welfare (Hardin, 1960, Nurmi and Rantala, 1973, 
Gleeson et al., 1989, Rakoff-Nahoum et al., 2004, Brunser et al., 2006, Gabriel et al., 2006, 
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Duan et al., 2010, Garrett et al., 2010, Crhanova et al., 2011, Lawley and Walker, 2013, 
Arrieta et al., 2014, Steele et al., 2016).  Healthy competition among microorganisms in a 
mature and diversified microbiota lead to better growth and fewer health issues (Munyaka et 
al., 2014).  Distinct members of the commensal microbiota may engage specific components 
of the immune system and in such a way participate in the regulation of intestinal immune 
homeostasis (Macpherson and Harris, 2004, Rakoff-Nahoum et al., 2004, Backhed et al., 
2005).  The commensal bacteria that first colonize in the lining of the intestines ensure that 
any other microorganisms in search of a new residence must compete for space and nutrients 
in order to survive and colonize the host (Hardin, 1960, Gabriel et al., 2006, Lawley and 
Walker, 2013).  Establishing a stable microbiota is also important because changes in gut 
microbe populations have been associated with altered epithelial permeability, which impacts 
host metabolism and gastrointestinal growth (Wei et al., 2012).   
Constant monitoring by the immune system in the gastrointestinal tract for the 
presence of pathogens, while tolerating the trillions of commensal microbiota, is a very 
specialized immune function in the gut and is central to the process of health and disease, as 
well as the rapid response towards harmful pathogens (Candela et al., 2010, Kabat et al., 
2014).  Balance between inflammation and regulation in the gut may be due to the 
community structure of the microbiota, and thus commensal microbes may be directly 
mediating health (Round and Mazmanian, 2009).  The mechanisms by which the intestinal 
microbiota beneficially modulate the immune system and maintain homeostasis in the gut are 
not fully understood.  There are several microbiota derivatives that influence the immune 
system in the host by targeting various cell types: intestinal epithelial cells, mononuclear 
phagocytes, innate lymphoid cells, and B- and T-lymphocytes (Kabat et al., 2014).  Round 
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and Mazmanian (2009) suggested that molecular interactions direct the development of 
immune responses, and in turn, the immune system shapes the composition of the microbiota.   
Dysbiosis, or alterations in the composition and/or development of the “normal” 
microbiota, may disturb the interactions between the development of the immune system and 
microbiota, which could lead to altered immune responses and effect overall health of the 
host (Round and Mazmanian, 2009, Atarashi et al., 2011, Kostic et al., 2014).  Dysbiosis can 
also occur from an overgrowth of commensal bacteria.  Overgrowth of commensal bacteria 
can have negative impacts on the host due to excessive uptake of nutrients by the microbes, 
thus making them unavailable for the host (Zaidel and Lin, 2003).  Overgrowth of specific 
species of microbes can also result in dysbiosis because not all commensal microbes are 
beneficial.  Some intestinal microbes can facilitate infection when they interact with other 
pathogenic viruses and parasites (Kabat et al., 2014).   
Dysbiosis causes mammals to develop IgG responses to commensal antigens and 
commensal-specific antibody responses that are entirely restricted to IgA (Macpherson et al., 
2000, Slack et al., 2009, Harmsen et al., 2012).  Dysbiosis results in dysregulated immune 
responses that underlie the development of intestinal inflammation (Strober, 2006, Round 
and Mazmanian, 2009, Neurath, 2014).  Dysboisis and immunologic dysregulation is the 
underlying cause of many non-infectious diseases (Round and Mazmanian, 2009).  Lack of 
systemic antibody responses against the microbiota is an indication that dysbiosis is not 
occurring and also an indication of a well-maintained microbiota population (Lochner et al., 
2011). 
The gastrointestinal microbiota have a wide range of effects on the development and 
responsiveness of not only the local immune system, but also the systemic immune system 
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and are a critical component in the proper development and function of the immune system 
(Wen et al., 2008, Round and Mazmanian, 2009, Wu et al., 2010, Kabat et al., 2014, Steele et 
al., 2016).  Altered gut microbiota are associated with allergenic disorders in and out of the 
gastrointestinal tract (Penders et al., 2007b).  Extravasation of the immune cells in other 
mucosal sites such as respiratory tissues, urogenital tissues, and mammary and salivary 
glands is known as the IgA cycle (Philips-Quagliata and Lamm, 1988).  The concept of the 
IgA cycle suggests that oral immune stimulation induces immune responses and distribution 
of IgA to other mucosal sites apart from the gut (Mestecky, 1987).  The IgA cycle may result 
from the increased mobilization of IgA+ cells from the mesenteric lymph node (Weiner, 
1997).  Oral immune stimulation has advantages over systemic immune stimulation by better 
priming the immune system to properly and efficiently respond to pathogens (Mestecky, 
1987).   
The cross-talk between the intestinal microbes and the gastrointestinal tract is crucial 
for proper development and homeostasis of the immune system in the intestines (Sansonetti 
and Medzhitov, 2009, Quigley, 2010).  Certain beneficial bacteria have evolved molecules 
(known as symbiosis factors) that induce protective intestinal immune responses and 
maintain gut homeostasis by protecting the host from damaging inflammatory responses 
(Mazmanian et al., 2008, Round and Mazmanian, 2009).  The ability of the commensal 
microbiota to exert both pro- and anti-inflammatory responses and the balances in the 
community structure of gut bacteria may be intimately linked to the proper function of the 
immune system (Round and Mazmanian, 2009, Klaenhammer et al., 2012).  While 
pathogenic organisms elicit immune responses that result in tissue damage during infection, 
commensal bacteria prevent inflammatory responses during colonization; however, under 
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specific conditions, the gut microbiota are able to induce inflammation (Round and 
Mazmanian, 2009).  Different classes or species of bacteria may induce diverse 
immunological functions (Round and Mazmanian, 2009). 
There are several key events in the neonatal period that shape the composition of the 
microbiota long-term and affect production and health status: gestation, birth, preweaning 
nutrition and management, and the timing and type of weaning (Steele et al., 2016).  
Transmission of microbiota from the dam to the neonate is essential to ensure the proper 
health and development in neonates (Penders et al., 2007a, Kabat et al., 2014).  Bacteria from 
the maternal gastrointestinal tract have been found in the umbilical cord blood, amniotic 
fluid, meconium, and placental and fetal membranes of the offspring from research 
conducted in humans and mice (Jimenez et al., 2005).   
During the neonatal period, the microbiota of the newborn is highly variable and goes 
through numerous changes to establish a stable population of microbes (Palmer et al., 2007).  
Simultaneously to the changes toward a stable microbiota, the immune system is developing 
in the young mammal.  Commensal gut microbes influence the development and 
functionality of the immune system (Macpherson and Harris, 2004).  Host health, 
gastrointestinal inflammation, age, gender, and environmental factors, such as geographical 
location, ethnicity, and diet, all can impact the intestinal microbiota in terms of bacterial 
groups represented and their relative abundance throughout a mammal’s life (Zoetendal et 
al., 2008, Hill and Artis, 2010, Hallam et al., 2014).  The form of delivery and events during 
and after birth such as hypoxia, hygiene of the environment, pre-weaning diet, vaccination, 
and use of antibiotics, also may alter the outcome of immune development and potentially 
effect production and health (Palmer et al., 2007, Hill and Artis, 2010). 
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Research conducted using germ-free animals demonstrates the necessity of the 
commensal gut microbiota in the proper development and functioning of the gut-associated 
lymphoid tissues, as well as the maturation and proper function of the immune system, 
nutrient absorption, and resistance to pathogenic infection (Falk et al., 1998, Macpherson and 
Harris, 2004, Bouskra et al., 2008, Round and Mazmanian, 2009, Hill and Artis, 2010, Berer 
et al., 2011, Lee et al., 2011, Chinen and Rudensky, 2012, Chung et al., 2012).  Germ-free 
animals have smaller Peyer’s patches, fewer plasma cells, fewer intraepithelial lymphocytes, 
impaired antimicrobial peptide and IgA secretion, defects in antibody production, and other 
immunologic deficiencies (Round and Mazmanian, 2009).  Research using germ-free animals 
also shows that the microbiota’s functions are species-specific, so colonization with microbes 
from a different species leads to reduced immune functions in the gut and altered pathogen 
adhesion (Heczko et al., 2000, Chung et al., 2012).  All of these functional defects observed 
in the germ-free animals can be reversed with the recolonization of a normal microbiota 
(Round and Mazmanian, 2009, Berer et al., 2011, Chinen and Rudensky, 2012).  The 
difference in host responses to microbiota that are from the same species as the host versus 
another microbiota from a different species could be due to multiple factors: host-specific 
bacterial species being able to induce a cytokine or chemokine that leads to the activation and 
recruitment of antigen-presenting cells that lead to T cell proliferation; host-specific bacterial 
species may be more efficient at penetrating the mucus layer or evading certain antimicrobial 
peptides; or host-specific microbiotas may regulate epithelial sensitivity in recognizing 
microbe-associated molecular patterns (MAMPs) through pattern recognition receptors when 
microbiotas from other species cannot (Chung et al., 2012).   
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The fetus’ gastrointestinal tract undergoes significant in utero development and much 
of the structural and functional capacities have been determined before birth through 
maternal and epigenetic factors (Warner et al., 1956).  Dams influence immunity in their 
offspring through the provision of antibodies both through the acquisition in utero and via 
colostrum and milk (Niewiesk, 2014).  The calf is inoculated with microbes from the dam 
during birth through the vaginal canal, maternal fecal matter, skin, and saliva (Steele et al., 
2016).  Maternal dendritic cells in Peyer’s patches may initiate bacterial uptake from the 
dams gastrointestinal tract into the placenta and milk to be transferred to the fetus (Thum et 
al., 2012, Aagaard et al., 2014).  It is very possible that maternal nutrition is a key factor in 
determining gastrointestinal structure and architecture, as well as the microbiota of their 
offspring (Fujiwara et al., 2008, Hallam et al., 2014, Steele et al., 2016).   
Milk is the primary source of nutrition for newborn mammals during a period of 
intense growth and development, but it also contains a plethora of commensal microbes, non-
digestible carbohydrates like oligosaccharides, antibodies, bioactive proteins, epithelial 
mucins, antimicrobial proteins, and other factors that help compensate for the immature 
intestinal immune system of the neonate (Patton et al., 1995, Peterson et al., 1998, Harmsen 
et al., 2000, Wold and Adlerberth, 2000, Sando et al., 2009, Koch et al., 2016).  Maternal 
antibodies may educate the neonatal immune system on newly acquired commensal species, 
thereby facilitating appropriate effector T cell responses to the microbiota during early life 
(Koch et al., 2016).  Additionally, consumption by the neonate of TGF-β and IL-10 from the 
dam’s milk aids in tolerogenic responses to commensal microbes and helps to inhibit 
translocation of bacteria (Garofalo et al., 1995). 
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Diet is one of the main factors that can change the diversity of gut microbial 
community (Brunser et al., 2006, Ley et al., 2008, De Filippo et al., 2010, Ochman et al., 
2010, Maslowski and Mackay, 2011).  Colostrum and milk from the dam is a primary source 
of anti-commensal IgG antibodies early in life and this anti-commensal IgG helps dampen 
the T helper cell driven immune responses to the newly acquired microbiota (Koch et al., 
2016).  Milk and colostrum from the dam also contain TGF-β and IL-10 which limit bacterial 
translocation and promote tolerogenic responses to the microbiota (Letterio et al., 1994).  
Systemic anti-commensal IgG antibodies creates immunity to the microbiota because IgG 
binds a significant portion of the microbiota to ensure tolerance towards the microbes is 
established (Koch et al., 2016).  Ingestion of IgA can mediate passive immunity to enteric 
infections (Lamm, 1997), aid in the broad recognition of microbes that colonize the intestines 
and preserve the intestinal barrier (Koch et al., 2016), and also reinforce the appropriate anti-
commensal immune responses (Macpherson et al., 2008).  Maternal IgA is not critical for 
initial regulation of the gut T helper cell responses, but maternal transmission of IgG does 
coordinate with IgA to limit mucosal T cell responses in a dual recognition, cooperative 
manner (Koch et al., 2016).  In most mammals, maternal antibodies acquired from the dam’s 
milk and colostrum, rather than in utero, are necessary and sufficient to prevent mucosal T 
cell responses and ensure rapid, non-inflammatory clearance of the microbes (Koch et al., 
2016). 
The exchange of microbiota between the dam and the calf is necessary to establish a 
balanced microbiota, although it is not known whether the quick removal from the calf from 
the dam after birth affects the gastrointestinal physiology, growth of the calf, or the calf’s 
health during the early stages of life (Jost et al., 2012, Steele et al., 2016).  However, 
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colostrum does have significant effects on all of these parameters by providing the calf with 
nutrition and bioactive components.   
Failure to thrive in calves without colostrum could be attributed to more than just 
failure to achieve passive immunity, but also to a dysregulated immunity to commensal 
antigens due to the absence of maternal antibodies and other non-nutritional factors contained 
in the colostrum (Smith and Little, 1922, Koch et al., 2016).  This demonstrates a possible 
broader function of IgG in establishing a well-functioning immune system in the calf.  
Maternal IgG helps to deliver microbial molecules to offspring by inducing tolerance of the 
microbes within the calf, which increases the number of intestinal innate lymphoid cells and 
reinforces barrier integrity (Gomez de Aguero et al., 2016).  Additionally, it is speculated that 
the exposure of the calf to specific bacteria (Lactobacillus) could be a possible mechanism to 
control cell junctions and gut closure (Steele et al., 2016).  The bioactive components in 
colostrum and milk play a key role in establishing microbiota balance and gut growth in the 
first days and weeks of a calf’s life (Malmuthuge et al., 2015).  Secretory IgA, immune cells, 
lactoferrin, oligosaccharides, and lysozyme, which hinder pathogen proliferation, are all 
found as bioactive components in milk and colostrum (Mountzouris et al., 2002, Mills et al., 
2011).   
Colostrum contains a large number of growth factors, including IGF-I, IGF-II, 
insulin, and epidermal growth factor.  These growth factors directly affect gut growth 
signaling pathways and epithelial cell proliferation (Roffler et al., 2003, Zitnan et al., 2005).  
Colostrum also contains microbes from the dam that also affect gut growth signaling 
pathways.  Pasteurization of colostrum changes the oligosaccharides in colostrum that 
specifically supported Bifidobacterium growth, resulting in no viable Bifidobacterium in the 
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colostrum (Malmuthuge et al., 2015).  In fact, fresh colostrum in the study by Malmuthuge et 
al. (2015) not only contained higher levels of Bifidobacterium, but there was less Escherichia 
coli in the ileum and colon of calves during the first 12 and 24 h of life that received 
unpasteurized colostrum.   
There are significant differences in the microbiota diversity of calves fed milk 
replacer instead of milk from the dam, in calves fed medicated feed, and in calves fed starter 
grain, in comparison to those not fed starter (Dethlefsen and Relman, 2011, Malmuthuge et 
al., 2013).  Changes in the bacterial diversity, expression of genes encoding host mucosal 
immune responses, and barrier functions can be altered by changes in the diet (Malmuthuge 
et al., 2013).  Antibiotics decrease populations of beneficial bacteria, and in particular, 
bacteria that produce butyrate for the host energy metabolism (Ubeda et al., 2010, Dethlefsen 
and Relman, 2011).  Solid feed consumption during preweaning is associated with increases 
in bacterial diversity and richness, especially in the rumen, and increases in volatile fatty acid 
concentrations (Laarman et al., 2012, Malmuthuge et al., 2013).  This enhancement in 
bacterial diversity and activity in the rumen may aid in the development of the rumen during 
weaning (Malmuthuge et al., 2013).  The addition of starter to preweaned diets tends to 
change gut bacterial richness, which eventually alter mucosal immune functions, gut barrier 
functions, gut maturation, early weaning, and better postweaning performances (Malmuthuge 
et al., 2013).  Starter consumption has been proposed to actually increase gut permeability 
and allow more bacterial products to breach the mucosal barrier, thus stimulating the 
expression of host pattern recognition receptors and further gut maturation and mucosal 
immune development (Malmuthuge et al., 2013).   
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During preweaning and weaning, significant changes occur within the gastrointestinal 
tract and in the microbiota population to help accommodate the calf’s shift from a liquid 
based diet to a forage based diet (Malmuthuge et al., 2013, Laukens et al., 2016).  Significant 
morphological changes occur to the gastrointestinal tract such as hyperplasia and reduction in 
depth of crypts and reduction in villus height (Kuzmuk et al., 2005, Gancarcikova et al., 
2009).  Morphological changes during weaning are impacted by dietary ingredients and are 
associated with gut microbial composition (Gancarcikova et al., 2009).  Changes in the 
gastrointestinal microbiota and stress to the calf associated with weaning are linked with 
increased expression of inflammatory cytokines, compromised ruminal and intestinal barrier 
function, and increased instances of enteric disruptions and diseases (Deplancke et al., 2002, 
Pie et al., 2004, Miclard et al., 2009, Steele et al., 2016).  Temporary decreased feed intakes 
are also associated with weaning.  Low feed intakes can compromise the gastrointestinal 
barrier function (Zhang et al., 2013).  Morphological and functional changes within the 
gastrointestinal tract during weaning are altered depending on the composition of the gut 
bacterial composition (Gancarcikova et al., 2009), thus it is important for a proper gut 
microflora to support these changes properly.   
The structure of the gastrointestinal tract and the changes throughout the different 
sections of the intestines are very important in the interactions between the host and 
microbiota.  Different species of microbes reside in very distinct regions along the intestines 
due to these structural changes and specific interactions with the host (Eckburg et al., 2005, 
Hill and Artis, 2010).  The cells of the lower gut encompass absorptive epithelial cells, 
mucus-secreting cells (goblet cells), immune cells (Peyer’s patches, Paneth cells, dendritic 
cells, and lymphocytes), and enteroendocrine cells (Peterson and Artis, 2014).  These 
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specialized cells carry out essential processes such as secretion of protective substances like 
mucus and antimicrobial peptides into the lumen, secretion of enzymes into the lumen, 
facilitation of nutrient absorption, and secretion of hormones (Peterson and Artis, 2014).  The 
gastrointestinal epithelium is continuously sensing the luminal composition to protect the 
epithelium against threats to its integrity and to enhance nutrient absorption, metabolism, and 
delivery of nutrients to other body tissues (Cant et al., 1996, Furness et al., 2013).  
Commensal microbes can act on several cell types (epithelial cells, dendritic cells and T 
cells), but the most important result of their interactions is the induction of regulatory T cells, 
which is crucial to limiting inflammation and disease (Round and Mazmanian, 2009). 
Mucus plays a critical role in calves and ruminants to maintain proper barrier function 
and house the epithelial-attached microbes (Gallo and Hooper, 2012, Steele et al., 2016).  
The mucus provides an extra layer of protection between the microbes and the host (Gallo 
and Hooper, 2012), as well as promotes tolerogenic responses of the host to the digesta and 
commensal antigens in the lumen of the intestines (Shan et al., 2013).  Disruption of the 
mucosal barrier function often induces pathological immune responses to the luminal 
contents that results in acute and chronic inflammation (Scheppach et al., 1992).  Goblet cells 
in the intestinal epithelium synthesize mucins that form the protective mucus gel covering the 
intestinal epithelium and contains antimicrobial peptides (Johansson et al., 2011).  Mucins in 
the mucosa help protect the epithelial cell surfaces from invasive pathogenic microorganisms 
by mobilization through nonspecific binding interactions with mucins, provide beneficial 
bacteria with potential binding sites, and serves as an energy source to some microbes 
(Patton et al., 1995, Dohrman et al., 1998, Forder et al., 2007, Hutsko et al., 2016).   
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Defects in the mucus layer resulting in a thinner mucus barrier allows increased 
contact of the microbiota with the intestinal epithelial cells and is associated with acute and 
chronic intestinal inflammation, pathogenic immune responses to luminal bacteria and 
microbial metabolites, and diseases such as cancer (Roediger, 1980, Breuer et al., 1991, Rath 
et al., 1996, Velcich et al., 2002, Van der Sluis et al., 2006, Fu et al., 2011).  Microbiota 
composition may also influence the structure of the mucus layer due to some commensal 
species that actually have a role in the degradation of this protective layer (Sonnenburg et al., 
2005, Koropatkin et al., 2012).   
The mucus layers are predominantly composed of mucin and other host-defense 
molecules produced by goblet cells, Paneth cells, and absorptive enterocytes (Kim and Ho, 
2010).  The submucosa lies beneath the mucosa.  It contains immune cells, such as dendritic 
cells and lymphocytes, and arterioles and venules.  The submucosal structure changes 
depending on the region of the lower gut (Steele et al., 2016).  The ileum is the site of the 
Peyer’s patches and it is the richest in immune cells, but the duodenum and colon are lined 
with mucous producing cells (Kim and Ho, 2010, Steele et al., 2016).  The villi length and 
crypt depth decrease from the duodenum to the colon because the majority of nutrient 
absorption occurs in the proximal small intestine (Turk, 1982).  The colon has the greatest 
microbial density and diversity (Kim and Ho, 2010).  The colon has a mucus layer that is 
divided into two zones as well. The inner, dense layer of mucus is firmly attached to the 
apical surface of the intestinal epithelial cells that is usually sterile and the second layer is a 
loose outer layer that provides a niche for certain commensals (Johansson et al., 2011).   
Innate lymphoid cells also reside in mucosal tissues and are descended from the 
lineage of innate leukocytes that display lymphoid morphology but lack specific antigen 
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receptors like T-cells and B-cells and are phenotypically different from myeloid cells (Spits 
et al., 2013).  Innate lymphoid cells have been found to aid in the tolerance of CD4+ T cells 
towards commensal microbes (Hepworth et al., 2013).  Certain innate lymphoid cells have 
important roles in the containment and dissemination of commensal microbes and in 
protective immune responses towards pathogens (Sonnenberg et al., 2012).  Chronic 
activation of innate lymphoid cells can cause intestinal inflammation (Buonocore et al., 
2010), which can cause dysbiosis in the gastrointestinal tract.   
Commensal microbes have the ability to regulate the innate lymphoid cells and 
intestinal mononuclear macrophages as well via the metabolites they produce (Kabat et al., 
2014), further supporting the symbiotic nature of the host-commensal microbe relationship.  
When the microbiota send out signals indicating distress, such as cytokines, the signals are 
rapidly sensed by intestinal epithelial cells and intestinal mononuclear macrophages, which 
triggers the innate lymphoid cells to respond (Kabat et al., 2014).   
Innate lymphoid cells have a role in the induction of intestinal IgA by producing 
specific cytokine signals, thus they are also able to signal back to stimulate the immune 
system (Kruglov et al., 2013).  Commensal bacteria also influence development of B cells 
residing in the gut and are strong inducers of secretory IgA production, and IgA is a key 
regulator of microbiota composition and of host exposure to intestinal bacteria (Macpherson 
et al., 2012).  Production of IgA in response to microbiota requires a high dosage of bacteria 
for induction to occur, but once production of IgA is stimulated, its production remains very 
persistent until it is signaled to stop (Hapfelmeier et al., 2010).  IgA has the special capability 
to alter production rapidly in response to shifts in microbiota composition.   
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IgA not only helps inhibit microbial adherence and prevent absorption of antigens 
from mucosal surfaces (Lamm et al., 1996), but it is also important in promoting barrier 
function by limiting bacteria from interacting with the intestinal epithelium and preventing 
microbial translocation to underlying tissues in the gastrointestinal tract (Cerutti and 
Rescigno, 2008, Rogier et al., 2014).  Some species of microbiota are more efficient in 
inducing an IgA response, due to their closer contact with the intestinal epithelium 
(Macpherson et al., 2012).  For example, lactic acid producing bacteria increase IgA 
production both locally and systemically at other mucosal sites by activating the adaptive 
immune system through stimulating mucosal B cells and CD4+ T cells (Perdigon et al., 1999, 
Corthesy et al., 2007).  Higher levels of lactic acid bacteria in calves could be essential to 
stimulate maturation of gut-associated lymphoid tissues and to increase secretory IgA, which 
would both boost the active immune responses when passive immunity obtained from 
colostrum is diminished (Malmuthuge et al., 2013).   
Since excessive IgA production due to microbial signaling could result in increased 
intestinal permeability due to increased inflammatory responses (Sartor, 1994), it is critical 
that IgA can have some feedback and impact on the commensal microbes as well.  IgA+ B 
cells may influence the microbiota through production of IgA or through elaboration of 
antimicrobial factors (Kabat et al., 2014) to help reestablish homeostasis.   
Intestinal mononuclear phagocytes comprise dendritic cells and macrophages, which 
are key players in intestinal homeostasis.  They link innate and adaptive immunity and 
participate in compartmentalization of the systemic and mucosal immune system (Kabat et 
al., 2014).  Intestinal mononuclear phagocytes secrete cytokines and chemokines that 
promote adaptive immune responses and T regulatory cell differentiation in mesenteric 
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lymph nodes (Sun et al., 2007, Varol et al., 2010).  Intestinal mononuclear phagocytes are 
signaled by intestinal commensal bacteria to regulate effector T cells that are critical in 
responding to extracellular pathogens (Kabat et al., 2014).  Some intestinal mononuclear 
phagocytes are crucial in promoting oral tolerance towards food antigens (Pabst and Mowat, 
2012).  Intestinal microbiota impact IgA production by influencing T-dependent intestinal 
IgA production due to some species of intestinal microbes being potent inducers of effector T 
cells and others being inducers of regulatory T cells (Kabat et al., 2014).  The differentiation 
of CD4+ T helper cells within the gut needs to be controlled such that T cells specific for 
commensals are either directed towards a regulatory T cell fate or are T helper 1 cells that are 
not responsive to the commensals (Lathrop et al., 2011).   
Sensing of microbiota constituents and metabolites by intestinal epithelial cells and 
intestinal mononuclear phagocytes help to maintain intestinal barrier function and ensure 
proper regulatory responses (Kabat et al., 2014).  Antigens and metabolites produced by the 
commensals and production of conditioning factors by intestinal epithelial cells and 
mononuclear phagocytes together regulate the activation of B and T cells in the gut (Kabat et 
al., 2014).  Extensive interactions between intestinal epithelial cells, intestinal mononuclear 
phagocytes, and microbes result in coordinated, flexible responses to different conditions or 
infections (Kabat et al., 2014).   
Diversity of microbial populations in the gastrointestinal tract can be altered by many 
factors, but one of the most prevalent factors being researched currently is the subtheraputic 
levels of antibiotics that have been commonly fed to livestock for decades.  Subtheraputic 
feeding of antibiotics have been shown to help improve growth rates and health status in 
livestock; however, there are numerous negative effects arising from this practice. 
24 
 
Microbes and Antibiotics 
Antibiotics are commonly fed to livestock at subtherapeutic levels due to the growth 
promotion and disease prevention that has been associated with their supplementation, 
leading to reductions in morbidity and mortality (Morrill et al., 1977, Braidwood and Henry, 
1990, Berge et al., 2005, Wileman et al., 2009).  Feeding farm animals feed containing 
antibiotics is controversial due to the possible emergence of antibiotic resistant bacteria 
(Salisbury et al., 2002).  The unintentional selection of bacteria that are resistant to 
antibiotics by feeding subtherapeutic levels could have important health consequences in 
both animals and humans (Boerlin et al., 2001, Chee-Sanford et al., 2001, Lauderdale et al., 
2002, Smith et al., 2004, Ho et al., 2010, McKinney et al., 2010).   
Due to concerns over the development of antibiotic resistance, subtherapeutic use of 
antibiotics was banned in the European Union in the late 1990s (Boerlin et al., 2001).  In the 
United States, the Food and Drug Administration (FDA) recently issued new rules limiting 
antibiotic use in milk replacer for calves (21CFR §520.1484; 21CFR §520.1660d).  Up to 
80% of E. coli isolates tested from mature heifers are  multi-drug resistant, typically 
exhibiting resistance to tetracycline, ampicillin, ceftiofur, florfenicol, chloramphenicol, 
spectinomycin, and streptomycin (Sawant et al., 2007).  It has been theorized that the 
antibiotic resistant bacteria are able to thrive on the additional nutritional resources that are 
made available after antibiotic treatment kills the drug-sensitive bugs (Heinemann et al., 
2000).   
Nutritional status, good management, and overall health may outweigh the benefits 
associated with subtherapeutic feeding of antibiotics since the benefits of medicated milk 
replacer have not been observed in young calves fed a higher plane of nutrition than 
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conventional feeding practices (Witte, 1998, Thames et al., 2012).  The feeding of antibiotics 
may actually lead to increased incidences of diarrhea due to disturbances in the beneficial gut 
microflora, especially in young animals (Rollin et al., 1986, Nord, 1993).  A recent study 
reported that 23% of dairy calves are treated with antibiotics at subtherapeutic levels in the 
milk during the preweaning phase (Windeyer et al., 2014).  The inclusion of oxytetracycline, 
tetracycline, and neomycin in milk replacer for young calves is one of the most common uses 
of subtherapeutic antibiotics in the U.S. dairy industry (Aschbacher and Feil, 1994, Berge et 
al., 2005).  Neomycin is not absorbed systemically, so functional activity of this antibiotic is 
restricted to the gastrointestinal tract (Aschbacher and Feil, 1994).  Oxytetracycline and 
tetracycline, in contrast, were found to be predominantly absorbed out of the gastrointestinal 
tract and thus useful for the prevention and treatment of respiratory infections (Aschbacher 
and Feil, 1994).  Calves fed antimicrobials in their milk are more likely to be resistant to 
multiple antibiotics when they were 2-4 weeks old than as newborns, further evidencing the 
development of antibiotic resistance (Berge et al., 2006).  One study has found, however, that 
calves tested less than 6 days old already showed resistance to 81% of the E. coli isolates 
obtained, whether they were fed medicated or non-medicated milk (Pereira et al., 2011), 
possibly due to exposure to the antibiotic resistant E. coli bacteria during birth or shortly 
after.   
The feeding of waste milk from cows treated with antibiotics or from the first few 
lactations after calving to dairy calves is very common practice since it is not saleable for 
human consumption (Chardavoyne et al., 1979, Langford et al., 2003).  The concentration of 
antibiotics in these milk sources fed to calves is variable and will depend on the number of 
cases, method of treatment, the withdrawal period, and amount being fed to the cows 
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producing the milk (Salisbury et al., 2002).  Testing of waste milk fed to calves has 
previously shown that the levels of pathogenic bacteria and antibiotics were both high (Selim 
and Cullor, 1997).  Research has shown that resistance of gut bacteria to antibiotics increased 
with increasing concentrations of the antibiotics in the milk fed to the calves (Langford et al., 
2003).  The resistance of the bacteria to antibiotics developed quickly and was residual, 
which could lead to the development of superbugs a facility (Langford et al., 2003).  
Antibiotic-resistant bacteria have been found more on farms with a high incidence of 
diarrhea in dairy calves, most likely due to treatment of scours with antibiotics (Gunn et al., 
2003).  One study involving calves that had ample amounts of good quality, clean colostrum 
concluded that medicated feeds did not improve health or growth (Kaneene et al., 2008).  
Studies have reported that calves fed waste milk had no difference in health or growth when 
compared to calves fed non-medicated milk, showing that waste milk was an acceptable food 
source in terms of growth and health of calves consuming the waste milk (Loveland et al., 
Chardavoyne et al., 1979, Keys et al., 1979, Keys et al., 1980, Kesler, 1981).   
Pasteurization of waste milk can significantly decrease the total number of bacteria by 
90-95% when done properly; however, recolonization of the milk occurs rapidly (Ruzante et 
al., 2008).  When antibiotics were added to pasteurized waste milk, a study reported that 
there is a higher percentage of diarrhea days in calves compared to no antibiotic addition, but 
there was no effect on respiratory rates (Berge et al., 2009).  Pasteurization does not 
eliminate residual antibiotics in the milk.   
Changes in regulations for feeding subtheraputic levels of antibiotics to modulate 
growth and health in calves, the negative impacts antibiotics have on the intestinal 
microflora, and the development of antibiotic resistant super bugs all demonstrate the need 
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for non-antibiotic alternatives to positively impact growth and health in animals.  There are 
numerous natural, non-antibiotic alternatives that have been studied and are promising 
effective replacements for antibiotics.  
Prebiotics Influencing the Microbiota 
Therapeutic feeding of antibiotics in diets of production animals has proven to 
enhance growth performance in farm animals by increasing weight gains, improving feed 
efficiencies and inhibiting the proliferation of pathogens (Coates et al., 1955, Thomke and 
Elwinger, 1998, Castanon, 2007, Midilli et al., 2008).  As regulations for the use of 
antibiotics continue to move towards minimal use of antibiotics and marketing agreements 
with retailers continue to prohibit antibiotic use, the need for non-antibiotic alternatives that 
help regulate immunity and growth will continue to grow.  The use of antibiotics as growth 
promoters is now banned in the European Union and is limited in the United States because 
of increases in antibiotic resistant bacteria (FDA, 2015).  In the spring of 2015, the Food and 
Drug Administration published new directives for the use of antimicrobials in livestock feed 
in the United States, which created a new category of products called veterinary feed 
directive drugs (FDA, 2015).  The drugs considered under this veterinary feed directive that 
are intended for use in or on animal feed must be used under the professional supervision of a 
licensed veterinarian (FDA, 2015).  The driving factor for the overhaul in regulations is the 
emerging evidence that antibiotic administration has negative effects on the microbiota of the 
person or animal receiving the antibiotics, negative effects on long term immunity and health 
of the person or animal, and may spread the antibiotic resistance gene to pathogens (Swann et 
al., 1969, Boyd and Massaut, 1999, Tollefson et al., 1999, Cross et al., 2007, Ueno et al., 
2011).  
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Prebiotics, non-digestible feed ingredients, and probiotics, living microbial feed 
supplements, have been proposed as feed additives that could accomplish the same benefits 
as antibiotics without concerns about withdrawal times or the potential for resistance 
development from pathogenic organisms.  Prebiotics and probiotics help maintain a healthy 
commensal microbial population in the gastrointestinal tract.  Probiotics and prebiotics have 
been widely accepted as gut microbiota stabilizers because they help inhibit pathogenic 
colonization while selectively stimulating the growth of bacteria that are capable of health-
promoting functions, such as bifidobacteria or lactobacilli (May et al., 1994, Gibson et al., 
2005, Brunser et al., 2006, Sharon, 2006, Baurhoo et al., 2007).  These ingredients can be fed 
independently or in conjunction.  Symbiotic additives that contain both pre- and probiotics 
can exert multiplied functional benefits including resistance to gastrointestinal bacterial 
infection, antibacterial activity, and improved immune status (Ghahri et al., 2013).  The use 
of these antibiotic alternatives ultimately results in effective and efficient immune responses 
by creating a more optimal gut environment for ingestion and digestion, providing suitable 
pH, and better availability of items necessary for the immune system to function properly 
(Roberfroid, 1998). 
Commensal microbes, also referred to as probiotics, play an important role in 
digestion.  Due to their location, the microflora inhabiting the gastrointestinal tract have a 
role in epithelial health through their ability to exclude pathogens, recognize pathogens, 
stimulate the development of the immune system, and moderate inflammatory responses, in 
addition to improving digestion (Gibson and Wang, 1994, Pathmakanthan et al., 1999, 
Schultsz et al., 1999, Hart et al., 2002, Swidsinski et al., 2002, Nazzaro et al., 2012).  There is 
a very complex relationship between diet, intestinal microbiota, their metabolites, and the 
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host immune system, and the intrinsic immunomodulation induced by different prebiotics 
acts additively or synergistically depending on other ingredients in the diet (i.e. energy and 
protein content or micronutrients like vitamins A and E and trace minerals) (Franklin et al., 
1998, Vos et al., 2007b, Moschen et al., 2012).  
Maintaining a healthy microbiota leads to less immune disturbances as well as 
increases feed efficiency for optimal growth and production.  Prebiotics act on the 
probiotics/commensal microbes in order to regulate metabolic reactions that produce toxic 
substances, stimulate endogenous enzymes, and by production of vitamins or antimicrobial 
substances such as organic acids to acidify the lumen, hydrogen peroxide, and bacteriocins 
(Houghton et al., 1997, Roberfroid, 2002, Hassanein and Soliman, 2010, Roodposhti and 
Dabiri, 2012).  Probiotics and prebiotics increase feed efficiency benefit by improving 
intestinal microflora populations and stimulating the host appetite, as well as encouraging 
proper development of the immune system (Erdogan et al., 2010).  The advantages of pre- 
and probiotics over the traditional antibiotic growth promoters are no withdrawal time, no 
residual effect, and no issues with microbial mutation resulting in resistant strains of 
pathogenic bacteria that don’t respond to typical methods of treatment (Hassanein and 
Soliman, 2010).  Antibiotics are broad-spectrum killers of microorganisms and limit the 
growth of detrimental microorganisms as well as growth and colonization of nonpathogenic 
bacteria (Visek, 1978).  Additionally, antibiotics are only effective against bacteria, whereas 
pre- and probiotics are able to minimize infection by all pathogenic organisms, including 
viruses and protozoans (Olson et al., 1998).  
Probiotics benefit the host in multiple ways including increasing mucin expression, 
secretion of antimicrobial factors, competitive epithelial adherence, and potentially 
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increasing total and pathogen specific IgA levels (Ohland and Macnaughton, 2010, Kadlec 
and Jakubec, 2014).  Probiotics administered to an animal contain live microorganisms in 
sufficient quantities to alter the microflora and exert beneficial effects in the host and that are 
capable of resisting gastric acids and bile salts to survive their transit along the 
gastrointestinal tract of the host (Gibson and McCartney, 1998, Schrezenmeir and de Vrese, 
2001, Kaur et al., 2002, Mountzouris et al., 2002, Salminen et al., 2005, Lo Curto et al., 
2011), while not being pathogenic to the host (Dugas et al., 1999).  Although the quantities of 
probiotic bacteria that are added to diets represent a small number compared to the 
commensal microbiota, this minority population is often able to exert a health effect because 
when ingested they pass through regions of the gastrointestinal tract that are sparsely 
colonized (the stomach, ileum, and duodenum) and may temporarily make up the dominant 
microbial populations in these areas (Lenoir-Wijnkoop et al., 2007).  Benefits of probiotic 
administration may also be due to a modification of the number and/or the physiology of 
some key resident species or by impacting the cross-talk between microbiota and the host 
(Lenoir-Wijnkoop et al., 2007).  A probiotic does not need to actually colonize the intestinal 
tract to exert effects on the host (Ohland and Macnaughton, 2010), although many probiotics 
do adhere to epithelial cells in the intestines (Parvez et al., 2006).  Probiotics will have to 
compete for nutrients and colonization sites with microbes already residing in the intestines 
(Gibson and McCartney, 1998, Mountzouris et al., 2002).  Some probiotics exert effects in a 
transient manner by influencing the existing microbiota as they pass through the 
gastrointestinal tract (Ohland and Macnaughton, 2010).  Probiotics attenuate intestinal 
inflammation and stress (Petrof et al., 2004), as well as improve the integrity of the 
gastrointestinal lining (Deshpande et al., 2007).  Probiotics also aid in preventing infections 
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in the gastrointestinal tract and pathogen adherence to the intestinal lining (Lee et al., 2000, 
Alvarez-Olmos and Oberhelman, 2001, Mukai et al., 2002).  Multi-strain probiotic feed 
additives may be more useful than a single strain because they result in the proliferation of 
more lactic acid bacteria than a single strain probiotic feed additive (Rolfe, 2000). 
The growth and metabolism of the established microflora is controlled largely by the 
prebiotic dietary substrates that escape digestion in the small bowel, and probably also by 
endogenous secretions of the gut (Stephen and Cummings, 1980, Hooper et al., 2012).  A 
prebiotic is ‘‘a selectively fermented ingredient that allows specific changes, both in the 
composition and/or activity in the gastrointestinal microflora that confers benefits upon host 
well-being and health” (Roberfroid, 2007).  A prebiotic substance selectively enhances the 
growth of beneficial bacteria (probiotics) in the intestine (Kontula et al., 1999, Menne et al., 
2000).  Prebiotics are specific types of carbohydrates and small fragments of carbohydrates 
that are indigestible to the host and used as feed additives to provide substrates to select 
beneficial bacteria, which favorably alters the gut microbiota (Midilli et al., 2008, Roto et al., 
2015).  Prebiotic substrates are not able to be digested by the pathogenic bacteria because 
they lack the appropriate enzymes  to cleave the molecular bonds (Roto et al., 2015).  
Prebiotics promote the function or viability of probiotics via their fermentation 
(Gibson and Roberfroid, 1995, Kadlec and Jakubec, 2014), unlike other fermentable 
carbohydrates (Rastall and Gibson, 2006).  Prebiotics must make it into the large bowel to be 
fermented in order to modify the microbiota in such a way that potentially health-promoting 
bacteria (especially lactobacilli and bifidobacteria) become numerically and/or metabolically 
predominant, and thus the harmful bacteria are repressed (Roberfroid, 1998, Roodposhti and 
Dabiri, 2012).  Prebiotics cannot be digested by α-amylase or other hydrolases in the upper 
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gastrointestinal tract of the host (Carabin and Flamm, 1999, Capitan-Canadas et al., 2014).  
Although certain peptides, proteins, and lipids are potential prebiotics, non-digestible 
carbohydrates, in particular non-digestible oligosaccharides, have received most attention 
due to their ability to selectively stimulate growth and/or activity of beneficial microbiota 
(Kawaguchi et al., 1993, Gibson and Roberfroid, 1995, Kaur et al., 2002, Rastall and 
Hotchkiss, 2003).  Oligosaccharides are the main nutritional source for the Lactobacillus 
genus, which is reflected in their residence in ecological niches rich in carbohydrate-
containing substrates, such as the mucosal membranes in animals (Bernardeau et al., 2008).  
The metabolism of prebiotic oligosaccharides is species- and strain-specific and 
depends largely on the prebiotic composition, size, structure (linkage types, branching), 
degree of polymerization, and also the population of microbes present in the gut (Sanz et al., 
2005, Shoaf et al., 2006, Roberfroid, 2007, Van Craeyveld et al., 2008, Damen et al., 2011).  
The intestinal microflora is nourished by two kinds of energy sources: non-digestible xylan-, 
pectin- and arabinose-containing dietary carbohydrates, such as plant-derived pectin, 
cellulose, hemicellulose and resistant starches, and endogenous mucus glycans, which 
constitute a reservoir to mitigate the effects of changes in availability of dietary 
polysaccharides (Flint et al., 2007).  Microbes have become specialized to have substrate 
preferences for resource partitioning, so niche adaptation mechanisms of these microbes may 
occur to minimize nutrient competition while also allowing metabolic syntrophy (cross-
feeding) with other gut commensals (Tannock et al., 2012, Ejby et al., 2013, Adamberg et al., 
2014).  
Due to the chemical structure of prebiotics, a fraction of ingested prebiotic substances 
are able to escape digestion by pancreatic and small-bowel enzymes in the gut and make it to 
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the large bowel (Cummings et al., 2001).  Fermentability differs with oligosaccharide 
structure, with greater catabolization occurring with linear oligosaccharides in comparison to 
branched oligosaccharides (Cummings et al., 2001).  The indigestibility of non-digestible 
oligosaccharides results from the configuration of the glycosidic bond between monomeric 
sugar units (Roberfroid, 1997, Conway, 2001).  The bacterial species present in the 
microbiota is also an important factor in controlling fermentation of short-chain 
carbohydrates in oligosaccharides (Lee and Gemmell, 1972, Cummings et al., 2001).  
The major products of prebiotic metabolism are short-chain fatty acids and other 
microbial metabolites, hydrogen, carbon dioxide, methane, hydrogen sulfide, lactate, 
pyruvate, ethanol, succinate, and bacterial cell mass (Lindgren and Dobrogosz, 1990, Levitt 
et al., 1995, Cummings et al., 2001, Lenoir-Wijnkoop et al., 2007).  Short-chain fatty acids 
and other microbial metabolites interact with immune cells and enterocytes and modify their 
activity (Le Poul et al., 2003, Karaki et al., 2008, Tazoe et al., 2009).  Short-chain fatty acids 
provide energy to the host and commensal microbes (Kaplan and Hutkins, 2000, Ploger et al., 
2012, Breton et al., 2015), acidify the luminal pH to suppress the growth of pathogenic 
organisms (Russell, 1992, Rycroft et al., 2001, Blaut, 2002), have bactericidal and 
bacteriostatic properties (Russell, 1992), improve energy efficiency (Roodposhti and Dabiri, 
2012), alter intestinal morphology (Roodposhti and Dabiri, 2012), improve the mucosal 
structure (Grand et al., 2013, Breton et al., 2015), stimulate intestinal epithelial cell 
proliferation, differentiation, and maturation (Ploger et al., 2012), improve gut barrier 
function (Gomez-Conde et al., 2007, Ploger et al., 2012), and influence intestinal motility 
(Dass et al., 2007).  Short-chain fatty acids are weak acids and effective as antimicrobials in 
their undissociated forms since they easily diffuse through the cytoplasmic membrane of the 
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microorganism (Davidson and Taylor, 2007).  Fatty acids dissociate in the cytoplasm of the 
pathogen which decreases pH and causes conformational changes of cytoplasmic proteins, 
enzymes, and nucleic acids (Davidson and Taylor, 2007).  Bacterially-derived short-chain 
fatty acids also have the ability to selectively expand the population of regulatory T cells 
(Tregs) in the gastrointestinal tract which helps to promote homeostasis and health, as well as 
reduce chronic inflammation (Smith et al., 2013). 
Changes to the commensal microbe population from prebiotics can be quite drastic 
even with relatively small quantities of prebiotics being added to the diet (Langlands et al., 
2004).  The beneficial effects of prebiotics are mainly attributed to modulation of the 
microbiota, increased colonic fermentation, and production of short-chain fatty acids (Bird et 
al., 2000, Topping and Clifton, 2001, Bird et al., 2007, Breton et al., 2015).  The desired 
result from prebiotic supplementation is an increase in bifidobacteria and lactobacilli in the 
gut (Langlands et al., 2004).  Prebiotics also decrease adherence of pathogenic organisms 
often by mimicking the binding sites on immune cell surfaces in order to competitively bind 
the pathogens (Chen et al., 2006, Shoaf et al., 2006, Vandeplas et al., 2010, Kadlec and 
Jakubec, 2014), accelerate recovery from gastrointestinal tract disturbances (Buddington et 
al., 2002), and can actually interact with the immune system to improve the host’s reaction 
on suboptimal vaccinations and increase resistance to various infections (Firmansyah et al., 
2001, Buddington et al., 2002).  Together, this results in prebiotics being able to affect the 
immune system directly or indirectly as a result of intestinal fermentation, promotion of 
growth of certain members of the gut microbiota, and microbial dependent immune 
regulation (Knudsen et al., 1993, Rakoff-Nahoum et al., 2004, Medzhitov, 2007).  The 
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immunomodulation effects of prebiotics are not restricted just to the gastrointestinal tract and 
can be observed systemically (Vos et al., 2007a). 
Prebiotics may influence the immune system directly and indirectly through 
interactions with pattern-recognition receptors like toll-like receptors, or by 
increasing/decreasing the populations of certain microbes, as a result of the intestinal 
fermentation (Langlands et al., 2004, Rakoff-Nahoum et al., 2004, Boehm et al., 2005, Loh et 
al., 2006, Medzhitov, 2007, Silva et al., 2009, van Hoffen et al., 2009, Vance et al., 2009, 
Capitan-Canadas et al., 2014, Ortega-Gonzalez et al., 2014).  The potential direct ligation of 
pattern recognition receptors on immune cells by prebiotic carbohydrate structures may result 
in immunomodulation by competing with lipopolysaccharide signaling and activation of 
cytokine production (Roberfroid et al., 2010, Ortega-Gonzalez et al., 2014).  Prebiotics have 
been shown to alter gut T regulatory cell populations in humans and mice, which is important 
because a proper immune response is a delicate balance between T regulatory cells and other 
immune cells (Round and Mazmanian, 2010).  Some gut microbes have evolved to escape 
host immune regulation by upregulating the T regulatory population in the host (Round and 
Mazmanian, 2010).  Prebiotics can transfer through the epithelial monolayers and regulate 
the subepithelial cells (Eiwegger et al., 2010).  Regulation of the subepithelial cells can result 
in lymphocyte modulation, which is another form of direct modulation of the immune system 
by prebiotics (Eiwegger et al., 2010).  These interactions with the immune system, possibly 
in combination with the pathogenic microbes present in the gastrointestinal tract, result in a 
variety of downstream events that result in cytokine production that modulates appropriate 
immune response for the microbial event (Rakoff-Nahoum et al., 2004, Medzhitov, 2007, 
Vance et al., 2009, Zenhom et al., 2011).  Beneficial effects of prebiotics on different 
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immune functions, such as the production of immunostimulating compounds, cytokines, 
chemokines, and immunoglobulins (particularly IgA), as well as macrophage phagocytosis, 
further support the notion that the prebiotics, their microbial fermentation products, the 
microbiome itself, and the immune system all have cross-talk back and forth (Silva et al., 
2009, Kim et al., 2013).  
The microbiota modifies digesta residues and can detoxify or generate oncogenic 
compounds depending on the microbe (Lenoir-Wijnkoop et al., 2007).  By properly 
nourishing the microbiota, it ensures that the microbiota community does not accept bacterial 
foreigners and is able to exert an antagonistic effect against pathogenic bacteria to elicit 
protection both within and outside the digestive tract (Lenoir-Wijnkoop et al., 2007).  
Additionally, increased microbial nitrogen flow and amino acids reaching the intestinal 
epithelium may aid overall growth and development due to the provisional nutrients that are 
available for the host rather than bacterial utilization, creating more energy and amino acid 
substrates available for protein synthesis (Yoon and Stern, 1996).  
Consumption of prebiotics is associated with numerous benefits in the host.  
Prebiotics are useful in enhancing the mucosal barrier function, which is very important 
because failure of the mucosal barrier to contain the bacterial flora that are normally present 
results in enhanced translocation and a more robust inflammatory response (Capitan-Canadas 
et al., 2014).  Probiotics and prebiotics can improve digestibilities of dry matter, energy, 
crude protein and amino acids and increase bioavailability and improve absorption of 
calcium and other minerals (Gibson, 1999, Kolida et al., 2002, Abrams et al., 2005, Li et al., 
2008, Kong et al., 2009, Roberfroid et al., 2010, Kong et al., 2011).  Increased bioavailability 
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of minerals can be translated into benefits to bone health in animals (Scholz-Ahrens et al., 
2002, Roberfroid et al., 2010).  
Prebiotics and probiotics are promising ways to correct dysbiosis.  Dysbiosis and the 
resulting inflammation increase the energy requirements of the enterocytes and impair the 
intestinal barrier function, which increases permeability to toxic substances and leads to 
digestive disturbances and allergenic responses (Hollander, 1999, Bischoff et al., 2014, 
Breton et al., 2015).  Typically, the presence of specific pathogenic bacteria and the lack or 
decrease in certain beneficial species are linked to the development of dysbiosis (Machiels et 
al., 2014).  Increasing overall microbial diversity with prebiotics may correct any imbalances 
in microbial populations.  Fermentation products from the microbiota consist of several 
short-chain fatty acids that are believed to exert trophic effects on the intestinal 
microarchitecture (Wong et al., 2006), which may alter intestinal ecology and modulate 
inflammation to increase intestinal health (Cavaglieri et al., 2003, Breton et al., 2015, Huff et 
al., 2015). 
Prebiotic and probiotic supplementation helps the host better deal with stressors and 
compromised immune function, such as heat stress, and decrease inflammation resulting 
from the stress and lowered immune function (Abe et al., 1995, Mane et al., 2009, Sohail et 
al., 2010).  Stress is any biological reaction developed by an animal when its homeostasis is 
threatened either physically or psychologically, and this stress usually leads to changes in 
microbial populations, metabolism, production performance, and intestinal microarchitecture, 
decreased development of intestinal morphology and function, decreases in feed intakes, 
increases in inflammation, and increases in adrenal hormone concentrations, such as 
corticosterone (Mitchell and Carlisle, 1992, Moberg, 2000, Lan et al., 2004, Jilling et al., 
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2006, Caso et al., 2008, Gareau et al., 2008, Lambert, 2009, Sohail et al., 2012).  Stress can 
lower resistance to many of the microorganisms present in the environment by both 
enhancing and suppressing proper immunological responses (Siegel et al., 2006).  A healthy 
and balanced microbial community normalizes adrenal gland activity and reduce production 
of stress related hormones, which is yet further support that maintenance of the commensal 
microbe population in the small intestine is very important for proper growth and 
development (Sohail et al., 2012).  Often, the more stress or dysbiosis the animal is under, 
the greater the magnitude of the positive in response of growth and health parameters to 
supplementation with pre- and probiotic (Midilli et al., 2008).  Additional possible causes of 
variations in growth and health responses to probiotic and/or prebiotic supplementation could 
be differences between strains, hybrids, age, sex, plane of nutrition, nutrient composition of 
the diet, microbial populations of the gastrointestinal tract, inclusion levels of probiotics and 
prebiotics in the diet, duration of supplementation, or other environmental conditions 
(Roberfroid et al., 1998, Midilli et al., 2008, Hutsko et al., 2016).  
Neonates are at risk to be deficient in probiotic intestinal colonization due to many 
factors such as preterm birth, use of antibiotics, and a complicated birth (Gewolb et al., 
1999).  Early nutritional intervention with prebiotic oligosaccharides and probiotics seem to 
be effective at priming the neonatal immune system in a balanced way that provides 
substantial protection both for allergy and infection both immediately and on a longer-term 
basis (Arslanoglu et al., 2007, Arslanoglu et al., 2008, Salminen and Isolauri, 2008).  Non-
digestible carbohydrate prebiotics are effective at lessening the severity of infections in 
neonates (Correa-Matos et al., 2003).  The immunological programming effect that results in 
the long-term protection against allergy and infection past the time of administration of 
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prebiotics, expands past the gastrointestinal tract to impact the total number of infections, 
respiratory tract infections, fever episodes, and antibiotic prescriptions during the first 2 years 
of life in infants (Arslanoglu et al., 2008).   
Prebiotic Supplements 
Plant, herbal, bacterial, fungal, acidifiers, feed enzymes, antioxidants, and other naturally 
derived products have been used in traditional medicine and as feed supplements to livestock 
diets for centuries (Wang et al., 1998, Steiner, 2006).  A feed ingredient can be made 
functional by the addition of a potential health promoting entity, reducing or removing 
concentrations of harmful components, and/or modifying the nature or the bioavailability of 
one or more components (Ziemer and Gibson, 1998, Korhonen, 2002, Roberfroid, 2002).  
The concept of a functional feed supplement has recently moved towards feed additives 
exerting a positive effect on the gut microbiota and led to the development of the feed 
additive group of prebiotics (Ziemer and Gibson, 1998).  Lipids, proteins, and carbohydrates 
can be made into functional feed additives. The use of functional feed supplements are used 
due to the antimicrobial activities, immune enhancement, and stress reduction responses  
from their addition to diets (Wang et al., 1998).  
Non-Digestible Oligosaccharides  
Non-digestible oligosaccharides are the most well-studied prebiotics.  There are 
numerous different types of non-digestible oligosaccharides, or carbohydrates, that have 
positive prebiotic effects as feed supplements, although these effects have not always been 
consistent between different studies.  Prebiotic oligosaccharides can originate from plant-
derived or milk-derived sources (Moro et al., 2006).  Prebiotics often contain the same 
glycoside residues and glycosidic linkages present in plant cell wall polysaccharides, such as 
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cellulose, hemicellulose, pectin, galactan, or polysaccharides, that are involved in plant 
energy storage like starch and inulin (Cecchini et al., 2013).  Non-digestible carbohydrates 
are able to stimulate immune responses independently of T cells (Bohn and BeMiller, 1995), 
as well as decrease digestive upsets and allergenic responses (Moro et al., 2006).  Binding 
sites on some prebiotic oligosaccharides structurally resemble receptor sites for pathogens on 
intestinal epithelial cells to enable specific prebiotics to recognize and adhere intestinal 
pathogens (Kunz et al., 2000, Shoaf et al., 2006).  
Mannan-oligosaccharides (MOS) and yeast prebiotics are currently the most well-
studied prebiotics. Mannans are a component of the yeast cell wall and are the primary 
antigenic components of whole yeast cells and cell walls (Ballou, 1970).  One mode of action 
for MOS is by providing competitive binding sites via their mannose-specific fimbriae for 
gram-negative intestinal pathogens, such as Salmonella and E. coli, to prevent the pathogens 
from attachment and colonization in the gastrointestinal tract (Ofek et al., 1977, Firon et al., 
1983, Sharon, 2006).  Additionally, MOS stimulates the immune system by inducing the 
expression of pro- and anti-inflammatory cytokines (Korneeva et al., 2012).  
Immunomodulation by oligosaccharides is not restricted to the gastrointestinal tract 
(Sonoyama et al., 2005).  
In addition to MOS, there are other yeast components that have prebiotic effects. 
Inclusion of yeast derivatives in animal feed is positively associated with growth 
performance and modification of gut morphology (Roto et al., 2015).  Soluble products, such 
as metabolites, that are present in yeast culture modulate the immune system by reducing 
inflammatory responses and oxidative stress (Jensen et al., 2007).  
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Yeast culture (YC) has been shown to modify rumen function in both calves and 
cows by stimulating fermentation, improving dry matter intake, average daily gains and 
growth, improvement of rumen pH, increased populations and growth rates of cellulolytic 
bacteria, and enhancing the initial digestion rate of forages (Quigley et al., 1992a, Callaway 
and Martin, 1997, Kumar et al., 1997, Robinson, 1997, Dann et al., 2000, Lesmeister et al., 
2004).  Several studies involving the feeding of YC to dairy calves in their grain reported 
improved health measured by minimized frequency of health treatments, reduced risk of 
morbidity and mortality, and reduced duration of disease (Cole et al., 1992, Seymour et al., 
1995, Magalhaes et al., 2008).  Profitability per calf by feeding YC was improved by $48 per 
calf in one study due to improved health and survivability of the calf (Magalhaes et al., 
2008).  Additionally, YC improved daily grain intakes, feed efficiencies and growth in one 
study (Lesmeister et al., 2004), but studies have found no differences in the same parameters 
with YC supplementation (Magalhaes et al., 2008).  
Yeast culture supplementation has shown positive effects in lactating dairy cows as 
well. Supplementation with YC improved milk production performance (Nocek et al., 2011).  
Enzymatically hydrolyzed yeast improved milk protein percentages and mammary health 
(Nocek et al., 2011).  In the same study, milk protein percentage was higher for cows 
supplemented with YC and enzymatically hydrolyzed yeast together than for those solely on 
YC or the control treatments (Nocek et al., 2011).  Cases of clinical mastitis for cows 
supplemented with YC and enzymatically hydrolyzed yeast were less than half those for 
control or YC supplemented cows (Nocek et al., 2011).  These results are possibly due to 
enteric nutrient sparing and a subclinical immune response due to the promotion of humoral 
immunity or by the prevention of a hyperimmune response (Nocek et al., 2011).  
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Supplementation of broiler diets with a killed, whole yeast cell prebiotic increased 
regulatory T cell percentage in the cecal tonsil which created an anti-inflammatory effect 
(Shanmugasundaram and Selvaraj, 2012).  This immunomodulation was a local effect; there 
was no alteration of the T regulatory cells in the spleen (Shanmugasundaram and Selvaraj, 
2012).  This specific prebiotic may have increased beneficial bacteria and decreased 
pathogenic bacteria to help remove proinflammatory immune signals (Shanmugasundaram 
and Selvaraj, 2012).  
Research on the addition of MOS to colostrum replacer for calves has resulted in 
conflicting results.  Many studies have reported MOS does not have any effect on passive 
transfer of immunity, incidence of diarrhea or pneumonia, mortality rates, or average daily 
gains between birth and weaning (Villettaz Robichaud et al., 2014).  In a recent study, the 
addition of MOS to pooled maternal colostrum resulted in a reduction of IgG absorption and 
lower serum IgG concentrations in calves (Brady et al., 2015).  Contrary to those studies, 
Lazarevic et al. (2010) reported that the addition of MOS to maternal colostrum significantly 
increased serum IgG concentrations for the first 21 d of life as compared with control calves 
not supplemented with MOS in maternal colostrum.  They proposed that the addition of 
MOS might be promoting immunoglobulin uptake through a role that carbohydrates may 
play in mediating communication between the gut and the immune system (Lazarevic et al., 
2010).  Passive transfer of IgG in calves is negatively associated with total bacteria counts in 
colostrum; therefore, MOS may interfere with the attachment of pathogens in the small 
intestine and thus enhance the absorption of colostral IgG (Godden et al., 2012, Villettaz 
Robichaud et al., 2014).  The differing results could be due to differing levels of bacterial 
contamination in the maternal colostrum between studies.  If the maternal colostrum did have 
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high levels of bacterial contamination, this may provide a greater opportunity for MOS to 
positively affect passive transfer by interfering with bacterial colonization of the gut 
(Lazarevic et al., 2010).  
Supplementation of MOS in pregnant mammals has positive impacts on the neonate.  
Specific immunity was enhanced by MOS supplementation in calves from cows 
supplemented with MOS as evidenced by a tendency for greater increases in serum protein 
concentrations from birth to 24 h and greater serum rotavirus neutralization titers at calving, 
even though there was no difference in colostral rotavirus neutralization titers (Franklin et al., 
2005).  Similar results have been reported in sows.  Sows supplemented with MOS before 
parturition had piglets that performed better than piglets from unsupplemented sows in part 
due to increased concentrations of Ig in colostrum of the supplemented sows (Newman and 
Newman, 2001, O’Quinn et al., 2001).  Supplementation with MOS increased overall 
immunoglobulin concentrations in the host by stimulating antibody production (Savage et al., 
1996), which could lead to higher levels of IgG in the colostrum of supplemented dams. 
The addition of MOS to milk replacer for dairy calves is a promising alternative to 
antibiotic supplements due to MOS supplementation improving fecal scores and reducing 
scours (Heinrichs et al., 2003).  No improvement in growth or average daily gains of calves 
fed milk replacer containing MOS were observed in that particular study, but there was a 
more rapid recovery from scouring in calves fed MOS and also higher grain intakes at 6 
weeks of age (Heinrichs et al., 2003). 
Supplementation with MOS has shown improvements in growth and feed intake in 
other studies involving numerous different species.  In a study involving broilers, MOS 
supplementation resulted in significantly improved body weight gains of broilers under heat 
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stress, indicating that MOS may have been able to help mitigate some of the negative effects 
of stress that commercial production animals encounter due to factors involving the 
environment, management, psychological status of the animal, or physical issues (Sohail et 
al., 2012).  Addition of MOS to dairy calf diets improved weight gains and grain intakes 
(Dvorak et al., 1997).  Improvement in average daily gains and feed efficiency has been 
observed in weaned piglets and pigs fed MOS (Davis et al., 2002, Burkey et al., 2004).  
Additionally, growth performance, nutrition efficiency, health status, and survival rates were 
enhanced in fish that consumed a diet containing MOS in several studies (Staykov et al., 
2007, Torrecillas et al., 2007, Burr et al., 2008, Salze et al., 2008). 
Supplementation of MOS reforms gut microflora and modulates the intestinal 
microbial population (Spring et al., 2000, Salze et al., 2008, Dimitroglou et al., 2009, 
Corrigan et al., 2012).  Calves and pigs fed MOS in a milk replacer had lower coliform 
concentrations than unsupplemented calves (Newman et al., 1993, Miguel et al., 2004).  In 
several studies, MOS enhanced bird performance characteristics, including live weight gains, 
feed conversion efficiencies, and feed consumption, possibly due to improvements in 
beneficial microflora (Parks et al., 2001, Hooge, 2004).  A study feeding MOS to turkeys 
resulted in beneficial effects on the bacterial community structure in the cecum, but there 
were no differences in feed consumption or feed conversion efficiencies (Corrigan et al., 
2012).  In contrast, another study reported that MOS improved average daily gains during 
particular growth phases of turkey poults in both challenged and non-challenged poults, but 
MOS did not increase concentrations of total lactobacilli in the gastrointestinal tract 
(Fairchild et al., 2001).  
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Supplementation with MOS products affects intestinal development, morphology, and 
function (Iji et al., 2001, Hutsko et al., 2016).  Supplementation with MOS increased crypt 
depth, villus height, and villus area (Hutsko et al., 2016).  The increase in crypt depth could 
be beneficial as it may represent an increase in the number of proliferating stem cells, which 
could increase the number of mucin producing goblet cells (Hutsko et al., 2016).  Feeding of 
Aspergillus meal, which is a product of fermentation and contains MOS, appears to enhance 
gut development by increasing villus height in the duodenum and ileum and allows the host 
to use more oxygen and maintain a higher metabolism (Solis de los Santos et al., 2005).  
In addition to MOS, β-glucans are another cell wall component in the yeast cell wall 
that has prebiotic activities including the ability to block adhesion of pathogenic bacteria to 
the mucous epithelium (Kogan and Kocher, 2007).  Beta-glucans are one of the most 
abundant forms of polysaccharides found inside the cell wall of some plants, bacteria, and 
fungus (Stone and Clarke, 1992, Azmi et al., 2012).  All β-glucans are glucose polymers 
linked together by a 1→ 3 linear β-glycosidic chain core and differ from each other by their 
length and branching structures (Stone and Clarke, 1992, Chan et al., 2009).  β-glucans of 
fungus have 1→6 side branches, whereas those of bacteria have 1→4 side branches (Stone 
and Clarke, 1992).  
Most β-glucans are considered non-digestible carbohydrates that are fermented to 
various degrees by the intestinal microbial flora (Wang et al., 2008).  In an aqueous solution, 
β-glucans undergo conformational changes into triple helix, single helix or random coils 
(Bohn and BeMiller, 1995).  The more complex that the conformational changes of the β-
glucan are, the more potent their immunmodulatory and anti-cancer effects (Bohn and 
BeMiller, 1995, Chan et al., 2009).  β-glucans exhibit significant systemic 
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immunomodulating effects on humoral and cellular immune responses (Vetvicka et al., 
2007).  
Beta-glucans are potent immunomodulators with effects on both innate and adaptive 
immunity (Chan et al., 2009).  The immunomodulatory properties of β-glucans are due to 
both microbial dependent effects from fermentation (Ohno et al., 1995, Wang et al., 2008), as 
well as microbial independent pathways in which β-glucans directly bind to specific 
receptors of immune cells and are internalized (Rice et al., 2005, Vos et al., 2007b).  β-
glucans target many immune cells including macrophages, neutrophils, monocytes, NK cells 
and dendritic cells (Chan et al., 2009).  β-glucans can bind to Dectin-1, a type II 
transmembrane protein receptor that binds β-1,3 and β-1,6 glucans, to be internalized by 
antigen-presenting cells resulting in stimulation and regulation of the innate immune 
response (Cheung et al., 2002, Brown et al., 2003, Cobb et al., 2004).  Internalization of 
soluble β-glucan by intestinal epithelial cells is not Dectin-1 dependent, as it is in 
macrophages (Rice et al., 2005).  Internalization by macrophages or other antigen-presenting 
cells resulted in the transportation to the spleen, lymph nodes, and bone marrow to stimulate 
a systemic immune response (Cheung et al., 2002, Chan et al., 2009).  Beta-glucans have 
been reported to activate CD4+ T cells through the MHC-II endocytic pathway, which 
requires the β-glucan to bind to MHC-II once internalized by an antigen-presenting cell for 
presentation to T helper cells (Cobb et al., 2004). 
Appropriate or low levels of β-glucans were found to be efficient stimulators of non-
specific immune functions in fish (Santarem et al., 1997).  Some β-glucans have been 
reported to have immunomodulatory effects by stimulating the induction of T-cells into T-
regulatory cells (Karumuthil-Melethil et al., 2008).  β-glucans increased proliferation and 
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responsiveness to antigen or cytokines via their pathogen-associated molecular patterns 
(PAMP) that prime a specific class of T cells (Hedges et al., 2007).  Supplementation of the 
diet with glucans was reported to improve respiratory burst activity, phagocytosis, lysozyme 
value, neutrophil function, and resistance against pathogens (Ogier de Baulny et al., 1996, Li 
and Gatlin Iii, 2004, Murphy et al., 2007).  Oral β-glucan supplementation can stimulate 
proliferation and activation of peripheral blood monocytes (Segain et al., 2000, Chan et al., 
2007, Demir et al., 2007).  Conversely, one study reported that a β-glucan rich diet in 
neonatal mice decreased intestinal integrity (Volman et al., 2011).  
Galacto-oligosaccharides (GOS) are another type of non-digestible oligosaccharides.  
Galacto-oligosaccharides are produced from lactose or lactulose, and comprised of a very 
complex mixture of carbohydrates that differ in linkage type, number, and order of 
monomers in the oligosaccharide chain (Hernández-Hernández et al., 2012).  More than 90% 
of GOS molecules are reported to arrive unchanged in the colon (Beards et al., 2010).  
Prebiotic activities of GOS are very dependent on the structure and differences have a 
considerable impact on susceptibility to in vivo gastrointestinal digestion (Depeint et al., 
2008, Hernández-Hernández et al., 2012).  Galacto-oligosaccharides have a bifidogenic 
effect (Shoaf et al., 2006, Depeint et al., 2008), but upon termination of supplementation the 
effects are reversed and the effects were dose dependent (Davis et al., 2010).  
Synthetic mixtures of GOS produced through enzymes from probiotic organisms 
confer different selectivity on microflora when fermented in the gastrointestinal tract due to 
β-galactosidase enzymes producing different specific glycosidic linkages (Rabiu et al., 2001).  
Galacto-oligosaccharides are mainly fermented by Bifidobacterium longum, B. bifidum, B. 
catenulatum, Lactobacillus gasseri, and L. salivarius (Maathuis et al., 2012).  One study 
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reported they stimulate propionate-producing microbes and inhibit the growth of acetate 
producers (Mwenya et al., 2004), but a more recent study reported that GOS fermentation led 
to increased acetate production (Maathuis et al., 2012).  Galacto-oligosaccharides have the 
greatest adherence inhibition of pathogens to the gastrointestinal tract by activity as a decoy 
receptor (Newburg, 1999, Sharon and Ofek, 2000, Mulvey et al., 2001, Shoaf et al., 2006).  
Galactosyl-lactose (a trisaccharide derived from Aspergillus oryzae and a component 
of GOS) added to dairy calf milk replacer resulted in lower fecal scores and fewer days of 
scouring than calves fed a control milk replacer not containing any prebiotics (Quigley et al., 
1997).  This study also reported that body weight and body weight gains were increased by 
52 and 72 g/d in response to antibiotics and galactosyl-lactose, respectively (Quigley et al., 
1997).  Changes in growth and feed efficiency observed by Quigley et al. (1997) appeared to 
be related to improvements in intestinal health and reduction of severity and duration of 
scours.  
Fructo-oligosaccharides (FOS) are yet another type of non-digestible oligosaccharide 
feed additive.  These compounds are naturally present in some edible plants such as 
Jerusalem artichoke tubers, chicory roots, and onions (Hidaka et al., 1988, Niness, 1999).  
They are fermented by resident microbiota in the colon to stimulate the growth and activity 
of beneficial bacteria, inhibit pathogenic organism colonization, and produce short-chain 
fatty acids that lower intraluminal pH and may increase mineral solubility (May et al., 1994, 
Seymour et al., 1995, Gibson, 1999, Grizard and Barthomeuf, 1999, Menne et al., 2000, 
Cummings and Macfarlane, 2002, Swanson et al., 2002, Abrams et al., 2005, Respondek et 
al., 2008, Roberfroid et al., 2010, Grand et al., 2013).  
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Short-chain FOS (scFOS) supplementation induced selective bifidogenic 
fermentation in the proximal colon, and long-chain FOS (lcFOS) maintained the metabolic 
activity of the flora in more distal parts of the colon due to slower fermentation (Coudray et 
al., 2003).  These scFOS are composed of a mixture of oligosaccharides consisting of glucose 
linked to fructose units by β-(1,2) links that are not digestible by mammalian enzymes and 
are fermented by some strains of Bifidobacterium and Lactobacillus in the large intestine of 
animals (Bunce et al., 1995, Howard et al., 1995, Roberfroid et al., 2010).  Short-chain 
fructo-oligosaccharides are soluble fibers naturally found in vegetables, such as onion, garlic, 
or wheat (Grand et al., 2013). 
Numerous studies have proven FOS have prebiotic effects.  Dietary supplementation 
with scFOS increases villus height and crypt depth in the large intestine (Howard et al., 
1995).  Supplementation with scFOS increased the total anaerobic microbial population in 
horses (Respondek et al., 2008, Philippeau et al., 2010).  When added to milk replacer for 
dairy calves, scFOS increased total production of short-chain fatty acids, butyrate in 
particular, and increased body weights (Grand et al., 2013).  The feeding of FOS and bovine 
serum in combination contributed to improved health, reduced scours, reduced use of 
electrolytes, and reduced incidence and severity of enteric disease in calves (Quigley et al., 
2002).  The addition of FOS to electrolytes administered to piglets with induced diarrhea 
increased recovery rates of intestinal beneficial bacteria (Oli et al., 1998).  Long-term feeding 
(28 days or more) with FOS or MOS  in broiler diets is a promising alternative to antibiotic 
growth promoters (Kim et al., 2011).  Feeding FOS or MOS increased the diversity and 
populations of lactobacilli, and decreased populations of E. coli and C. perfringens in the 
ileum of broilers in that particular study; however, no significant differences were found 
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between control and FOS or MOS supplemented groups in overall feed intake, feed 
conversion, and mortality (Kim et al., 2011).  
Inulin belongs to the fructan dietary fiber class.  Chicory inulin supplementation in 
young growing animals improves whole-body mineral content, which is important to ensure 
proper growth and immune responses in the animal (Roberfroid et al., 2002).  Inulin 
increased digestibility of crude protein and fat, as well as improved production performance 
in broiler birds (Chen, 2003, Alzueta et al., 2010).  Dietary supplementation of inulin is 
widely used to modify gut microbiota composition for better performance in the swine 
industry (Van Loo, 2007, De Lange et al., 2010).  In pigs, inulin improved the microbial 
balance (Patterson et al., 2010). FOS and inulin stimulate cytokine secretion resulting in 
monocyte activation (Capitan-Canadas et al., 2014).   
Another source of prebiotic carbohydrates are lactose derivatives from whey 
processing, such as lactulose and lactitol (Kontula et al., 1999).  These lactose derivatives are 
disaccharides that are not absorbed in the human small intestine and serve as substrates for 
colonic microbes (Kontula et al., 1999).  Gut microbes are able to break down lactulose via 
the same pathways that lactose and GOS are digested (Cecchini et al., 2013).  Lactulose 
consumption positively affects gut microflora by enhancing the growth and metabolism of 
beneficial bacteria such as lactobacilli and bifidobacteria (Mendez and Olano, 1979, Mizota, 
1994).  
Germinated barley fiber (GBF) has prebiotic properties. Feeding GBF results in 
reduced mucosal damage and diarrhea.  Supplementation with GBF also improved severe 
bloody diarrhea and attenuation of colonic mucosal damage via the maintenance and repair 
of epithelial cells, increased short-chain fatty acid production, especially butyrate, by 
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microflora, reduced colonic pH, increased water retention in the feces, and improved fecal-
forming ability (Kanauchi et al., 1998a, Kanauchi et al., 1998b, Kanauchi et al., 1999, Araki 
et al., 2000, Kanauchi et al., 2001, Bamba et al., 2002).  The protein fraction of germinated 
barley does not show this same prebiotic effect, most likely due to lack of increase in 
butyrate production (Bamba et al., 2002).  In this same research study, butyrate administered 
orally or cecally didn’t reduce severe bloody diarrhea because it was not able to improve 
fecal-forming ability in the host (Bamba et al., 2002).  
Fiber from psyllium has been studied for its potential effects on digestive function, 
rate of passage, nutrient absorption, intestinal morphology, and intermediary metabolism (Yu 
et al., 2009).  Psyllium is fermented by fecal microflora (Costa et al., 1989, Edwards et al., 
1992, Campbell and Fahey, 1997, Swanson et al., 2001).  The addition of psyllium to milk 
replacer for healthy neonatal calves resulted in increased viscosity of digesta in the 
abomasum and colon, decreased dry matter content of colonic digesta and feces, and 
decreased passage rate of digesta in the total digestive tract (Cannon et al., 2010a).  Pysllium 
attenuated secretory diarrhea induced by enterotoxigenic Escherichia coli in piglets (Hayden 
et al., 1998).  Cannon et al. (2010b) reported that fermentable fibers such as psyllium 
increased volatile fatty acid concentrations in the lower digestive tract and gastrointestinal 
tract mass of many mammals.  When psyllium was added to milk replacer in a follow up 
study, Cannon found that psyllium increased fermentation in the colon, mass of the total 
gastrointestinal tract, and populations of bifidobacteria and lactobacilli in the reticulo-rumen 
(Cannon et al., 2010b).  
It is not known to what extent supplemented oligosaccharides may cross the brush 
border membrane of the intestine, although some oligosaccharides in milk do so (Kunz et al., 
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2000, Gnoth et al., 2001, Sonoyama et al., 2005).  If gastrointestinal absorption of prebiotics 
occurs, a direct interaction with cells from the immune system may occur (Eiwegger et al., 
2010).  Eiwegger et al. (2010) reported support for this theory in an in vitro trial where 
supplementation with an oligosaccharide fraction from human milk led to mononuclear cell 
maturation through modulation of cytokine production. 
Studies involving the addition of non-digestible carbohydrates to diets of different 
animals have been inconsistent in their findings regarding whether non-digestible 
carbohydrates exerted a positive, prebiotic effect on the host.  Several studies have found no 
change at all in comparison to the control diet (Abney, 2001, Angel et al., 2005, Parks et al., 
2005, Stanczuk et al., 2005, Brunser et al., 2006, Juśkiewicz et al., 2006, Hill et al., 2008, 
Dimitroglou et al., 2010).  This could partly be due to processing and purity of the non-
digestible carbohydrates used in different experiments.  Enzymatic processing of yeast cell 
wall at optimal temperature, time, and pH yields a more consistent exposure of binding sites 
than chemical or mechanical fractionation processing (Balasundaram and Harrison, 2006, 
Pitarch et al., 2008).  Yeast strain, yeast growth media, carrier, and drying processes also are 
critical to their activity and differentiation (Nocek et al., 2011).  The differences in results of 
studies involving prebiotics could also be due to lack of health or environmental challenges 
during the trial to reveal the effects of the products (Angel et al., 2005). 
Because lactulose, FOS, and GOS have the ability to resist digestion by the host, be 
fermented by intestinal microflora and the stimulation of selective stimulation of growth 
and/or activity of beneficial intestinal bacteria, and they have been proposed to be the most 
promising options for prebiotics (Bouhnik et al., 2004, Gibson et al., 2004).  
Glucooligosaccharides, isomaltooligosaccharides, lactosucrose, polydextrose, soybean 
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oligosaccharides, and xylooligosaccharides are additional prebiotics that may be potentially 
effective in mammals (Gibson et al., 2004). 
Short-Chain Fatty Acids  
Fatty acids have functions beyond being an energy source in mammals (Sander et al., 
1959, Kato et al., 1989, Guilloteau et al., 2004).  Several short-chain fatty acids (SCFA) have 
prebiotic and immunomodulatory properties.  Butyrate is the most well studied SCFA as a 
prebiotic.  Since some medium-chain and polyunsaturated fatty acids have antimicrobial and 
antiviral properties (Hristov et al., 2004), fatty acids sources such as coconut oil, canola oil, 
flax oil, and fish oil have also been researched.  
Butyrate is a product of microbial fermentation and has widespread effects on growth, 
digestibility, and feed efficiency in healthy and immune compromised animals.  Butyrate is 
used as an energy source by enterocytes (Segain et al., 2000), stimulates cell proliferation, 
differentiation, and maturation (Pouillart, 1998, Partanen and Mroz, 1999, Kotunia et al., 
2004, Franco et al., 2005, Mroz, 2005, Manzanilla et al., 2006, Hill et al., 2007, Mazzoni et 
al., 2008, Guilloteau et al., 2009, Guilloteau et al., 2010a), improves intestinal barrier 
function, reduces enterocyte apoptosis, and that it has anti-inflammatory effects (Segain et 
al., 2000, Sengupta et al., 2006).  Butyrate has immunomodulatory properties due to its 
ability to modulate the antimicrobial host defense peptide gene expression (Sunkara et al., 
2011, Sunkara et al., 2012).  Butyrate improved rumen development and had a mitotic effect 
on ruminal papillae in several studies (Mentschel et al., 2001, Górka et al., 2011a, Górka et 
al., 2011b).  Butyrate improves the intestinal microflora (Biagi et al., 2007). 
Sodium butyrate (SB) is often used instead of butyric acid itself in feed additives 
because SB is solid, stable, and much less odorous than butyric acid (Guilloteau et al., 
54 
 
2010b).  A positive effect on small intestine development and weight gains has been reported 
in calves with SB supplementation in milk replacer (Pietrzak et al., 2008, Górka et al., 2011a, 
Górka et al., 2011b, Górka et al., 2014).  Supplementation with SB in calf milk replacer 
contributed to increased nutrient digestibility because it was an important regulator of 
pancreatic juice secretion and stimulated pancreatic development (Guilloteau et al., 2004, 
Guilloteau et al., 2010b).  In that same study, it was concluded that SB needs to be 
administered orally; duodenal SB infusion did not produce the same effects in calves.  This 
could be due to differences in enzyme activity and pancreatic secretions that resulted in 
different administration forms.  Gόrka et al. (2011a and 2014) obtained similar results when 
supplementing calf milk replacer or starter meal with SB.  Supplementation in either diet 
affected small intestine morphology and brush border enzyme activity in the small intestine, 
increased pancreatic secretion, stimulated rumen development, increased digestibility of the 
diet, increased body weight gains, and increased the health of the calves; however, their 
results only showed an effect on calf health when a calf was supplemented with SB in both 
diets (Górka et al., 2011a, Górka et al., 2014).  Glucagon-like peptide 2 (GLP-2) is an 
important stimulator of intestinal development (Burrin et al., 2005) and was stimulated by SB 
supplementation in starter meal and milk replacer (Górka et al., 2011a, Górka et al., 2014).  
Sodium butyrate positively affected calf performance and health when added to milk 
replacer, as evidenced by stimulated intestinal cell proliferation, villus growth, and digestive 
enzyme activity (Guilloteau et al., 2004, Guilloteau et al., 2009).  Butyrate has also been 
found to trigger effective immune responses that lead to the elimination of infectious agents, 
involving phagocytosis and production of proinflammatory factors (Brown, 2006).  
Supplementation with SB stimulated defense systems through heat-shock proteins (HSP) and 
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modified immune and inflammatory responses in several research trials (Ren et al., 2001, 
Millard et al., 2002, Bocker et al., 2003).  Heat-shock proteins protect cells with intensive 
metabolism and in times of stress and are a wound healing component with cytoprotective 
effects (Wischmeyer et al., 1997, Welsh and Gaestel, 1998), protecting cells against 
environmental stress like elevated temperature, oxidative stress, pH and osmolarity changes, 
and electromagnetic fields, and by functioning as chaperone proteins (Zylicz and 
Wawrzynow, 2001, Sikora and Grzesiuk, 2007, Guilloteau et al., 2009).  Supplementation of 
SB in chickens under stress resulted in preservation of growth performance (Zhang et al., 
2011).  SB addition to the solid feed for piglets during weaning improved piglet performance 
by increasing body weight gains (Galfi and Bokori, 1990). 
When fed, SCFAs are quickly absorbed by the intestinal mucosa, are high in energy, 
are readily metabolized by intestinal epithelium and liver, stimulate sodium and water 
absorption in the colon, and are trophic to the intestinal mucosa (Koruda et al., 1990, 
Tappenden et al., 1996).  Since butyrate is absorbed by the small intestine (Manzanilla et al., 
2006), orally administered butyrate may not reach the large intestine if not given in high 
enough quantities, which could be why some studies reported  that orally administered 
butyrate did not improve the integrity or proliferation of the intestinal mucosa (Butzner et al., 
1996).  
Blends of fatty acids are also used to modulate growth and immune function due to 
the SCFAs in other fat sources that are used as energy sources for the intestinal microbes.  A 
research trial using coconut oil and canola oil improved growth and reduced scours in 
neonatal calves whether the oils were supplemented together or separately (Hill et al., 2007).  
Another study using a commercially available product that is a blend of butyric acid, coconut 
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oil, and flax oil supplemented into calf milk replacer resulted in improved growth rates and 
feed efficiency, reduced scours incidences, enhanced immune response enteric challenges, 
and improved recovery from vaccinations along with increased antibody responses with 
feeding the supplement for as little as 6 days (Hill et al., 2011). 
Phytonutrients and Herbal Extracts  
Many plants and herbs produce secondary metabolites that may be useful as feed 
additives because of their biologically active constituents (Wallace, 2004).  Plant-derived 
bioactive compounds, also referred to as phytonutrients (PN) or phytobiotics, such as 
phenolic compounds, essential oils, tannins, and saponins, express prebiotic activities 
including antimicrobial properties and inhibition of pathogens (Cowan, 1999, Panda et al., 
2006, Bakkali et al., 2008, Giannenas and Kyriazakis, 2009).  Some PN are resistant to 
microbial degradation in the rumen and could reach the small intestine in a biologically 
active form, hence exerting a prebiotic effect (Franz et al., 2010).  
Several phytonutrients in plants are effective in enhancing metabolism, but due to low 
bioavailability, supplementation has previously resulted in poor absorption, rapid 
metabolism, and rapid systemic elimination (Anand et al., 2007, Ferruzzi, 2010).  Many PN 
contain β-glucans that contribute to their immunomodulatory properties. (Ooi and Liu, 2000, 
Chang, 2002).  Another mechanism for the proinflammatory and pro-oxidative effect of 
dietary phenolics is the production of hydrogen peroxide, which damages bacterial 
membrane components, proteins, and DNA, coupled with phenolic oxidation (Lambert and 
Elias, 2010).  
The benefits of the phytogenic additives, spices, herbals, and their extracts, is due to 
modulation of gut microbiota, improvement in digestibility of feeds, stimulation of the 
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immune system, antimicrobial activities, anti-inflammatory properties, and antioxidant 
properties (Windisch et al., 2008, Costa et al., 2013).  Phytogenic additives are used in 
animal nutrition as appetite, digestion stimulants, antioxidants, and preventatives and 
treatments of pathological conditions (Hashemi and Davoodi, 2011).  The phenol and 
flavonoid content of plant extracts has been correlated with their inhibitory effect against 
bacterial pathogens by disruption of the bacterial envelope and forming complexes with the 
cell wall (Gonzalez et al., 1992, Bisignano et al., 1999, Rauha et al., 2000, Owen et al., 2003, 
Kurek et al., 2011).  
Carob extracts from the leaves and fruit of the carob tree have an antibacterial activity 
and antimicrobial compounds (Eldahshan, 2011, Meziani et al., 2015).  The antibacterial 
activity of carob extracts may be attributed to the presence of different bioactive compounds 
such as tannins, phenolic acids, flavonoids, and flavonoidal glycosides that impact growth 
and metabolism of microorganisms (Meziani et al., 2015).  The toxicity of tannins from 
carob extracts to various bacteria, fungi, and other microbial pathogens has been 
demonstrated in several studies (Henis et al., 1964, Kivçak et al., 2002, Taguri et al., 2006, 
Rodríguez et al., 2009, Hsouna et al., 2011, Ibrahim et al., 2013).  Tannins’ antibacterial 
effect may be due to their role as iron chelators that deprive microorganisms of an essential 
element (Scalbert, 1991).  
Tannins from carob extracts influenced the FA composition of milk in lactating cows 
by altering ruminal biohydrogenation pathways of unsaturated FA and improved feed 
efficiencies (Vasta et al., 2008, Dschaak et al., 2011).  Excessive amounts of tannin 
consumption compromise protein and carbohydrate digestion, reduce feed intakes, and 
reduce animal performance due to issues with their palatability and negative effects on 
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digestion (Broderick et al., 1991, Reed, 1995).  The denaturing of proteins by tannins has led 
to reductions in secretions by the intestinal mucosa (Das et al., 1999). 
Pomegranate extracts from the juice of pomegranates contain polyphenolic 
compounds, primarily punicalagin and ellagitannins, which possess antimicrobial, 
antioxidant, anti-inflammatory, antimitotic, and immunomodulatory properties (Adams et al., 
2006, Jayaprakasha et al., 2006, Rosenblat and Aviram, 2006).  Supplemented polyphenols 
from pomegranate extracts in preweaned dairy calves improved lymphocyte function which 
impacts humoral and cell-mediated immunity with active immunization (Oliveira et al., 
2010).  In a study supplementing rats with high levels of pomegranate extract, reduced intake 
and growth in the first 15 days of feeding was observed before improved growth rates 
occurred (Cerdá et al., 2003).  A different study involving the feeding of pomegranate seed 
extract to rats with induced diarrhea resulted in decreased defecation and gastrointestinal 
motility, possibly due to a reduction in fluid pooling into the intestine (Das et al., 1999).  
Garlic (Allium sativum) and garlic oil have antimicrobial, antioxidant, and 
anticarcinogenic properties and exhibit beneficial effects on the cardiovascular and immune 
systems (Garthwaite et al., 1994, Lang et al., 2004, Mirunalini et al., 2010).  Allicin, a major 
active component of garlic, enhanced proinflammatory responses in acute phase infection by 
parasites in mice (Feng et al., 2012), as well as inhibited growth of bacteria by binding to 
pathogenic microorganisms (Cavallito and Bailey, 1944, Rabinkov et al., 1998).  Allicin 
inhibits fungal and viral diseases (Davis et al., 1990, Weber et al., 1992).  
Black seed and cumin spice seeds fed at higher rates could induce a positive effect on 
organs involved in the immune system due to active components that exhibit antioxidant, 
antibacterial and anti-inflammatory activities (Alimohamadi et al., 2014).  The bursa of 
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Fabricius and thymus are two lympho-epithelial organs where the maturation and 
proliferation of B- and T -lymphocytes, respectively, take place that have been positively 
affected by black seed and cumin spice seeds added to feeds (Alimohamadi et al., 2014).  
Feeding higher levels of these spice additives could additionally improve lipid metabolism 
(Alimohamadi et al., 2014).  Feeding black cumin seeds has increased carcass characteristics 
in broilers (Al-Beitawi and El-Ghousein, 2008), as well as increased production performance 
(Al-Beitawi et al., 2009). 
A phytonutrient study of several different additives (curcumin, garlic extract, and 
capsicum) had subtle or no effects on blood cells and chemistry, nutrient digestibility, fecal 
bacterial diversity, antioxidant status, or expression of mRNA in liver for key enzymes in 
dairy cows when administered post-ruminally (Oh et al., 2013).  All phytonutrients studied 
did, however, appear to have an immune-stimulatory effect by activating and inducing the 
expansion of CD4 cells in the cows (Oh et al., 2013).  
Mixtures of Prebiotics 
Many prebiotic additives being researched are mixtures of several types of prebiotics, 
often one of them being a non-digestible carbohydrate.  The immunomodulation induced by 
different prebiotic additives often act additively or synergistically when multiple forms of 
prebiotics are used due to the complex relationships between diet, intestinal microbiota, their 
metabolites, and the host immune system (Chassard and Lacroix, 2013). 
A recent study supplementing a prebiotic mixture of GOS and maltodextrins 
exhibited bifidogenic properties by promoting increases in the populations of 
Bifidobacterium and inhibiting growth of undesirable bacteria (Musilova et al., 2015).  A 
change in SCFA production was also observed with acetic acid being most predominant and 
60 
 
butyrate being second most (Musilova et al., 2015).  The increased acetic acid production 
correlated with their finding of the mixture being bifidogenic because the acetic acid is the 
main SCFA produced by bifidobacteria.  
A mixture of short-chain GOS and long-chain FOS has prebiotic activities and 
immunomodulatory effects in animal models (Vos et al., 2006, Vos et al., 2007a).  This may 
be due to similarities in the oligosaccharide composition of this mixture and maternal milk 
(Boehm et al., 2003).  Supplementation with short-chain GOS and long-chain FOS was 
shown to be able to increase in the number of bifidobacteria and lactobacteria in the host 
microbiome (Fanaro et al., 2005, Knol et al., 2005, Moro et al., 2006).  This combination also 
increased bone mineralization, density and structure due to an increase in Ca, P and Mg 
absorptions to help improve growth and bone development in young animals (Bryk et al., 
2015). 
Greater weight gains were achieved by adding a combination of FOS, and short-chain 
fatty acids, sodium diacetate, and decoquinate, into milk replacer compared with 
supplementing the milk replacer with solely SCFA (Webb et al., 1992).  In another study, the 
short-chain GOS and long-chain FOS mixture led to significant reductions in the cumulative 
incidences of allergic manifestations and in the number of infectious episodes during 18 
months after the termination of oligosaccharide supplementation (Arslanoglu et al., 2008). 
A supplement containing FOS and inulin was found to trigger and stimulate the gut 
mucosal immune system (Benyacoub et al., 2008).  This combination also increased the 
number of bifidobacteria and lactobacilli, while reducing pathogenic microorganism 
populations.  Additionally, FOS and inulin supplementation is effective in preventing 
diarrhea caused by rotavirus (Swanson et al., 2002).   
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Using prebiotics with probiotics has been shown to improve the efficacy of both 
products in several situations.  A synbiotic is defined as a mixture of probiotics and 
prebiotics that beneficially affects the host by activating the metabolism of one or a limited 
number of health promoting bacteria and/or by stimulating their growth selectively and 
improving the host’s welfare (Salehimanesh et al., 2016).  A synbiotic mixture of a lactic 
acid producing probiotic and an inulin prebiotic provided protection to the host of bacterially 
infected mice by enhancing mucosal immune responses, reduced bacterial loads, and 
significantly reduced intestinal proinflammatory cytokines (Foye et al., 2012).  These 
findings support that early administration of synbiotic mixture leads to a potential indirect 
role of prebiotic inulin in regulating mucosal immune response by modulating the colonic 
microbial communities and lactic acid producing bacteria directly attenuating the mucosal 
inflammatory and immune responses through the secretion and expression of 
proinflammatory cytokines.  A trial performed with the combination of prebiotic inulin with 
the probiotic Lactobacillus rhamnosus and dietary fiber from soy polysaccharides further 
demonstrated the positive effects of synbiotics (Agustina et al., 2007).  Diarrhea duration and 
severity in the infants involved in their study was reduced significantly by supplementation 
of their mixture (Agustina et al., 2007).  Their combination of additives was supportive that it 
could be added to infant formulas for developing countries that have high incidences of 
infantile diarrhea.  
A synbiotic combination in calves has resulted in greater average daily gains than 
when calves received a probiotic or a prebiotic alone, which may be due to synergistic effects 
of the synbiotic supplement on the beneficial microflora (Roodposhti and Dabiri, 2012).  
Calves had lower E. coli levels in their gastrointestinal tract with either a prebiotic, a 
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probiotic, or a synbiotic, in comparison to calves that received unsupplemented milk, but 
calves receiving the synbiotic had the greatest reduction in E. coli levels (Roodposhti and 
Dabiri, 2012).  
A commercial synbiotic mixture containing FOS, allicin, and gut-active microbes 
performed equally to antibiotic supplementation on overall body weight gains, severity of 
scours, starter grain intakes, and body weight gains in dairy calves (Donovan et al., 2002).  A 
synbiotic combination of a lactic acid producing probiotic and prebiotic inulin may enhance 
host protection from pathogens through immunomodulation within the gut (Grau et al., 
2006).  
Synbiotics have not always shown positive results in studies, possibly due to 
administration forms, probiotic strains administered, type of prebiotics administered, and/or 
levels of supplementation.  Salehimanesh et al. (2016) found that supplementation of diet 
with prebiotic improved humoral immune responses in a manner that was superior to 
symbiotic supplementation.  In their study, treatments had no significant effect on microbial 
population of the selected bacteria in ileum and that consumption of the probiotic, the 
prebiotic, or the synbiotic mixture in diet of broilers had no significant effect on daily feed 
intake, daily body weight gain, feed conversion ratio, carcass traits, intestinal morphology, or 
bacterial populations of ileum.  
Herbal residues combined with other prebiotics are emerging as viable alternatives 
for antibiotics as feed additives for commercial production, such as ginger and inulin 
(Samanta et al., 2015).  Samanta et al. (2015) demonstrated a significant shift in the gut 
microbial composition in grower pigs when comparing supplementation with prebiotics, 
inulin or ginger, or with antibiotics, tetracycline, to the non-supplemented, control pigs.  
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More importantly, they observed a significant increase in the abundance of the beneficial 
microbes Bacteroides intestinalis, Selenomonas infelix, Selenomonas sp., and Eubacterium 
oxidoreducens with inulin or ginger supplementation as compared to control or tetracycline 
supplementation.  Additionally, a significant reduction in the abundance of pathogenic 
microorganisms was evident following supplementation of inulin or ginger in comparison to 
the control or tetracycline (Samanta et al., 2015).  
Probiotic Supplements 
Numerous non-antibiotics besides prebiotics positively affect growth and health in 
mammals, including probiotic bacteria, serum based products, bismuth salts, kaolin-pectin, 
enzymes, and charcoal.  They are often evaluated against antibiotics fed at therapeutic levels.  
Out of all of the non-antibiotic additives that are not prebiotics, probiotics show the most 
promise for a viable and effective non-antibiotic alternative.  There are numerous clinical and 
animal studies on probiotic bacteria that have demonstrated their potential for prevention and 
treatment of a variety of conditions both in the gastrointestinal tract and systemically 
(Sanders et al., 2013).   
The health and growth of commercial production animals are adversely affected by 
weather, major stress events like transportation, marketing, dietary changes, nutritional 
deficiencies, exposure to infectious agents and, most significantly, by the animal’s immune 
status.  Often these events lead to decreased feed consumption, impaired immune function, 
reductions in gastrointestinal barrier function, increase in coliform bacteria, and decreases in 
the protective gastrointestinal microflora, such as lactobacilli (Blecha et al., 1984, Fuller, 
1989, Cray et al., 1998, Loerch and Fluharty, 1999, Nabuurs et al., 2001, Soderholm and 
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Perdue, 2001).  The use of any type of antibiotic to treat illness and disease in animals leads 
to a significant increase in antibiotic-associated diarrhea (Bergogne-Berezin, 2000), possibly 
due to antibiotics’ negative impacts on beneficial microbe populations.  Probiotic 
consumption can ultimately result in a significant reduction in antibiotic use for various 
illnesses (Saavedra et al., 2004).   
Lactobacillus probiotics improve the beneficial microbe population of the host 
(Sanders, 1993).  Lactic acid producing bacteria (LAB) are capable of delivering enzymes 
and other substances into the intestine to possibly help to control intestinal flora (Ayebo, 
1980).  These LAB also inhibit the growth of pathogenic bacteria through decreasing pH in 
the intestines by production of lactic acid and through competitive attachment of pathogenic 
bacteria (Riddell et al., 2010).  Specific LAB have the ability to improve intestinal 
physiology, bacterial metabolic activity, prevent DNA damage and mutations, stimulate 
regulatory cytokine production, and produce a variety of antimicrobial substances such as 
organic acids, diacetyl, hydrogen peroxide, and bacteriocins (Rowland et al., 1998, 
Wollowski et al., 1999, Sreekumar and Hosono, 2000, Chen et al., 2005).  Lactobacillus 
acidophilus aids in weight maintenance during time of stress and exerts antagonistic actions 
against intestinal and food-borne pathogens and related organisms (Sabine, 1963, Cruywagen 
et al., 1996).  L.  acidophilus probiotics introduced early in life enhance host defenses against 
pathogenic infection, reduce mucosal intestinal inflammation, and attenuate injuries to the 
intestinal barrier (Chen et al., 2005).  Supplementation with L. rhamnosus reduces respiratory 
tract infections and other various infections typically treated with antibiotics, inducing a 
systemic immunomodulation (Hatakka et al., 2001).  L. casei supplementation in mice 
influenced the microflora positively during administration, but these effects were quickly 
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reversed when supplementation ended (Yin et al., 2014).  L. casei also reduced intestinal 
inflammation (Tien et al., 2006).   
There are numerous other bacterial species that have probiotic effects.  Lactobacillus 
spp., Bifidobacterium spp., and Enterococcus spp.  are currently the most commonly used 
bacterial species in probiotic products (Saarela et al., 2000).  Bifidobacteria supplementation 
to the diets of calves increased body weight gains and reduced fecal scores (Abe et al., 1995).  
Since Firmicutes were shown to be the most prevalent phylum of commensal bacteria in 
calves, one group supplemented calves with Faecalibacterium prausnitzii (Foditsch et al., 
2015).  Supplementation with F.  prausnitzii increased gastrointestinal health evidenced by 
decreased incidences of severe diarrhea, lowered mortality rates, and increased weight gains 
during the preweaning period (Foditsch et al., 2015).  This could be due to the anti-
inflammatory properties, improved gut integrity, and increased butyrate production 
associated with F.  prausnitzii (Foditsch et al., 2015).  These effects were only observed with 
oral administration of the probiotic, not rectal.   
There are marked differences on effects exhibited in the host when different strains of 
the same species of bacteria are supplemented.  In a study conducted with 3 different strains 
of L.  acidophilus, only one of the 3 strains were able to act in the gastrointestinal tract to 
efficiently inhibit most Gram-positive and Gram-negative bacteria and beneficially modify 
the intestinal flora (Sreekumar and Hosono, 2000). 
Probiotics can either contain multi-strain or single-strain bacteria.  Synergistic effects 
are observed when multi-strain probiotics are supplemented that may be attributed to the 
multi-strain probiotics more effectively creating a probiotic niche that enhances colonization 
of commensal bacteria (Timmerman et al., 2004).   
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Probiotic additives often need to be species-specific for maximum beneficial impact 
in the animal, however, multi-strain probiotics from a different species do elicit some 
benefits (Timmerman et al., 2005).  Timmerman et al.  (2005) conducted a study in calves 
that used a multispecies probiotic (MSPB) containing different probiotic species of human 
origin and a calf-specific probiotic (CSPB) containing 6 Lactobacillus species isolated from 
calf feces and selected on the basis of a combination of characteristics.  Both probiotics 
improved growth rates during the first 2 weeks, reduced digestive and respiratory diseases, 
reduced antibiotic usage, reduced mortality, improved average daily gains, and improved 
feed efficiencies.  The MSPB increased weight gains in calves that were sick and had 
diarrhea relative to calves supplemented with the CSPB.  Supplementation with MSPB also 
reduced the need for therapeutic treatments against gastrointestinal diseases.  The CSPB 
reduced the incidences of diarrhea and the load of pathogenic bacteria in the feces.  The 
differences in modes of action could have been due to the CSPB better colonizing the gut in 
calves than the MSPB (Timmerman et al., 2005).  Additionally, it was observed that CSPB 
was more effective at eliciting a positive reaction in the host in lower doses than the MSPB.   
Live yeast is another type of probiotic.  Live yeast supplementation in animal feed 
has demonstrated positive associations with growth performance and modification of gut 
morphology (Roto et al., 2015).  When immune-compromised calves were supplemented 
with live yeast, calves experienced fewer days with scours, improved grain intakes, increased 
body weight gains, and improved blood parameters during the preweaning period (Galvão et 
al., 2005).  In lactating cattle, live yeast supplementation increased feed intake, milk 
production, buffering capacity and ruminal pH, ruminal volatile fatty acid production, and 
digestibility of feeds (Desnoyers et al., 2009).  Improvement in performance and health with 
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live yeast supplementation is most likely due to improved growth and activity of fiber-
degrading bacteria and fungi, stabilization of rumen pH, prevention of lactate accumulation, 
improved ruminal microbial colonization, and stimulation of fermentation during the 
preweaning period (Fonty and Chaucheyras-Durand, 2006).  Additionally, live yeast may 
contribute growth factors for rumen microbes, enhance anaerobic environments with oxygen-
scavenging compounds, and nutritional competition with other commensal rumen microbes 
(Fonty and Chaucheyras-Durand, 2006, Marden et al., 2008).   
Not all studies have concluded that probiotic supplementation to diets was beneficial.  
Supplementation of calf milk replacer with a direct fed microbial probiotic did not improve 
intakes, affect any growth parameters, and had a negative effect on fecal scores  (Geiger et 
al., 2014).  Live yeast probiotic included in starter grain diets for calves did not show any 
effect (Quigley et al., 1992b).   
Summary 
 Thousands of studies have been conducted to see how different feed additives, 
environmental conditions, and event effect the overall health and growth of animals.  
Recently, it has become more apparent that almost always these factors are correlated with 
changes in the commensal microbial community structure within the gastrointestinal tract of 
animals. Prebiotics and probiotics are promising alternatives to antibiotics to improve the 
health and growth of animals by positively shifting the microbiota populations to a more 
ideal microbial community. Further research is needed to fully understand the most effective 
modes to alter the commensal microbes and how to best impact the stability of the optimal 
community diversity.  
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Interpretive Summary 
Prebiotics, non-digestible feed ingredients, have been proposed as non-antibiotic feed 
additives to improve animal health and growth rates by maintaining a healthy gastrointestinal 
tract commensal microbial population.  Calves supplemented in the milk diet with Galacto-
oligosaccharides (GOS), carob meal (CAR), or a butyric acid (BA) responded with prebiotic 
effects in comparison to the control (CON) group.  Supplementation with GOS and BA 
increased preweaning weight gains.  Calves in the CON group had less stimulation of their 
adaptive immunity than other treatment group calves.  Stimulation of lymphocytes differed 
between all treatments, which was associated with some differences in morbidity and 
mortality between treatments.   
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ABSTRACT 
Antibiotics fed at subtheraputic levels have been used improve growth and help 
prevent disease in dairy calf milk diet for decades.  Recent changes to the regulations of 
antibiotics added to feeds have led to prebiotics being proposed as viable options to be used 
as non-antibiotic feed additives.  These additives function to improve health and growth rates 
by maintaining a healthy commensal microbial population in the gastrointestinal tract.  The 
objective of this study was to evaluate three different prebiotics’ effects on growth and health 
in dairy calves when added to the milk diet.  Four-hundred eighty-two dairy calves were 
randomly assigned to one of four milk diet treatments: control diet (CON), a Galacto-
oligosaccharide additive diet (GOS), carob meal additive diet (CAR), or a butyric acid 
additive diet (BA).  Weight gains, morbidity, mortality, and mitogen proliferation with 
related cell counts were measured.  Calves supplemented with GOS, CAR, and BA were all 
found to respond with prebiotic effects in comparison to the CON group.  Supplementation 
with GOS significantly improved weight gains the first 77 d of age, increased T-lymphocyte 
stimulation in the first several weeks of life, and provided a long lasting positive effect on B-
lymphocyte stimulation when stress was simulated.  Supplementation with CAR increased B-
lymphocyte stimulation with and without the presence of stress and decreased the number of 
diarrhea treatments provided.  Supplementation with CAR did not improve T-lymphocyte 
stimulation and significantly increased pneumonia treatments administered.  Similar to GOS, 
supplementation with BA significantly increased weight gains the first 77 d of life and 
increased T- and B-lymphocyte stimulation when introduced to stress.  Calves on the BA diet 
had more diarrhea treatments, but less treatments for pneumonia.  These results further 
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support the prebiotic properties of GOS, CAR, and BA, but more research is needed to 
understand the mechanism through which the prebiotics impact health and growth in the calf.   
Key Words: prebiotics, Galacto-oligosaccharide, carob meal, butyric acid, calves 
INTRODUCTION 
 Adding therapeutic antibiotics to the diets of production animals enhances growth 
performance by increasing weight gains, improving feed efficiencies, and inhibiting 
proliferation of pathogens (Thomke and Elwinger, 1998, Castanon, 2007, Midilli et al., 
2008).  As regulations for the use of antibiotics continue to reduce their use, the need for 
non-antibiotic alternatives to help regulate immunity and growth of production animals 
continue to grow.  The use of antibiotics as growth promoters was banned in the European 
Union in the late 90’s (Boerlin et al., 2001) and is limited in the United States due to 
concerns over increases in antibiotic resistant bacteria (FDA, 2015).   
Prebiotics, or non-digestible feed ingredients, have been proposed as feed additives to 
effectively replace antibiotics without withdrawal times or the potential for resistance 
development from pathogenic organisms.  Prebiotics are gut microbiota stabilizers by 
inhibiting pathogenic colonization while selectively stimulating the growth of bacteria that 
are capable of health-promoting functions (Gibson et al., 2005, Brunser et al., 2006, Sharon, 
2006, Baurhoo et al., 2007).  Antibiotics are broad-spectrum killers of microorganisms and 
limit the growth of detrimental microorganisms, as well as growth and colonization of 
nonpathogenic bacteria (Visek, 1978).  The use of prebiotics ultimately results in effective 
and efficient immune responses by creating a more optimal gut environment for ingestion 
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and digestion, providing suitable pH, and better availability of items necessary for the 
immune system to function properly (Roberfroid, 1998). 
Calves and other neonates are at risk to be deficient in commensal microbe intestinal 
colonization due to many factors such as preterm birth, use of antibiotics, and complications 
during birth (Gewolb et al., 1999).  Immunological programming results from early prebiotic 
administration and leads to long-term protection against allergy, total number of infections, 
fever episodes, and antibiotic usage in young animals (Arslanoglu et al., 2008). 
There are numerous types of prebiotics used as feed additives currently.  Galacto-
oligosaccharides (GOS) are a type of non-digestible oligosaccharide.  GOS is produced from 
lactose or lactulose, and is comprised of a very complex mixture of carbohydrates  
(Hernández-Hernández et al., 2012).  Prebiotic activities of GOS are very dependent on the 
structure and susceptibility to gastrointestinal digestion (Depeint et al., 2008, Hernández-
Hernández et al., 2012).  Studies have shown that GOS has a bifidogenic effect (Shoaf et al., 
2006, Depeint et al., 2008). 
 Carob meal is a prebiotic derived from the seed of the carob tree (Ceratonia siliqua) 
and is less well studied.  The prebiotic effects of carob extracts may be attributed different 
bioactive and antimicrobial compounds such as tannins, phenolic acids, flavonoids, and 
flavonoidal glycosids that impact growth and metabolism of microorganisms (Meziani et al., 
2015).  Tannins and phenolic compounds are plant-derived bioactive compounds known as 
phytonutrients.  Phytonutrients express prebiotic activities including antimicrobial properties 
and inhibition of pathogens (Panda et al., 2006, Bakkali et al., 2008, Giannenas and 
Kyriazakis, 2009).   
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Several fatty acids have functions beyond being an energy source in mammals and 
have prebiotic and immunomodulatory properties (Guilloteau et al., 2004).  Butyrate is the 
most well studied short-chain fatty acid (SCFA) as a prebiotic and is also a naturally 
occurring product of microbial fermentation.  Butyric acid has widespread effects on growth, 
digestibility, and feed efficiency in healthy and immune compromised animals (Mazzoni et 
al., 2008, Guilloteau et al., 2009, Guilloteau et al., 2010a).  
 The objective of this study was to evaluate the suitability of GOS, carob meal, and 
butyric acid as prebiotic additives for use in dairy calf milk diets. 
MATERIALS AND METHODS 
 Animal procedures were under the direction of the advising veterinarian at the facility 
where the research was conducted, Parma, Idaho. 
Animals and Housing 
 Five hundred four dairy calves were obtained within 24-h from birth at 7 dairies in 
southern Idaho and brought to a commercial calf ranch in Southwestern Idaho.  Calves were 
obtained over an 11-d period.  The calves were all heifer calves that were Holstein, Jersey, or 
crosses between Holstein and Jersey breeds.  Calves were weighed upon arrival, randomly 
assigned to a treatment, and a blood sample was taken to be tested for failure of passive 
transfer via total serum protein levels.  Twenty-two calves died within 72-h of birth from 
infection by enteric pathogens prior to ingesting 4 feedings of milk diet, and therefore before 
ingesting significant amounts of either treatment diet.  Death losses, therefore, was unrelated 
to treatment.  Calves were housed individually in wooden hutches from arrival at the calf 
ranch to 77 d of age, and then moved into groups (n = 25 calves per pen) from day 78 until 
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the conclusion of the study at day 130.  The pens were outdoor pens sheltered by a shade 
covering.  Pens were re-bedded 2-3 times per week, fresh water was given twice daily, and a 
complete texturized starter grain was provided daily after 1 week of age.  A starter diet with 
18% CP was provided daily at a level to ensure ad libitum access (Cargill, Incorporated, 
Minneapolis, MN).   
 Additional weights were obtained when calves were moved from hutches to group 
pens 77 d of age and 130 d of age, which was the conclusion of the study, for a measurement 
of growth.  Blood samples were obtained at 2 wks of age, 4 wks of age, and 3 months of age 
from a subset of calves in each treatment group.   
Feeding Regime 
 Calves were enrolled onto the study at the first afternoon feeding upon arrival.  
During the trial, calves were fed supplemented waste milk twice daily at 0530 and 1530 h via 
a bottle.  All calves were fed 2 L per feeding for the first 15 d of the trial with a combination 
of waste milk collected from dairies that the calves originated from and a 20% protein, 20% 
fat powdered milk replacer (Calva Products, Inc., Acampo, CA).  These were combined to 
provide a 13% solids solution.  Fifteen days after the start of the trial, all calves were 
switched to 3 L per feeding through day 49 of a combination of waste milk collected from 
the dairies that the calves originated from, a liquid milk concentrate replacer (Calva Products, 
Inc., Acampo, CA), and a 20% protein, 20% fat powdered milk replacer (Calva Products, 
Inc., Acampo, CA) to provide a 13% solids solution.  Day 50 through 63, calves were fed a 
single 3 L feeding per day of the same combination.  Calves were weaned on day 64.  The 
concentrations of each product going into the milk diet mixture changed from day to day, but 
was not different between treatments because the solution was created using a computer-
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automated batch mixer.  Additionally, the commercial calf ranch added 5.8 g/d/head of a 
probiotic to help reduce Salmonella (Surveillance, MicroBasics, Eden, Idaho) and 0.1 g/d of 
another probiotic (Bovamine, CHR Hansen, Milwaukee, WI) to all treatments of milk every 
day, which was a part of protocols at the facility both before and during the study.  Calves 
were randomly assigned to one of four treatments upon arrival treatments were implemented 
that same day with the PM feeding of milk (126 calves per treatment).   
Dietary Treatments 
 The treatments were added to separate milk diet batches mixed in batch mixing tanks.  
The CON treatment did not contain any additional prebiotic additives beyond the normal 
farm protocols in the milk diet.  The GOS treatment contained 9.5 g/calf/feeding of the 
galacto-oligosaccharide prebiotic additive that was a whey permeate rich in GOS added to 
the milk diet (Milk Specialties Global Animal Nutrition, Eden Prairie, MN).   The whey 
permeate rich in GOS was manufactured under proprietary procedures, but generally it was 
produced from the residual whey left after cheese making that was ultrafiltered by membrane 
technology to isolate the protein fraction from the lactose.  The lactose is crystallized and 
subjected to enzymatic digestion with β-galactosidases to attack the o-glucosyl group of the 
lactose and yield a variety of compounds such as lactose, glucose, galactose, and 
oligosaccharides that collectively are named GOS.  The CAR treatment contained 15 
g/calf/feeding of a commercially produced carob meal prebiotic additive in the milk diet 
(Caromic 105, Euroduna Rohstoffe GmbH, Germany).  This carob meal additive was 
manufactured from the deseeded fruit of the Ceratonia siliqua L.  carob tree.  The BA 
treatment contained 1.25 g/calf/feeding of a commercially manufactured butyric acid 
prebiotic additive that is comprised of butyrins that are glycerol esters of butyric acid added 
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to the milk diet (ProPhorce SR 130, Perstorp Holding AB, Sweden).  There were 117 calves 
in the control group, 110 calves in the GOS group, 117 in the CAR group, and 120 calves in 
the BA group.   
Passive Immunity 
 Passive immunity was measured in calves upon arrival at the research site by 
collecting blood via jugular venipuncture and testing for total serum protein.  Initial blood 
total protein concentrations were measured on all calves (Table 3.1). Calves that died did 
have statistically lower initial blood total protein concentrations when compared to calves 
that survived (0.85 g/dl; P = 0.0024).  There were 30.3% of the calves in the trial that had 
failure of passive transfer of immunity and total serum protein concentrations less than 5.5 
g/dl (n = 146), however across all treatments calves had similar initial total serum protein 
levels.  
Morbidity and Mortality 
 Morbidity treatments and mortality were recorded for individual calves via RFID tags 
in the DairyComp305 computer program (Valley Agricultural Software, Tulare, CA). 
Cell Population Counts 
 Peripheral blood samples were obtained via jugular venipuncture at 2-, 4-, and 12 wks 
of age from a total of 40 calves (10 calves per dietary treatment) using 10 ml evacuated test 
tubes (Vacutainer brand tubes, Becton-Dickinson, Franklin Lakes, NJ) containing 143 USP 
units sodium heparin.  Blood samples were collected and shipped over night with ice packs to 
a microbiology lab at Iowa State University in Ames, Iowa.  Blood samples were used for 
cell population counts determined by a Mascot™ Hemavet® 850 machine (CDC 
Technologies Inc., Oxford, CT) and for mitogen proliferation assays. 
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Mitogen Proliferation 
 Proliferation assays non-specifically measure lymphocyte activation and determines 
the immunocompetence of an animal (Mond and Brunswick, 1994).  For the mitogen 
proliferation assays, concavalin A (ConA), lipopolysaccharide (LPS), corticosterone (Cort), 
and LPS with Cort were used to stimulate the cells in the samples.  ConA stimulates T-
lymphocytes, while LPS stimulates B-lymphocytes.  Cort was added to simulate a stress 
response.  Cells in the samples were stimulated at two different concentrations: sub-optimal 
and optimal.  ConA at 1.0 µg/ml, LPS at 0.1 µg/ml, Cort at 0.1 µg/ml, and LPS 0.1 µg/ml 
with Cort at 0.1 µg/ml are considered suboptimal conditions, and demonstrate the ability of 
lymphocytes to respond to low levels of antigen.  ConA at 2.5 µg/ml, Cort at 1.0 µg/ml, and 
Cort at 1.0 µg/ml with LPS at 0.1 µg/ml concentrations, however, are considered optimal 
conditions and should stimulate a majority of lymphocytes capable of proliferation to 
respond to the antigen.   
 To prepare the blood for use in the proliferation assay for T-cell function and B-cell 
function, whole blood was diluted 1:10 using RPMI 1640 medium (Life Technologies, Grand 
Island, NY) that was supplemented with 50µg/ml gentamicin, 25 mM HEPES (4(2-
hydroxyethyl)-1-piperazine ethanesulfonic acid), and 2 mM of L-glutamine (supplemented 
media).  Diluted whole blood was plated in 96-well cell culture plates (Corning® Costar®, 
Cambridge, MA) with stock mitogens that were diluted in supplemented media.  Equal 
volumes of blood and mitogens were plated in triplicate to attain final concentrations of 
mitogens as follows: Con A (Sigma-Aldrich® Cell Culture Reagents, St.  Louis, MO) at 
concentrations of 0, 1.0, and 2.5 µg/ml; LPS (Sigma-Aldrich® Cell Culture Reagents, St.  
Louis, MO) at concentrations of 0 and 0.1 µg/ml; Cort (Sigma-Aldrich® Cell Culture 
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Reagents, St.  Louis, MO) at concentrations 0, 0.1, and 1.0 µg/ml; and for Cort plus LPS at 
concentrations of  0.1 and 0.1 µg/ml, respectively, as well as 1.0 and 0.1 µg/ml, respectively, 
to represent functionality under stress conditions.  The plates containing ConA were then 
incubated for 62 h at 37˚C, 100% humidity, and 7% CO₂.  The LPS and Cort plates were 
incubated for 86 h at 37˚C, 100% humidity, and 7% CO₂.  The plates were then pulsed with 1 
µCi/well of [³H] thymidine (PerkinElmer Life Sciences, Inc., Boston, MA) and incubated 
again for 9-10 h.  The cellular DNA was harvested onto glass-fiber paper (Skatron 
Instruments Inc., Sterling, VA) using a Skatron Combi Cell Havester (Skatron Instruments 
Inc., Sterling, VA).  The dried samples on the glass-fiber paper were suspended in 1.5 ml of 
CytoScint ES Scintillation Cocktail (ICN Biomedicals, Costa Mesa, CA) and analyzed by a 
Packard TriCarb 2100TR Liquid Scintillation Analyzer (Packard BioScience Company, 
Downers Grove, IL).   
Statistical Analysis 
 Analysis of variance was performed using the general linear model and mixed 
procedures of SAS (SAS Institute Inc., 2016).  Dependent variables included weight gain, 
morbidity, mortality, and mitogen proliferation.   
 Results were analyzed according to treatment groups.  Significance was declared at P 
< 0.05 unless otherwise noted and probability values between 0.05 and 0.15 were defined as 
tendency towards significance.  Standard errors presented were for the differences among 
least squares means.   
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RESULTS  
Weight Gain 
 Between d 1 and d 77 (hutches) BA calves had higher weight gains than the CON and 
CAR groups (P =  0.0249).  Additionally, the GOS treatment group had significantly higher 
weight gains in the hutch than the CAR treatment group.  Weight gains while calves were 
housed in group pens (from 78 days until the end of the trial) or total weight gains were not 
significantly different between treatments (Table 3.2 and Figure 3.1).   
Mitogen Proliferation 
 Before analyzing the data obtained from the mitogen proliferation assays, data was 
corrected to account for the number of lymphocytes present in the sample, as counted by the 
Mascot™ Hemavet® 850 machine (CDC Technologies Inc., Oxford, CT).  For the statistical 
analysis, we compared differences in data between treatments by sampling period.  There are 
some trends suggesting differing treatments were able improve the efficiency of the calf’s 
immune system or accelerate the development of adaptive immunity (Table 3.3).   
 T-lymphocyte stimulation by ConA demonstrated numerous differences in T-
lymphocyte activity across the 4 treatment groups (Figure 3.2).  At all the 2 wks of age, 
calves in the CON and CAR treatment groups had significantly lower stimulation of T-
lymphocytes at all three levels of ConA in comparison to calves on the GOS and BA 
treatment groups (ConA 0 P = 0.0001, ConA 1.0 P = 0.0010, ConA 2.5 P = <0.001).  
Suboptimal stimulation of the T-lymphocytes in calves from the GOS treatment group at the 
2 wk sampling was also higher than the BA treatment group calves (P = 0.0010).  At the 4 
wk sampling, GOS had initial higher counts of T-lymphocytes in comparison to calves on the 
other treatments (ConA P = 0.0025), but there were no other significant differences between 
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treatment groups.  The sampling at 4 wks of age didn’t show differences in the total number 
of T-lymphocytes initially, but at 12 wks of age, calves on the GOS and BA treatments had 
lower stimulation at suboptimal stimulation levels (P = <0.0001) and at optimal stimulation 
levels (P = 0.0005).  Collectively, this could suggest a difference in the development of the 
active immune system in calves from the CON and CAR treatment groups leading to lower 
T-lymphocyte activity in the first few weeks of life, but increased stimulation after passive 
immunity is depleted and their own immune system is functioning more.  The altered 
stimulation of the immune system could also be due to a difference in the gastrointestinal 
microbial population in the CON and CAR groups from the GOS and BA groups since 
interactions between the commensal microbes and immune system help to regulate and 
stimulate host immune reactions.   
 B-lymphocyte stimulation by LPS with and without Cort to stimulate stress 
demonstrated differences in immune system stimulation between treatments as well (Figure 
3.3).  At 2 wks of age, calves on the BA treatment had higher initial counts of B-lymphocytes 
(P = 0.0268), as well a tendency for higher stimulation of B-lymphocytes at suboptimal 
levels of Cort (P = 0.0709) and a significantly higher stimulation at optimal levels of Cort (P 
= 0.0324).   
 Results from the 4 wks of age sampling demonstrated many differences, but overall 
calves from the CAR and CON treatment groups had the highest stimulation responses.  
There was a significant difference between the initial numbers of B-lymphocytes in groups, 
with calves in the CON and CAR treatment groups with them having higher initial numbers 
compared to calves from the other groups (P = 0.0049), as well as higher stimulation with 
suboptimal LPS concentrations (P = 0.0281). At suboptimal Cort concentration stimulation 
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for the 4 wk sampling, calves from the GOS treatment group had lower stimulation of B-
lymphocytes than calves from the other treatment groups (P = 0.0077).  Additionally, 
stimulation at suboptimal Cort and LPS concentrations and optimal Cort with suboptimal 
LPS concentrations for the 4 wk sampling period showed calves from the CAR treatment 
group had higher stimulation of B-lymphocytes than calves from the other groups (P = 
0.0042, P = 0.0334). Stimulation of B-lymphocytes with just optimal concentration levels of 
Cort resulted in calves on the CAR treatment having the highest stimulation which was 
significantly higher than all other treatments, the CON group calves having the second 
highest stimulation which was significantly higher than the GOS treatment, and the calves on 
the BA having the third highest stimulation which was also significantly higher than the 
response of the calves on the GOS treatment (P = 0.0027). 
 Results from the 12 wk of age sampling period did not show any differences in initial 
B-lymphocyte cell counts. When B-lymphocytes from calves in the CON group were 
stimulated at suboptimal concentrations of Cort they responded with higher stimulation 
levels than calves from any other treatment group (P = 0.0001), but at suboptimal 
concentrations of Cort and LPS, and optimal concentrations of Cort and LPS, they responded 
with significantly lower stimulation than calves on the other treatments (P = 0.0525, P = 
0.0423), thus resulting in a significantly lower percent difference. Stimulation of B-
lymphocytes with optimal levels of Cort resulted in calves on the CON treatment having 
significantly lower stimulation than calves on the GOS or CAR treatments (P = 0.0282). This 
indicates that calves on the CON treatment had higher B-lymphocyte responses to stress than 
calves from the other treatment groups at 12 wks of age.  
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 Thus, supplementation with GOS and BA may have stimulated the active immune 
system’s responsiveness within the first several weeks of life by an increase in T-lymphocyte 
concentrations and activity, but B-lymphocytes were not stimulated as easily as calves in the 
CON and CAR treatment groups. This result coupled with the B-lymphocytes after 2 wks of 
age being less stimulated could mean that the immune system is being stimulated at a 
different threshold in the GOS and BA fed calves than in calves in the CON and CAR 
groups.  Additionally, calves on the CON treatment may have had more intense responses to 
stimulation to stress, which is not a desirable thing and indicates a less efficient immune 
response compared to calves on other treatments.  
Morbidity 
 A high proportion of calves from each treatment group received medical treatments 
for various infections or diseases; however, there were no observed differences between 
treatment groups for the number of calves that received medical treatments throughout the 
study.  When analyzing the number of calves receiving medical treatments per treatment 
group for the neonatal period (less than 22 d of age), calves on the BA treatment had a 
tendency for more calves to be treated compared to calves in the CON and CAR groups (P =  
0.0939) (Table 3.4, Figure 3.4).  There were no observed differences in the number of calves 
treated after 22 d of age between treatment groups.   
 Morbidity was also analyzed by the number of total treatments per infection/disease 
between the treatment groups (Table 3.4, Figure 3.5).  There were no significant differences 
between calves afflicted with Mycoplasma, septicemia, or joint infections in any of the 
treatment groups.  For treatments of diarrhea, or scours, calves in the BA group had a higher 
total number of treatments received in comparison to the calves on the CAR diet (P =  
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0.0473); however, calves in the CAR group received more total treatments for pneumonia 
than the BA group calves (P =  0.0232). 
Mortality 
 Mortality was analyzed according to death loss during the first 21 d of age (neonatal), 
after 22 d of age (postnatal), and total death loss.  There were no differences between 
treatment groups for neonatal or total death loss (Table 3.5).  There was a trend (P =  0.1267) 
for calves in the CON group to have higher postnatal death loss.   
DISCUSSION AND CONCLUSION 
 Specific prebiotics may have better potential to alter the health and growth of animals 
consuming them on different operations, or combinations of prebiotics may be more potent 
than one source of prebiotics.  Prebiotics tested in this research trial clearly had different 
effects on the calves consuming them.  The results from this study on weight gains, 
morbidity treatments, and T- and B-lymphocyte stimulation would agree with that theory.   
 The success of passive transfer of immunity was not different between treatment 
groups for this study, but total serum protein levels were significantly lower for calves that 
died during the study.  Failure of passive transfer of immunity is associated with a much 
higher risk of illness and death in a calf, and this correlation was present in the current study.   
 Overall weight gains between treatment groups did not differ.  Weight gains during 
the first 77 d of life when calves were housed individually in hutches for the calves in the BA 
group were significantly higher than weight gains for calves in the CON and CAR groups, as 
well as for calves in the GOS group in comparison to the CAR group of calves.  This could 
be due to differences in feed efficiency during the preweaning period between treatments.  
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Surprisingly, calves on the BA group actually a higher number of medical treatments, which 
is often correlated with a decrease in average daily gain.   
 T-lymphocyte and B-lymphocyte stimulation with the mitogen proliferation assays 
showed large differences in immune system stimulation between calves from the 4 treatment 
groups.  Calves on the BA and GOS treatments, had greater stimulation of their T-
lymphocytes and adaptive immune system during the first few weeks of life in comparison to 
calves on the CON and CAR diets.  At 12 wks of age, T-lymphocyte stimulation for the BA 
and CON treatment group calves resulted in higher levels of stimulation than calves in the 
other treatment groups.  However, overall B-lymphocyte stimulation with and without the 
simulation of stress resulted in higher stimulation for calves in the CON and CAR treatment 
groups, beyond the 2 wks of age.  At 2 wks of age, calves from the BA treatment group had 
increased stimulation levels of B-lymphocytes, but this did not last past the first few weeks of 
life.  From 4 wks of life on, calves on the CON and CAR groups had higher B-lymphocyte 
stimulation than calves from the GOS and BA treatment groups.  Additionally, calves on the 
CON group had a much higher response to suboptimal stimulation with Cort, indicating that 
their immune systems may be overstimulated in stressful situations which could drain energy 
reserves and lead to increased inflammation.   
 Overall, data from the mitogen proliferation assays indicate that calves in the CON 
and CAR groups had less stimulation of their adaptive immune system during the prenatal 
phase of life and postweaning than calves on the GOS and BA treatments.  Stimulation of the 
B- and T-lymphocytes differed between the calves receiving GOS, CAR, or BA treatments in 
the manner that each prebiotic treatment improved the active immunity of calves in each 
treatment group: GOS supplementation stimulated the T-lymphocytes early on in the calf’s 
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life and increased stimulation of B-lymphocytes during periods of stress later in life after 
weaning; the CAR diet better stimulated the B-lymphocytes with and without the addition of 
Cort to simulate stress; and the BA treatment stimulated the adaptive immune system of 
calves mainly through stimulation of T-lymphocytes and by improving B-lymphocyte 
function early in life and during times of stress.   
 Morbidity rates were relatively high during this study, but since it was conducted at a 
commercial calf ranch with around 10,000 head of calves on milk from multiple dairies, 
relatively high levels of medical treatments are typical in comparison to a small operation 
that doesn’t bring in outside calves from other locations.  There were some interesting results 
regarding the number of calves per treatment group and the total number of medical 
treatments per disease between treatment groups that suggest differences in effects of the 
prebiotics tested.  There was a tendency for calves in the BA group to have a higher number 
of calves treated in the first 21 days of age in comparison to calves in the CON and CAR 
groups.  Total number of diarrhea treatments, or scours, within calves on the BA treatment 
were significantly higher than the total number of treatments given to calves in the CAR 
group; however, calves from the CAR group had significantly more total treatments for 
pneumonia than BA fed calves.  This may relate back to the results observed with the 
differences between immune system stimulation of prebiotic additives.  Calves fed BA had 
higher T-lymphocyte levels and increased stimulation of T-lymphocytes than CAR fed calves 
during the first four wks of the study, as well as increased levels of B-lymphocytes from the 
2 wk sampling with a higher stimulation response when Cort was introduced.  Thus, the 
immune system may have been strongly responding to the diarrhea infection within the calf 
and resulted in the difference of lymphocyte concentrations during these first few weeks of 
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life.  Conversely, the CAR fed group of calves had lower T-lymphocyte concentrations and 
stimulation during at least the first 4 wks of life, but at 4 wks of age, the B-lymphocyte 
concentration was increased in calves over the GOS and BA supplemented calves.  Both the 
BA and CAR fed calves had improved levels and stimulation of lymphocytes during the 
periods that presented the most infection and disease requiring medical treatments, which 
further shows alterations in the activation of the immune system between treatments.   
 Mortality was overall not significantly different between treatments; however, during 
the post weaning period of after 72 d of life, the calves in the CON group did have 
statistically more calves die in comparison to the calves in the GOS group.  This could be due 
to decreased immune function and lymphocyte stimulation in the calves from the CON 
treatment, as evidenced by the mitogen proliferation assay results.   
 Recently, research involving supplementation in dairy calves with the same source of 
GOS has shown the ability of GOS to promote the commensal bacterial population, with 
increases in Lactobacillus and Bidfidobacterium relative abundance, more developed 
intestinal epithelial structures, and greater fermentation in the colon (Castro et al., 2016a, 
Castro et al., 2016b).  These modes of action for GOS could explain why calves in the 
present study had increased weight gains during the first 77 d of life, as well as the increased 
T-lymphocyte concentration and stimulation early on, with long-lasting increases in B-
lymphocyte stimulation in the presence of stress.  Although previous studies have also found 
that GOS exhibited a bifidogenic effect (Shoaf et al., 2006, Depeint et al., 2008), other 
studies have not concluded that the beneficial effects of GOS last past the time of 
administration as seen in the present study (Davis et al., 2010).  Since the prebiotic activities 
of GOS are highly dependent on the structure of the GOS being supplemented, differences in 
144 
 
activity may be due to the structure of the GOS in this study versus previous studies (Depeint 
et al., 2008, Hernández-Hernández et al., 2012). 
 Carob extracts from the leaves and fruit of the carob tree have previously been shown 
to have an antibacterial activity and contain antimicrobial compounds (Eldahshan, 2011, 
Meziani et al., 2015).  Tannins in carob extracts are toxic to numerous bacteria, fungi, and 
other microbial pathogens (Rodríguez et al., 2009, Hsouna et al., 2011, Ibrahim et al., 2013).  
Calves on the CAR treatment may have had lower incidences of diarrhea due to the tannins 
exhibiting a local antibacterial/antimicrobial effect in the gastrointestinal tract; however, 
increases in pneumonia treatments in the CAR group suggest that the effects of carob extracts 
are localized to the gastrointestinal tract.   
 Butyrate is used as an energy source by enterocytes (Segain et al., 2000), stimulates 
cell proliferation, differentiation, and maturation (Pouillart, 1998, Partanen and Mroz, 1999, 
Kotunia et al., 2004, Franco et al., 2005, Mroz, 2005, Manzanilla et al., 2006, Hill et al., 
2007, Mazzoni et al., 2008, Guilloteau et al., 2009, Guilloteau et al., 2010a), improves 
intestinal barrier function, reduces enterocyte apoptosis, and that it has anti-inflammatory 
effects (Segain et al., 2000, Sengupta et al., 2006).  Butyrate has immunomodulatory 
properties due to its ability to modulate the antimicrobial host defense peptide gene 
expression (Sunkara et al., 2011, Sunkara et al., 2012).  Collectively, these positive effects on 
the host from BA supplementation could help explain the improved weight gains during first 
77 d of life in calves fed the BA treatment in the present study, as well as the increased T-
lymphocyte stimulation and improved B-lymphocyte stimulation when stress was introduced 
in the present study.  Butyrate has also been shown to improve the intestinal microflora 
(Biagi et al., 2007), but how quickly this occurs has not been well researched.  A possible 
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reason why calves on the BA treatment had higher total medical treatments for diarrhea, but a 
reduced rate of pneumonia treatments, could be due to butyric acid not positively effecting 
the microflora quickly enough in the neonatal calves.   
 In conclusion, GOS, CAR, and BA supplementation in calves were all found to have 
some prebiotic effects in the current study in comparison to calves on the CON treatment 
group.  The calves in the GOS treatment group had improved weight gains during the first 
77d of age, increased T-lymphocyte stimulation in the first several wks of life, and 
experienced a long lasting positive impact on B-lymphocyte stimulation when stress was 
simulated.  Calves from the CAR treatment group had increased in B-lymphocyte stimulation 
with and without the presence of stress, but did not experience an impact on T-lymphocyte 
levels or stimulation.  The calves supplemented with CAR additionally had received a higher 
number of treatments for pneumonia, but fewer diarrhea treatments.  The BA supplemented 
calves exhibited an increase in weight gains during the first 77d of life, increased T-
lymphocyte stimulation, and increased B-lymphocyte stimulation early in life and when 
introduced to stress, similar to calves receiving the GOS treatment.  However, unlike the 
calves from the GOS treatment group, calves on the BA diet had a higher number of 
treatments administered for diarrhea, but reduced treatments for pneumonia.  Collectively 
these results further support the prebiotic properties of GOS, CAR, and BA, but further 
research is needed to understand the mechanism through which each prebiotic impacts the 
health and growth of the calf.  These prebiotics are examples of non-antibiotic alternatives 
that have the potential to positively regulate the growth and immune functions in animals and 
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exhibit the desired effects that subtheraputic antibiotic administration has been long 
associated with.   
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Table 3.1.  Mean total serum protein levels by treatment group and for calves that died versus 
those that survived*. 
  CON GOS CAR BA P-value 
Total Protein g/dl 5.83 5.66 5.86 5.71 NS 
      
  Calves that Died Calves that Survived P-value 
Total Protein g/dl 5.35 5.85 0.0024 
CON: Calves in the control group fed a milk diet without any prebiotic additives (n = 119). 
GOS: Calves in the group fed the milk diet with the GOS additive (n = 116). 
CAR: Calves in the group fed the milk diet with the carob meal additive (n = 117). 
BA: Calves in the group fed the milk diet with the butyric acid additive (n = 121). 
Calves that Died: Calves in all treatments that died (n = 29). 
Calves that Survived: Calves in all treatments that survived (n = 444). 
*Blood samples for total serum protein analysis were taken upon arrival at the calf ranch 
when calves were put into their hutches. 
 
 
Table 3.2.  Mean weight gains in kilograms by treatment group. 
 
  CON GOS CAR        BA SE P-value 
Wt gains d 1-77 b, c48.04 a, b49.67 c47.09 a, b50.27 0.89 0.0249 
Wt gains d 78-130 85.81 85.62 85.90 88.94 2.21 NS 
Total Gain 133.85 135.28 132.99 139.21 4.47 NS 
CON: Calves in the control group fed a milk diet without any prebiotic additives (Wt gains d 
1-77 n = 105, Wt gains d 78-130 n = 48, Total Gain n = 48). 
GOS: Calves in the group fed the milk diet with the GOS additive (Wt gains d 1-77  n = 102, 
Wt gains d 78-130 n = 51, Total Gain n = 51). 
CAR: Calves in the group fed the milk diet with the carob meal additive (Wt gains d 1-77  n 
= 100, Wt gains d 78-130 n = 40, Total Gain n = 40). 
BA: Calves in the group fed the milk diet with the butyric acid additive (Wt gains d 1-77  n = 
105, Wt gains d 78-130 n = 48, Total Gain n = 48). 
a-cWithin a row, means not sharing a common script differ (P < 0.05). 
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Table 3.3.  Mean mitogen proliferation assay counts data by treatment group. 
  CON GOS CAR BA SE P-value 
Con A 0       
2 wks of age b791.87 a2050.89 b991.81 a2544.38 275.07 0.0001 
4 wks of age a962.91 1678.80 a1113.16 a1861.60 180.29 0.0025 
12 wks of age 693.09 849.62 852.47 698.56 64.06 NS 
Con A 1.0       
2 wks of age a6621.45 b173760.25 a7559.36 ab76193.99 30360 0.0010 
4 wks of age 21429.27 9949.82 20533.16 17781.85 7956.29 NS 
12 wks of age a12046.38 b3333.81 b4071.12 a10441.62 1164.59 <0.0001 
Con A 2.5       
2 wks of age b17609.75 a298698.80 b21754.46 a331115.70 49827 <0.0001 
4 wks of age 35692.87 43937.04 40275.38 52576.04 13611 NS 
12 wks of age a17610.63 b6742.39 b10049.68 a18535.85 2108.55 0.0005 
Cort/LPS (0/0)       
2 wks of age a1087.94 a1061.97 a1030.81 1420.76 98.00 0.0268 
4 wks of age a,1548.36 b,882.44 a2010.44 b1026.92 228.49 0.0049 
12 wks of age 735.35 839.31 872.80 742.25 96.66 NS 
Cort/LPS (0/0.1)       
2 wks of age 1140.79 1096.57 1085.02 1287.04 103.68 NS 
4 wks of age a3680.56 b1859.97 a3553.56 b2163.57 508.15 0.0281 
12 wks of age 827.41 830.91 929.83 773.62 82.42 NS 
Cort/LPS (0.1/0)       
2 wks of age a953.51 a1039.95 a997.87 1270.13 88.29 0.0709 
4 wks of age a1147.25 883.87 a1327.00 a1081.65 110.94 0.0077 
12 wks of age 1785.27 a748.33 a808.32 a674.02 173.61 0.0001 
Cort/LPS (0.1/0.1)       
2 wks of age 1026.92 1207.51 1090.43 1341.10 103.38 NS 
4 wks of age a1545.30 a1090.49 2138.24 a1402.10 192.05 0.0042 
12 wks of age 623.51 a849.36 a902.82 a842.82 73.64 0.0525 
Cort/LPS (1.0/0)       
2 wks of age a952.70 a1056.50 a945.19 1312.79 95.03 0.0324 
4 wks of age a, b1110.60 a, c798.23 1368.73 a, b, c1002.47 99.45 0.0027 
12 wks of age a552.73 735.02 766.25 a640.91 52.48 0.0282 
Cort/LPS (1.0/0.1)       
2 wks of age 1058.36 1170.53 991.98 1212.30 114.58 NS 
4 wks of age a1277.50 a935.13 1805.91 a1234.59 201.21 0.0334 
12 wks of age 601.58 a841.86 a872.73 a810.79 70.65 0.0423 
% Difference       
2 wks of age 93.57 105.29 92.85 94.07 4.72 NS 
4 wks of age 46.77 59.55 66.48 63.45 12.78 NS 
12 wks of age 78.14 a101.72 a98.67 a105.03 6.56 0.0277 
CON: Calves in the control group fed a milk diet without any prebiotic additives (n = 10). 
GOS: Calves in the group fed the milk diet with the GOS additive (n = 10). 
CAR: Calves in the group fed the milk diet with the carob meal additive (n = 10). 
BA: Calves in the group fed the milk diet with the butyric acid additive (n = 10). 
a-cWithin a row, means not sharing a common script differ (P < 0.10). 
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Table 3.4.  Mean morbidity numbers by treatment group. 
 
  CON GOS CAR BA SE P-value 
Total Calves Treated 112 93 112  108 15.79 NS 
 # of Calves Treated by Period        
<22d of age 62 a74 64  a79 5.11 0.0939 
22-71d of age 52 52 57    49 5.22 NS 
72+d of age 59 45 49     52 5.18 NS 
# Total Treatments/Disease        
Diarrhea a68 a75 66     a90 6.83 0.0473 
Mycoplasma 122 114 120    110 10.25 NS 
Pneumonia 26 22 a36     a18 5.56 0.0232 
Septic 12 2  18     18 3.58 NS 
Joints 2 12    0       0 0.97 NS 
CON: Calves in the control group fed a milk diet without any prebiotic additives (n = 117). 
GOS: Calves in the group fed the milk diet with the GOS additive (n = 110). 
CAR: Calves in the group fed the milk diet with the carob meal additive (n = 117). 
BA: Calves in the group fed the milk diet with the butyric acid additive (n = 120). 
aWithin a row, means not sharing a common script differ (P < 0.10). 
 
 
Table 3.5.  Mean mortality numbers by treatment group. 
  CON GOS CAR BA P-value 
Calves <22d of age 2 3 4 2 NS 
Calves 22+d of age 9 a2 a4 a4 0.1267 
Total 11 5 8 6 NS 
 
CON: Calves in the control group fed a milk diet without any prebiotic additives (n = 117). 
GOS: Calves in the group fed the milk diet with the GOS additive (n = 110). 
CAR: Calves in the group fed the milk diet with the carob meal additive (n = 117). 
BA: Calves in the group fed the milk diet with the butyric acid additive (n = 120). 
aWithin a row, means not sharing a common script differ (P < 0.15). 
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Figure 3.1.  Mean weights in kilograms of calves by treatment group (least squares means ± 
standard error of the mean). 
 
CON: Calves in the control group fed a milk diet without any prebiotic additives (Hutch 
Gains n = 105, Group Pen Gains n = 48, Total Gain n = 48). 
GOS: Calves in the group fed the milk diet with the GOS additive (Hutch Gains n = 102, 
Group Pen Gains n = 51, Total Gain n = 51). 
CAR: Calves in the group fed the milk diet with the carob meal additive (Hutch Gains n = 
100, Group Pen Gains n = 40, Total Gain n = 40). 
BA: Calves in the group fed the milk diet with the butyric acid additive (Hutch Gains n = 
105, Group Pen Gains n = 48, Total Gain n = 48). 
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Figure 3.2. Mean mitogen proliferation counts for T-lymphocytes by treatment group and by 
sampling period. 
 
CON: Calves in the control group fed a milk diet without any prebiotic additives (n = 10). 
GOS: Calves in the group fed the milk diet with the GOS additive (n = 10). 
CAR: Calves in the group fed the milk diet with the carob meal additive (n = 10). 
BA: Calves in the group fed the milk diet with the butyric acid additive (n = 10). 
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Figure 3.3. Mean mitogen proliferation counts for B-lymphocytes with and without 
corticosterone to simulate stress and percent difference demonstrating the difference of 
suboptimal B-lymphocyte stimulation with and without stress simulated by treatment group 
and by sampling period. 
 
CON: Calves in the control group fed a milk diet without any prebiotic additives (n = 10). 
GOS: Calves in the group fed the milk diet with the GOS additive (n = 10). 
CAR: Calves in the group fed the milk diet with the carob meal additive (n = 10). 
BA: Calves in the group fed the milk diet with the butyric acid additive (n = 10).  
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Figure 3.4.  Mean morbidity numbers by total number of calves given medical treatments by 
treatment and by time period (least squares means ± standard error of the mean). 
 
CON: Calves in the control group fed a milk diet without any prebiotic additives (n = 117). 
GOS: Calves in the group fed the milk diet with the GOS additive (n = 110). 
CAR: Calves in the group fed the milk diet with the carob meal additive (n = 117). 
BA: Calves in the group fed the milk diet with the butyric acid additive (n = 120). 
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Figure 3.5.  Mean morbidity numbers by the infection or disease that the calves were given 
medical treatments for by treatment group (least squares means ± standard error of the 
mean). 
 
CON: Calves in the control group fed a milk diet without any prebiotic additives (n = 117). 
GOS: Calves in the group fed the milk diet with the GOS additive (n = 110). 
CAR: Calves in the group fed the milk diet with the carob meal additive (n = 117). 
BA: Calves in the group fed the milk diet with the butyric acid additive (n = 120). 
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Interpretive Summary 
There are negative effects associated with the gastrointestinal microbial diversity from 
antibiotics fed at subtheraputic levels to livestock for increased health and growth.  There is 
little known about how different milk diet compositions affect bacterial community diversity 
in calves.  Four milk replacer diets were evaluated for effects on growth, health, and 
gastrointestinal bacterial diversity. There were no discernable in the parameters except in 
gastrointestinal bacterial diversity. Differing milk diets showed an effect on the bacterial 
community populations in the gastrointestinal tract of calves depending on if they included 
alternative proteins and/or antibiotics. 
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ABSTRACT 
Antibiotics are commonly fed to livestock at subtherapeutic levels for growth 
promotion and disease prevention.  There are negative effects associated with antibiotics on 
gastrointestinal microbial diversity.  There is little known about what effects non-milk 
derived proteins in a milk replacer have on a calf, or the effects of antibiotics added to 
alternative protein milk replacers on the bacterial community diversity in calves.  Four milk 
replacer diets were evaluated for their effects on growth, health, and gastrointestinal bacterial 
diversity.  The control diet was a milk replacer with all of the protein coming from milk-
derived sources (AM-).  The treatment diets consisted of the same all milk protein milk 
replacer with the addition of medication (AM+), a milk replacer with 10% of the protein 
replaced with non-milk derived proteins (ALT-), and finally the same alternative protein 
milk replacer with the addition of medication (ALT+).  There were no discernable 
differences in growth, fecal scores, morbidity, or mortality. Differences in gastrointestinal 
bacterial diversity between calves on the ALT- and ALT+ compared to the other treatments 
demonstrated a beneficial effect on the bacterial community with increased populations of 
Bifidobacterium and Lactobacillus.  Calves on the AM+ diet did not have the same positive 
changes in microbial populations over the course of the study that calves on other diets had. 
Calves from the AM+ treatment had lower population levels of Blautia microbes and higher 
levels of Prevotella microbes overall.  Calves on the ALT- diet exhibited the greatest number 
of changes to their bacterial diversity in comparison to calves on other treatments.  Results 
from the current study further confirm the impacts that diet has on the microbial diversity and 
microbial community development in animals.  Changing a portion of the protein sources to 
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alternative proteins and the addition of medication to the milk replacer fed to the calves in 
this study resulted in differing bacterial community structures.   
Key Words: calf, microbiota, growth, alternative proteins, antibiotics 
INTRODUCTION 
 Antibiotics are fed to livestock at subtherapeutic levels because of their growth 
promotion and disease prevention benefits (Braidwood and Henry, 1990, Berge et al., 2005, 
Wileman et al., 2009).  There has been, and continues to be controversy related to livestock 
production animal feeds containing antibiotics because of the possible emergence of 
antibiotic resistant bacteria from the unintentional selection of bacteria that are resistant to 
antibiotics and the important health consequences in both animals and humans (Smith et al., 
2004, Ho et al., 2010, McKinney et al., 2010). 
Nutritional status, good management, and overall health may outweigh the benefits 
associated with subtherapeutic feeding of antibiotics, since the benefits of medicated milk 
replacer have not been observed in young calves fed a higher plane of nutrition than 
conventional feeding practices (Witte, 1998, Thames et al., 2012). Feeding antibiotics may 
lead to increased incidences of diarrhea due to disturbances in the beneficial gut microflora, 
especially in preweaned animals (Rollin et al., 1986, Nord, 1993).  The inclusion of 
oxytetracycline, tetracycline, and neomycin in milk replacer for young calves is one of the 
most common uses of subtherapeutic antibiotics in the U.S. dairy industry (Berge et al., 
2005). Neomycin is not absorbed systemically and its activity is restricted to the 
gastrointestinal tract (Aschbacher and Feil, 1994). Oxytetracycline and tetracycline, in 
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contrast, are predominantly absorbed out of the gastrointestinal tract and thus useful for the 
prevention and treatment of respiratory infections (Aschbacher and Feil, 1994).   
Calves exposed to antibiotic resistant bacteria during or shortly after birth or fed 
antimicrobials in their milk are more likely have bacteria resistant to multiple antibiotics 
within the first couple weeks of life than as newborns, further evidencing the development of 
antibiotic resistance (Berge et al., 2006, Pereira et al., 2011).  Resistance of gut bacteria to 
antibiotics increased with increasing antibiotic concentrations in the milk fed to calves and 
was residual, which could lead to the development of superbugs on the facility (Langford et 
al., 2003).  A higher rate of antibiotic-resistant bacteria have been found more on farms with 
a high incidence of diarrhea in dairy calves, most likely due to scours treatment with 
antibiotics (Gunn et al., 2003).  The form of delivery and events during and after birth such 
as hypoxia, hygiene of the environment, pre-weaning diet, vaccination, and use of antibiotics, 
may also alter the commensal microbe population, the outcome of immune development, and 
potentially effect production and health (Palmer et al., 2007, Hill and Artis, 2010).  
 There are significant differences in the diversity of microbiota in calves fed milk 
replacer instead of dams’ milk, in calves fed medicated feed, and in calves fed starter grain, 
in comparison to those not fed starter (Dethlefsen and Relman, 2011, Malmuthuge et al., 
2013).  It is not well known if changes in protein sources in milk replacer effect the diversity 
and structure of commensal microbe populations significantly, but it is possible since 
alternative proteins, such as plant proteins, are digested differently than milk proteins by the 
calf.  Changes in the bacterial diversity, expression of genes encoding host mucosal immune 
responses, and barrier functions can be altered by changes in the diet (Malmuthuge et al., 
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2013).  Antibiotics decrease populations of beneficial bacteria, and in particular bacteria that 
produce butyrate for the host energy metabolism (Ubeda et al., 2010, Dethlefsen and Relman, 
2011).   
 The objective of this study was to evaluate if protein sources in calf milk replacer 
and/or medication added to the milk replacer alter the gastrointestinal microbiota, growth, or 
health of dairy calves during the preweaning period. 
MATERIALS AND METHODS 
 Animal procedures were under the direction of the advising veterinarian.  This 
research was conducted at a commercial facility in Boscobel, Wisconsin. 
Animals and Housing 
 Thirty-six Holstein bull calves were obtained prior to 1 wk of age from two sale barns 
near Boscobel, Wisconsin.  Two calves died on the second day of the study from infection by 
enteric pathogens prior to ingesting significant amounts of milk replacer, and therefore 
before ingesting significant amounts of any treatment diet.  Death losses, therefore, were 
assumed to be unrelated to treatment and the calves were not included in the study that died.  
Calves were transported to the research site in Boscobel, Wisconsin, where they were housed 
individually in hutches.  The study lasted for 7 wks and calves were not weaned during the 
study. 
Dietary Treatments 
 Before the trial, calves were fed a 22% crude protein, 20% fat all milk commercial 
milk replacer twice daily via a bottle at a level of 283g of powder reconstituted to 2 L of 
water for the first two wks and then at a level of 348g of powder reconstituted to 2 L of water 
164 
 
for the remainder of the study (Milk Specialties Global Animal Nutrition, Eden Prairie, MN).  
Calves were randomly assigned to one of four treatments upon arrival and milk replacer 
treatments were implemented two days following the arrival of the second group of calves (9 
calves per treatment).  The treatments were all milk replacers with a 22% crude protein and 
20% fat level.  The control treatment (AM-) milk replacer had all milk derived proteins as 
the source of protein and no medication added (Milk Specialties Global Animal Nutrition, 
Eden Prairie, MN).  The second treatment (AM+) milk replacer had all milk derived proteins 
as the source of protein (Milk Specialties Global Animal Nutrition, Eden Prairie, MN) and a 
medication pack added to it at a rate of 0.8 oz/hd/feeding (CalfAlly NT Add Pack, Milk 
Specialties Global Animal Nutrition, Eden Prairie, MN).  The third treatment (ALT-) was a 
milk replacer with wheat isolate, plasma, and milk derived proteins and no antibiotics added 
(Milk Specialties Global Animal Nutrition, Eden Prairie, MN).  The final treatment (ALT+) 
was a milk replacer with wheat isolate, plasma, and milk derived proteins (Milk Specialties 
Global Animal Nutrition, Eden Prairie, MN) and a medication pack added to it at a rate of 0.8 
oz/hd/feeding (CalfAlly NT Add Pack, Milk Specialties Global Animal Nutrition, Eden 
Prairie, MN).  A starter diet containing 20% protein and Deccox (Big Gain, Inc, Mankato, 
MN) was offered beginning d 1 and daily dry feed refusals by group were recorded.   
Milk Replacer Treatments 
 All milk replacers are commercially available milk replacers that were manufactured 
by Milk Specialties Global Animal Nutrition (Eden Prairie, MN).  All treatments were 22% 
protein, 20% fat partially agglomerated formulas.  In the ALT- and ALT+ milk replacer, 10% 
of the total protein was substituted with hydrolyzed wheat proteins and bovine plasma 
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proteins, with 5% per total milk protein content being substituted with each alternative 
protein.  In the AM+ and ALT+ treatments, 23g per feeding of CalfAlly NT (Milk Specialties 
Global Animal Nutrition) was added to the milk replacer to deliver 1000 mg of neomycin 
and oxytetracycline per day. 
Passive Immunity 
 Passive immunity was measured in all calves 24 hr after arrival at the research site by 
collecting blood via jugular venipuncture. Serum protein was determined via refractometry 
by the advising veterinarian. 
Measurements 
 Calf fecal scores were recorded daily, as well as all treatments administered.  Fecal 
scores were taken by the same researcher throughout the study and based on a scale of 1 to 4: 
1 is normal and firm; 2 is soft and spreads easily; 3 is very loose with no watery separation; 
and 4 is very watery.  Weights obtained at the beginning and the end of the study, d1 and d 
42, respectively.  Fecal samples were obtained at d 7 and d 42 of the trial. Pens were bedded 
daily with wheat straw and fresh water was provided twice daily. 
Fecal Microbiota Samples 
  Fecal samples were obtained from all calves at d 7 and d 42 of the study. Swabs were 
used to obtain fecal samples from the calves, individually bagged, frozen at -18°C, and 
shipped to Dr. Mark McGuire’s laboratory at the University of Idaho (Moscow, ID) for 
storage at −80°C until DNA extraction could be performed.  Bacterial taxa were 
characterized with the use of high-throughput sequencing.  Bacterial community structure (at 
each taxonomic level) were visualized and analyzed with the use of stacked bar charts, 
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principal component analysis (PCoA), and multivariate analyses such as nonmetric 
multidimensional scaling (NMDS). 
Extraction and Amplification of Bacterial DNA 
 Changes in bacterial populations between treatment groups from the fecal samples 
obtained were assed in a laboratory at the University of Idaho (Moscow, ID).  Samples were 
stored at −80°C until DNA extraction.  Total microbial DNA was extracted using a 
QIAamp® Fast DNA Stool Mini Kit (QIAGEN Catalog no. 51504, QIAGEN, Valencia, CA) 
following the manufacturer’s protocol, which implements mechanical disruption (i.e., bead 
beating) and is an effective method for DNA extraction from digesta from diverse species 
(Hart et al., 2015).  A solution of TE 50 (10 mM Tris-HCl and 50 mM EDTA, pH 8; 500 µL) 
was used as a negative control.  Extracted DNA was eluted in AE buffer and stored at -80°C 
until further analysis.  A dual-barcoded 2-step PCR was conducted to amplify the V1–V3 
hypervariable region of the bacterial 16S rRNA gene; a 7-fold degenerate forward primer 
targeting position 27F and a reverse primer targeting position 534R were used. 
 DNA was amplified in a dedicated PCR hood, and the PCR mixture (50 µL) 
contained the following: 0.25 µM primers (Integrated DNA Technologies), 4 µL DNA 
extract, and a PCR master mix containing a final concentration of 1X PCR buffer (Life 
Technologies), 3 mM MgCl2 (Life Technologies), 0.24 mg/mL BSA (Sigma), 0.2 mM 
deoxyribonucleotide triphosphate (Life Technologies), and 0.05 U/mL AmpliTaq DNA 360 
polymerase (Life Technologies).  The PCRs were conducted with the use of an Applied 
Biosystems 2720, Veriti, or ProFlex model thermocycler under the following conditions: 
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95°C for 2 min, then 95°C for 1 min, 51°C for 1 min, and 72°C for 1 min for 30 cycles, and 
then a final extension step of 72°C for 10 min.  Samples were held at 4°C in the 
thermocycler.   
 Products from the first PCR were electrophoresed on 1% agarose gels made with tris-
acetate-ethylenediamine tetraacetic acid (40 mM Tris, 20 mM acetic acid, and 1 mM EDTA) 
buffer and containing ethidium bromide (0.0007 g/L).  Gels were allowed to run for 30 min 
at 80 V, and bands were viewed with the use of a BioRad UltraCam Digital Imaging System. 
Samples with high-quality amplicons (a relatively bright band of interest at ~534 bp), low 
primer-dimers, and absence of unwanted bands or smears were deemed acceptable for the 
second PCR reaction.  The PCR products were diluted (1:14) with nuclease-free water and 
subjected to a second round of PCR in a reaction mix containing 0.75 µL primers with dual-
index barcodes and Illumina sequencing adapters (University of Idaho Institute for 
Bioinformatics and Evolutionary Studies Genomics Resources Core Facility).  The quality of 
the second PCR amplicons was evaluated with the use of a QIAxcel DNA screening cartridge 
(QIAGEN), and DNA quantified with the use of PicoGreen (Life Technologies).   
 An appropriate volume of each amplicon (containing 50 ng DNA) was pooled to 
create a composite sample for high-throughput sequencing.  Amplicon pools were size-
selected with the use of AMPure beads.  The cleaned amplicon pool was quantified with the 
use of a KAPA Illumina library quantification kit (KAPA Biosciences) and the Applied 
Biosystems StepOne Plus real-time PCR system.  Sequences were obtained with the use of 
an Illumina MiSeq v3 paired-end 300 bp protocol for 600 cycles.  
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Sequence Analysis 
 Raw DNA sequence reads were processed with the use of the python application 
dbcAmplicons (https://github.com/msettles/dbcAmplicons).  The dbcAmplicons application 
was designed to process Illumina double-barcoded amplicons generated in the manner 
described above.  Specifically, the application performs processing of raw reads 
(preprocessing), joining of overlapping paired reads into longer single reads, classification of 
reads to the genus level, and generation of abundance tables.  During preprocessing, barcodes 
were allowed to have ≤1 mismatch (Hamming distance), and primers were allowed to have 
≤4 mismatches (Levenshtein distance), as long as the final 4 bases of the primer perfectly 
matched the target sequence.  Reads identified as not having a corresponding barcode and 
primer sequence were discarded.  dbcAmplicons uses a modified version of FLASH (Magoč 
and Salzberg, 2011) to join overlapping reads and the Ribosomal Database Project Bayesian 
classifier (Wang et al., 2007) to assign sequences to phylotypes.  Reads were assigned to the 
first Ribosomal Database Project taxonomic level with a bootstrap value ≥50%. 
Statistical Analysis 
 For the performance data, analysis of variance was performed using the general linear 
model and mixed procedures of SAS (SAS Institute Inc., 2016).  Dependent variables 
included weight gain, fecal scores, morbidity, and mortality.  Significance was declared at P 
< 0.05 unless otherwise noted and probability values between 0.05 and 0.15 were defined as 
tendency towards significance.  Standard errors presented were for the differences among 
least squares means. 
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 Results were analyzed according to treatment groups.  There were 7 calves in the 
AM- control group, 8 calves in the AM+ group, 8 calves in the ALT- group, and 8 calves in 
the ALT+ group.  
 For the fecal microbiome data, characterization of bacterial community composition, 
and diversity was done via sequence counts that were standardized and converted to relative 
abundance values with the use of the decostand function in R (vegan package, version 
0.98.945).  Principal coordinate analysis (PCoA) and nonmetric multidimensional scaling 
(NMDS) were conducted in R to visualize the degree of bacterial similarity between the 
treatments and sample periods on the OTU-based Bray-Curtis distance matrix (Borcard et al., 
2011).  The significance in bacterial community diversities between different treatment 
groups and sample periods were analyzed using the general linear mixed models of SAS 
(SAS Institute, Inc., 2016).  Standard errors presented were for the differences among least 
squares means.  
RESULTS 
Passive Immunity 
 There were 11 calves total (34.4%) that had failure of passive transfer of immunity 
with total serum protein concentrations less than 5.5 g/dl (n = 32). Calves that died in the 
study died did not have lower initial total serum protein levels when compared to the calves 
that survived.  Calves had similar initial total serum protein levels over all dietary treatments 
(Table 4.2).   
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Weight Gain 
 Weights at d 7, d 42, and total weight gains were not different by treatment (Figure 
4.1). 
Fecal Scores 
 Fecal scores did differ between dietary treatment groups, although in wk 3 calves on 
the AM+ treatment did have a tendency to have higher fecal scores compared to calves in all 
other treatment groups (P =  0.0773; Table 4.3).  There was a tendency for calves in the AM+ 
during wk 7 to have improved fecal scores over calves in other groups (P =  0.1081).    
Morbidity and Mortality 
 There were no significant differences in the number of calves receiving medical 
treatments for scours or pneumonia between treatment groups (Table 4.4).  There were no 
differences in the number of calves that died during the study.  The AM-, AM+, and ALT- 
groups each had one calf die with no calves dying in the ALT+ treatment group.  
Bacterial Community Diversity 
 Bacterial community diversity was analyzed according to overall abundance 
percentage from the average of data from the two sampling periods (Table 4.6) and according 
to percentage abundance by sampling period (Table 4.7).  Overall, ~98% of the total bacterial 
community at the phyla level were from 4 phyla communities (Figure 4.2).  Firmicutes made 
up 58% of the total, followed by Bacteroidetes (30%), Actinobacteria (7.6%), and 
Proteobacteria (2.4%). Calves in the present study on the ALT- diet had significantly higher 
levels of Firmicutes between the two sampling periods than calves on the AM+ diet (P =  
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0.0283).   Calves from the AM- diet had a significantly higher percentage of Proteobacteria 
in the combined sampling analysis than calves from any other treatment group (P =  0.0320).  
 When comparing the phyla composition percentages between treatments, there were 
several significant differences that led to the differences observed from the combined data. 
The calves fed the ALT- diet had a significantly higher percentage of Firmicutes in the 
second sampling when compared to calves on the AM+ diet (P =  0.0239).  Calves from both 
the AM- and ALT- groups had increases in the percentage of Firmicutes in the second 
sample over the first sample (P =  0.0560 and P =  0.0379, respectively).  Calves on the AM+ 
diet showed a trend in the percentage of Actinobacteria increasing for sample 2 in 
comparison to sample 1 (P =  0.0999).  Although calves on the AM- had significantly higher 
levels Proteobacteria overall and for the first sampling, there was a significant decrease in 
this bacterial community for the second sampling which brought their percentages down to 
be in line with calves from the other treatment groups (P =  0.0025).  
 The bacterial community composition at the genus level overall was made up mainly 
by 4 populations of bacterial communities, as well as a large portion of the readings from the 
samples that were unclassified (Figure 4.3).  The unclassified readings comprised 17.06% of 
the genus community composition, followed by Bacteroidetes (12.94%), Blautia (11.89%), 
Prevotella (10.16%), and Faecalibacterium (6.01%). Although Bifidobacterium (1.84%) and 
Lactobacillus (1.03%) were not one of the 5 most abundant genus communities, we did 
include them in our tables due to the positive effects associated with increases in their 
populations.  Additionally, at the genus level we used a PCoA plot to show the variation 
among samples by treatment (Figure 4.4) and sampling times (Figure 4.5), as well as a 
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NMDS plot to visualize the similarities and dissimilarities among bacterial communities 
between treatments (Figure 4.6) and sampling times (Figure 4.7).  
 In the combined sample periods data, the Blautia genus tended to be increased in 
calves from the ALT- group over other groups (P =  0.0633).  The Blautia genus of bacteria 
is known to breakdown complex polysaccharides to short-chain fatty acids in the 
gastrointestinal tract (Biddle et al., 2013).  Bifidobacterium population percentage from the 
data combining the two sampling periods were significantly increased in overall in the ALT+ 
(P =  0.0433).  
 When sample periods were analyzed individually between treatments, there were 
numerous significant differences.  The unclassified genus bacteria significantly decreased in 
all calves across treatments between the first and second samples (AM- P = 0.0030, AM+ P = 
0.0137, ALT- P =  0.0058, and ALT+ P =  0.0002).  Blautia populations increased between 
sample 1 and sample 2 for the calves on the AM- group (P =  0.018) and this population 
tended to be higher in the AM- fed calves than the AM+ calves for the second sample (P =  
0.0914).  Blautia populations also tended to be increased for the calves receiving the ALT- 
diet in the second sample when compared to the first (P =  .1078), but were significantly 
higher for the second sample from calves on the ALT- treatment than the calves consuming 
the AM+ diet (P =  0.0298).  Prevotella microbes had increased populations in the second 
sample from calves receiving the AM+ diet than calves on the AM- and ALT- diets (P =  
0.0551 and P = 0.0378, respectively).  Faecalibacterium microbial populations were 
significantly higher in calves on the ALT+ for the second sample period in comparison to the 
first (P =  0.0008), and were also significantly higher for the second sample than populations 
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in calves receiving the AM- and the AM+ diets (P =  0.0476 and P =  0.0248, respectively).  
Calves receiving the ALT- treatment also had significant increases in the population 
percentage of Faecalibacterium with the second sample over the first sample (P =  0.0043). 
 Bifidobacterium and Lactobacillus both had numerous changes in population 
percentages between sample periods and treatments. Bifidobacterium tended to increase in 
the second sample when compared to the first sample for calves consuming the AM- and 
ALT+ treatments (P =  0.0885 and P =  0.0739, respectively).  Calves in the ALT+ treatment 
group had significantly higher Bifidobacterium populations in the second sample period than 
calves on the AM+ treatment (P =  0.0278) and tended to be higher than calves on the AM- 
and ALT- treatments (P =  0.0085 and P =  0.0739).  Lactobacillus populations were highest 
for the calves receiving the ALT- diet for the second sample over calves on other treatments 
(AM- P =  0.0455, AM+ P =  0.1217, ALT+ P =  0.0652).  The Lactobacillus populations 
tended to increase significantly between the first and second sampling period with a change 
in percentage from 0.2352% to 7.287% (P =  0.0917). 
DISCUSSION AND CONCLUSION 
Bacterial community diversity varies during the first few weeks of life in neonatal 
calves.  The microorganisms of the mammalian gut have evolved to aid the gastrointestinal 
epithelium, as well as to provide benefits to the host through biochemical and metabolic 
pathways not found in the host genome: provision and absorption of essential nutrients 
(Hooper and Gordon, 2001, Candela et al., 2010, Delzenne and Cani, 2011), metabolism of 
non-digestible feeds and carbohydrates produced by other microbes (Hooper and Gordon, 
2001, Korakli et al., 2002, Brisbin et al., 2008, Hoffmann et al., 2009), providing energy 
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sources for the intestinal epithelium microbes (Hooper and Gordon, 2001), protection against 
colonization by opportunistic pathogenic organisms (Asahara et al., 2001, Round and 
Mazmanian, 2009), production of bacterocins and antimicrobial peptides, contributions to the 
development of the intestinal tissues, repair of and protection against epithelial damage 
(Rakoff-Nahoum et al., 2004, Guarner, 2006, Brisbin et al., 2008, Hoffmann et al., 2009, 
Gallo and Hooper, 2012, Hooper et al., 2012, Belkaid and Hand, 2014), providing a 
protective biofilm, promoting development and maintenance of a healthy immune system, 
and regulating innate immune responses to protect the gastrointestinal environment 
(Macpherson and Harris, 2004, Backhed et al., 2005, Gallo and Hooper, 2012, Goto and 
Kiyono, 2012,).  
Although there were no discernable differences in growth, fecal scores, morbidity, or 
mortality, the alternative protein sources in the milk replacer as well as the addition of 
antibiotics did have an effect on bacterial diversity that could have long-lasting impacts on 
the calf.  Calves on the AM+ diet did not have the same positive changes in microbial 
populations over the course of the study that calves on other diets had. Calves from the AM+ 
treatment had lower population levels of Blautia microbes and higher levels of Prevotella 
microbes overall.  These differences could be due to the antibiotics that the calves on this 
group were consuming daily over the course of the study.  
 Calves on the ALT- diet exhibited the greatest number of changes to their bacterial 
diversity in comparison to calves on other treatments.  The increase in Bifidobacterium and 
Lactobacillus observed in the calves on the ALT- diet could have positive impacts on 
digestion efficiency and the immune function in calves.  Lactobacilli and bifidobacteria are 
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both well-known commensal microbial species that are very important in maintaining 
homeostasis of the gastrointestinal microbiota (Sandine, 1979, Stephenson et al., 2010).   
Increasing populations of these microbes even in small amounts exhibits positive effects on 
the host.  Lactic acid producing bacteria increase IgA production both locally and 
systemically at other mucosal sites by activating the adaptive immune system through 
stimulating mucosal B cells and CD4+ T cells (Perdigon et al., 1999, Corthesy et al., 2007).  
Higher levels of lactic acid bacteria in calves could be essential to stimulate maturation of 
gut-associated lymphoid tissues and to increase secretory IgA, which would both boost the 
active immune responses when passive immunity obtained from colostrum is diminished 
(Malmuthuge et al., 2013).  
Maintaining a healthy microbiota leads to less immune disturbances as well as 
increases feed efficiency for optimal growth and production.  The driving factor for the 
overhaul in feed level antibiotic regulations is the emerging evidence that antibiotic 
administration has negative effects on the hosts’ microbiota, immunity and health, and may 
spread the antibiotic resistance gene to pathogens (Swann et al., 1969, Boyd and Massaut, 
1999, Tollefson et al., 1999, Cross et al., 2007, Ueno et al., 2011).  Antibiotics are broad-
spectrum killers of microorganisms and limit the growth of detrimental microorganisms, as 
well as growth and colonization of nonpathogenic bacteria (Visek, 1978).  There is a very 
complex relationship between diet, intestinal microbiota, their metabolites, and the host 
immune system, and the intrinsic immunomodulation induced by different ingredients in the 
diet (Franklin et al., 1998, Vos et al., 2007, Moschen et al., 2012).   
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Results from the current study further confirm the impacts that diet has on microbial 
diversity and microbial community development in animals.  Changing a portion of the 
protein sources to alternative proteins and the addition of medication to the milk replacer fed 
to calves on this study resulted in differing bacterial community structures.  Calves fed diets 
containing alternative protein sources with or without antibiotics added had improvements in 
their bacterial diversity that could result in better digestion, growth of the animal, and 
immune system enhancements.  Faecalibacterium are part of the Firmicute phylum.  
Firmicute microbes have anti-inflammatory properties, as well as improve gut integrity and 
butyrate production in animals (Foditsch et al., 2015).  The increases in Faecalibacterium 
populations observed in the calves on both treatments containing alternative sources of 
protein could positively impact overall health and growth of the calves.  Calves on the ALT- 
diet had the highest level of Firmicutes in comparison to all other treatments, and had 
improvements in Faecalibacterium populations in the second sample.  
Calves in the treatment group receiving milk replacer that has proteins solely from 
milk sources had improvements in the bacterial community diversity as well, including 
increases in Bifidobacterium populations.  Calves on the same milk replacer with antibiotics 
added to it did not have the same increases in Bifidobacterium.  The feeding of subtheraputic 
levels of antibiotics in the AM+ diet could have led to this difference in Bifidobacterium 
populations.  Nutritional status, good management, and overall health may outweigh the 
benefits associated with subtherapeutic feeding of antibiotics since the benefits of medicated 
milk replacer have not been observed in young calves fed a higher plane of nutrition than 
conventional feeding practices (Witte, 1998, Thames et al., 2012).   
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 In conclusion, all four diets tested in this study resulted in changes to the bacterial 
community diversity of the calves in different manners, although there were no discernable 
differences in health or growth of the calves.  Calves consuming all milk protein diets did not 
have the same improvements in Faecalibacterium that calves on the milk replacer with 
alternative protein sources exhibited.  Calves on the diets containing alternative protein 
sources with or without antibiotics additionally had increases in Bifidobacterium, and calves 
consuming this diet without the addition of antibiotics also had improvements in 
Lactobacillus population levels.  Overall, this trial shows the benefits of non-medicated milk 
replacer in dairy calves and possibly benefits associated with non-milk derived protein 
sources on the microbial community diversity.  Further research is needed to evaluate the 
effects of the microbial diversity changes on long-term health of the dairy calves that were 
observed in this study with the milk replacer containing hydrolyzed wheat and plasma.   
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Table 4.1. Mean initial total serum protein levels of calves by dietary treatment group. 
 Dietary Treatments   
  AM- AM+ ALT- ALT+ SE P-value 
Total Serum Protein g/dl 5.61 5.25 5.51 5.64 0.38 NS 
AM-: Calves in the control treatment group fed an all milk protein milk replacer diet without 
any antibiotic additives (n = 8). 
AM+: Calves in the treatment group fed an all milk protein milk replacer diet with antibiotic 
additives (n = 9). 
ALT-: Calves in the treatment group fed milk replacer with some of the protein content 
coming from non-milk sources without any antibiotic additives (n = 9). 
ALT+: Calves in the treatment group fed milk replacer with some of the protein content 
coming from non-milk sources with antibiotic additives (n = 8). 
 
 
Table 4.2. Mean fecal scores per week by dietary treatment group. 
 Dietary Treatment   
  AM- AM+ ALT- ALT+ SE P-value 
Wk 1 2.93 2.88 2.97 3.03 0.07 NS 
Wk 2 2.29 2.07 2.17 2.21 0.16 NS 
Wk 3 2.00 2.21 2.02 2.00 0.07 0.08 
Wk 4 1.86 1.75 1.84 1.82 0.05 NS 
Wk 5 1.78 1.71 1.73 1.82 0.05 NS 
Wk 6 1.57 1.57 1.52 1.52 0.04 NS 
Wk 7 1.50 1.38 1.50 1.50 0.04 0.11 
AM-: Calves in the control treatment group fed an all milk protein milk replacer diet without 
any antibiotic additives (wk 1 n = 8, wk 2-7 n = 7). 
AM+: Calves in the treatment group fed an all milk protein milk replacer diet with antibiotic 
additives (wk 1 n = 9, wk 2-7 n = 8). 
ALT-: Calves in the treatment group fed milk replacer with some of the protein content 
coming from non-milk sources without any antibiotic additives (wk 1, n = 9, wk 2 n = 9, 
wk3-7 n = 8). 
ALT+: Calves in the treatment group fed milk replacer with some of the protein content 
coming from non-milk sources with antibiotic additives (wk 1-7 n = 8). 
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Table 4.3. Number of calves treated with antibiotics for scours and pneumonia during the 
study by dietary treatment group. 
 Dietary Treatment   
  AM- AM+ ALT- ALT+ SE P-value 
Scours 5 2 4 4 1.52 NS 
Pneumonia 0 1 2 0 0.88 NS 
AM-: Calves in the control treatment group fed an all milk protein milk replacer diet without 
any antibiotic additives (n = 8). 
AM+: Calves in the treatment group fed an all milk protein milk replacer diet with antibiotic 
additives (n = 9). 
ALT-: Calves in the treatment group fed milk replacer with some of the protein content 
coming from non-milk sources without any antibiotic additives (n = 9). 
ALT+: Calves in the treatment group fed milk replacer with some of the protein content 
coming from non-milk sources with antibiotic additives (n = 8).
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Table 4.4. Mean abundance of bacteria percentages from combined data from the 2 sample 
periods by phylum and genus by dietary treatment group.  
 
  Dietary Treatments   
Phylum Overall AM- AM+ ALT- ALT+ SE P-value 
Firmicutes 58 a, b56.61 b53.56 a64.18 a, b57.64 0.14 0.0239 
Bacteroidetes 30 31.44 31.16 26.74 30.55 0.16 NS 
Actinobacteria 7.6 5.44 8.08 5.90 8.56 0.45 NS 
Proteobacteria 2.4 3.93 a1.83 a1.51 a1.33 0.36 0.0320 
Total 98       
Genus        
Unclassified 17.06 16.93 15.00 15.75 12.26 0.20 NS 
Bacteroidetes 12.94 15.43 11.80 10.30 14.90 0.23 NS 
Blautia 11.89 10.86 8.50 16.18 10.12 0.23 0.0663 
Prevotella 10.16 8.04 14.49 8.58 9.32 0.29 NS 
Faecalibacterium 6.01 3.21 4.79 5.23 5.74 0.36 NS 
Total 58.06       
        
Bifidobacterium 1.84 b0.90 b1.18 ab1.72 a2.88 0.50 0.0433 
Lactobacillus 1.03 0.33 0.14 1.34 0.20 1.90 NS 
AM-: Calves in the control treatment group fed an all milk protein milk replacer diet without 
any antibiotic additives (n = 7). 
AM+: Calves in the treatment group fed an all milk protein milk replacer diet with antibiotic 
additives (n = 7). 
ALT-: Calves in the treatment group fed milk replacer with some of the protein content 
coming from non-milk sources without any antibiotic additives (n = 8). 
ALT+: Calves in the treatment group fed milk replacer with some of the protein content 
coming from non-milk sources with antibiotic additives (Sample 1 n = 8, Sample 2 n = 7). 
abWithin a row, means not sharing a common script differ (P < 0.05). 
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Table 4.5. Mean abundance of bacteria percentages by phylum and genus by dietary treatment group per sampling period.  
AM-: Calves in the control treatment group fed an all milk protein milk replacer diet without any antibiotic additives (n = 7). 
AM+: Calves in the treatment group fed an all milk protein milk replacer diet with antibiotic additives (n = 7). 
ALT-: Calves in the treatment group fed milk replacer with some of the protein content coming from non-milk sources without 
any antibiotic additives (n = 8). 
ALT+: Calves in the treatment group fed milk replacer with some of the protein content coming from non-milk sources with 
antibiotic additives (Sample 1 n = 8, Sample 2 n = 7). 
a-dWithin a row, means sharing a common script differ (P < 0.15). 
 
  Mean per Sample Period and by Dietary Treatment Group  P-values 
Phylum AM- 1  AM- 2 AM+ 1 AM+2 ALT-1 ALT-2 ALT+ 1 ALT+ 2 SE a b c d e 
Firmicutes a49.77 a63.2 51.74 c55.37 b57.24 bc70.57 52.83 62.31 0.14 0.0560 0.0379 0.0239   
Bacteroidetes 33.65 29.32 30.07 32.27 30.81 23.03 31.19 29.91 0.16      
Actinobacteria 5.92 4.99 a15.13 a4.16 8.80 3.92 12.40 5.82 0.45 0.0999     
Proteobacteria abc8.35 a1.81 b2.19 1.53 c1.54 1.48 1.96 0.90 0.36 0.0025 0.0040 0.0019   
               
Genus               
Unclassified a25.88 a10.63 b21.57 b10.17 c23.05 c10.45 d25.59 d5.38 0.20 0.0030 0.0137 0.0058 0.0002  
Bacteroidetes 13.61 17.45 9.14 15.12 9.63 11.01 12.25 18.00 0.23      
Blautia a6.50 ac17.60 7.45 bcd9.68 b12.75 bd20.32 7.63 13.31 0.23 0.0180 0.1078 0.0914 0.0298  
Prevotella 10.33 a6.23 12.57 ab16.70 12.46 b5.83 9.69 8.97 0.29 0.0551 0.0378    
Faecalibacterium a1.34 ad7.50 3.49 e6.51 b2.38 b11.12 c2.10 cde14.70 0.36 0.0211 0.0043 0.0008 0.0476 0.0248 
               
               
Bifidobacterium a0.37 ac2.19 0.96 d1.45 1.24 e2.37 b1.67 bcde4.94 0.50 0.0885 0.0739 0.0662 0.0278 0.0739 
Lactobacillus 0.2157 b0.5107 0.088 c0.2292 a0.2352 abcd7.287 0.1570 d0.2670 1.90 0.0917 0.0455 0.1217 0.0652   
1
8
6
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Figure 4.1. Mean weights in kilograms of calves by dietary treatment group at d 1, d 42, and 
total weight gains (least squares mean ± standard error of the mean). 
 
AM-: Calves in the control treatment group fed an all milk protein milk replacer diet without 
any antibiotic additives (n = 7). 
AM+: Calves in the treatment group fed an all milk protein milk replacer diet with antibiotic 
additives (n = 8). 
ALT-: Calves in the treatment group fed milk replacer with some of the protein content 
coming from non-milk sources without any antibiotic additives (n = 8). 
ALT+: Calves in the treatment group fed milk replacer with some of the protein content 
coming from non-milk sources with antibiotic additives (n = 8). 
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Figure 4.2. A stacked bar graph showing the overall abundance of phyla between individual 
samples that are clustered by dietary treatment group and by sampling period. 
 
AM-: Calves in the control treatment group fed an all milk protein milk replacer diet without 
any antibiotic additives (n = 7). 
AM+: Calves in the treatment group fed an all milk protein milk replacer diet with antibiotic 
additives (n = 7). 
ALT-: Calves in the treatment group fed milk replacer with some of the protein content 
coming from non-milk sources without any antibiotic additives (n = 8). 
ALT+: Calves in the treatment group fed milk replacer with some of the protein content 
coming from non-milk sources with antibiotic additives (Sample 1 n = 8, Sample 2 n = 7). 
 
 
 
 
     Sample1 Sample2    Sample1 Sample2     Sample1   Sample2      Sample1   Sample2 
                AM+                    AM-                   ALT-                        ALT+ 
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Figure 4.3. A stacked bar graph showing the overall abundance of genus between individual 
samples that are clustered by dietary treatment group and by sampling period. 
 
AM-: Calves in the control treatment group fed an all milk protein milk replacer diet without 
any antibiotic additives (n = 7). 
AM+: Calves in the treatment group fed an all milk protein milk replacer diet with antibiotic 
additives (n = 7). 
ALT-: Calves in the treatment group fed milk replacer with some of the protein content 
coming from non-milk sources without any antibiotic additives (n = 8). 
ALT+: Calves in the treatment group fed milk replacer with some of the protein content 
coming from non-milk sources with antibiotic additives (Sample 1 n = 8, Sample 2 n = 7). 
 
  
       Sample1   Sample2   Sample1 Sample2    Sample1   Sample2       Sample1   Sample2 
                   AM+                   AM-            ALT-                ALT+ 
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Figure 4.4. PCoA plot visualizing the variation among samples between dietary treatment 
groups. The closer the points are to one another, the more similar they are. 
 
AM-: Calves in the control treatment group fed an all milk protein milk replacer diet without 
any antibiotic additives (n = 7). 
AM+: Calves in the treatment group fed an all milk protein milk replacer diet with antibiotic 
additives (n = 7). 
ALT-: Calves in the treatment group fed milk replacer with some of the protein content 
coming from non-milk sources without any antibiotic additives (n = 8). 
ALT+: Calves in the treatment group fed milk replacer with some of the protein content 
coming from non-milk sources with antibiotic additives (Sample 1 n = 8, Sample 2 n = 7). 
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Figure 4.5. PCoA plot visualizing the variation among samples between sample periods. The 
closer the points are to one another, the more similar they are. 
 
Sample 1: Bacterial communities from combined sample data for the d 7 sampling period (n 
= 30).  
Sample 2: Bacterial communities from combined sample data for the d 42 sampling period (n 
= 29).   
Sample 1 
Sample 2 
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Figure 4.6. NMDS plot visualizing the similarities among bacterial communities between 
dietary treatment groups. The closer the points are to one another, the more similar they are. 
 
AM-: Calves in the control treatment group fed an all milk protein milk replacer diet without 
any antibiotic additives (n = 7). 
AM+: Calves in the treatment group fed an all milk protein milk replacer diet with antibiotic 
additives (n = 7). 
ALT-: Calves in the treatment group fed milk replacer with some of the protein content 
coming from non-milk sources without any antibiotic additives (n = 8). 
ALT+: Calves in the treatment group fed milk replacer with some of the protein content 
coming from non-milk sources with antibiotic additives (Sample 1 n = 8, Sample 2 n = 7). 
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Figure 4.7. NMDS plot visualizing the similarities among bacterial communities between 
sampling periods. The closer the points are to one another, the more similar they are. 
 
Sample 1: Bacterial communities from combined sample data for the d 7 sampling period (n 
= 30).  
Sample 2: Bacterial communities from combined sample data for the d 42 sampling period (n 
= 29). 
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CHAPTER 5 
GENERAL CONCLUSIONS 
 The research studies summarized represent part of a continuing endeavor to better 
understand the interactions between the host and the commensal microbiota, as well as ways 
to affect the bacterial community diversity in a way that improves the health and growth of 
the animal.  It also represents a continuing effort to better comprehend bioactive feedstuffs 
and their effects on animals at different ages.   
 This represents a stepping stone to finding non-antibiotic alternatives that can 
positively affect calf health and growth.  Many feed additives have non-nutritive benefits that 
have the potential to improve the immune function of calves.  By improving the growth and 
immune function of the calves early on in life, their health later in life and production will 
also be improved.  
 Regulations for the use of antibiotics will continue to move towards minimal use of 
antibiotics, making the need for non-antibiotic alternatives that help regulate immunity and 
growth very important.  The overall objective of these two research studies was to observe 
the effects of changes in diets including antibiotics, prebiotics, and alternative proteins on 
calf growth, performance, immune function, and microbial community diversity populations.  
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